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Abstract  
Background: Numerous treatments for Spontaneous Osteonecrosis of the Knee (SONK) 
have been described, but there is little guidance regarding which joint-preserving 
treatments to use for different disease stages.   
 
Aims: To assess the effectiveness and appropriateness of non-operative and operative 
joint-preserving treatments for SONK as a whole, as well as for different disease stages. 
Methodology: A systematic review with narrative synthesis of four bibliographic databases 
was undertaken to identify studies evaluating the effectiveness (clinical, radiological 
outcomes and failure rates) of joint-preserving treatment for SONK. The findings of the 
review were then used to inform a 2-round Delphi study involving an international expert 
panel to establish consensus on preferred first and second-line treatments for different 
disease stages.  
Results: Twenty eligible studies were identified: 8 described non-operative measures and 
14 surgical interventions (2 studies described several treatments). One study was a 
randomised controlled trial evaluating foot orthoses, which proved more effective than 
usual treatment with analgesia and physiotherapy. Supportive treatment with analgesia and 
restricted weight bearing, bisphosphonates and most other joint-preserving surgical 
interventions had promising results from small case series. 
Nineteen experts contributed to the first round of the Delphi study and 14 to the second 
round.  Consensus was achieved for 3 months of rest and analgesia as first-line treatment 
in early and intermediate-stage disease, without consensus on the most appropriate 
second-line treatment. For late-stage disease, consensus was not reached for first-line 
treatment although 50% agreed against joint-preserving therap. For second-line treatment, 
78.6% would use arthroplasty.  
Conclusions: Rest and analgesia with or without restricted weight-bearing appears to be 
an appropriate, and often effective first-line treatment for early or intermediate-stage 
disease. Arthroplasty, rather than joint-preserving therapy is the most commonly utilised 
treatment for late-stage disease. However, existing research is limited, and higher-level 
evidence is required before being able to definitively state which joint-preserving treatments 
are most effective for SONK of different stages.  
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1. CHAPTER ONE: INTRODUCTION 
This chapter provides an overview of the anatomy of the knee and the resulting 
pathological processes that can occur in the joint resulting in disease, with a specific 
focus on spontaneous osteonecrosis. The proposed theories regarding underlying 
pathophysiology as well as the differing features and clinical findings in comparison to 
other similar disease processes occurring around the knee joint will be discussed, 
followed by a brief overview of the existing treatment modalities used in current 
practice.  
1.1. Anatomy of the Knee 
 
The knee is the largest and most superficial synovial joint in the body and is made up 
of three articulations; two femorotibial articulations between the lateral and medial 
femoral and tibial condyles, and one patellofemoral articulation between the femur and 
patella. (Moore & Dalley, 2006).  
The knee has an extensive arterial blood supply, derived primarily from five main 
branches of the popliteal artery. The superior medial and lateral, the middle (posterior), 
and the inferior medial and lateral genicular arteries form a rich anastomosis to supply 
the knee joint (figure 1.1), (Shim & Leung, 1986). The highly vascular structure of the 
knee is involved in all aspects of growth, repair and metabolism (Brandi & Collin-
Osdoby, 2006). There is increasing evidence to suggest that abnormalities in blood 
supply around the knee can be directly related to either the initiation or progression of 
numerous disease processes and has been implicated in the development of both 
osteoarthritis and osteonecrosis (Findlay, 2007). 
1.2. Spontaneous Osteonecrosis  
 
Spontaneous osteonecrosis of the knee (SONK) was first described as a clinical entity 
in 1968 by Ahlbäck et al. It is a condition characterised by bone necrosis, with 
subchondral fracture, subsequent segmental collapse and arthrosis (Ahlbäck, et al., 
1968). SONK usually presents with acute onset of severe pain localised to the medial 
side of the knee, with the absence of any risk factors associated with osteonecrosis 
such as steroid use, alcohol excess or associated autoimmune diseases (Ahlbäck, et 
al., 1968; Karim, et al., 2015). The knee is the second most common site to be affected 
by spontaneous osteonecrosis, after the hip, and constitutes 10% of all cases (Mont, et 
al., 1997; Mont, et al., 2000). The medial femoral condyle is by far the most commonly 
affected area in the knee, being involved in up to 94% of cases (Al-Rowaih, et al., 
2 
 
1993); SONK can also involve the tibial plateau and patella (Ecker & Lotke, 1994; 
Lotke, et al., 2004; Pollack, et al., 1987). 
 
Figure 1-1: Genicular anastomosis, providing blood supply to the knee joint (Moore KL, 2009) 
Permission granted for reproduction from publisher Wolters Kluwer (appendix 11). 
 
1.3. Aetiology 
 
The aetiology of SONK is still not fully understood and several differing views on the 
pathogenesis have been proposed. One theory is that a raised intra-osseous pressure 
secondary to local inflammation or vascular insufficiency from impaired microcirculation 
leads to ischaemia and eventual osteonecrosis. The evidence for this theory is limited 
to a small number of studies (Aglietti, et al., 1983; Ecker & Lotke, 1994; Karim, et al., 
2015; Marcacci, et al., 2016). A cadaveric study of twelve knees demonstrated that the 
medial femoral condyle had a limited blood supply, compared to the extensive intra and 
extra-osseous blood supply of the lateral femoral condyle (Reddy & Frederick, 1998). 
This further supports the link between vascular insufficiency and SONK, given the 
increased incidence of disease in the medial compared to the lateral femoral condyle 
(Al-Rowaih, et al., 1993).  
A mechanical or traumatic theory has also been proposed, suggesting a connection 
between subchondral insufficiency fractures and the onset of SONK (Marcacci, et al., 
2016; Yamamoto & Bullough, 2000).  Subchondral insufficiency fractures are 
atraumatic fractures, often occurring in overweight, elderly patients with osteoporosis. If 
such fractures occur and fail to heal, repetitive micromotion can lead to infiltration of 
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synovial fluid, with subsequent detachment and fragmentation of an osteochondral 
fragment, leading to necrotic changes in this disconnected area (Marcacci, et al., 
2016).  This theory was initially described by Lotke et al (1977) and has since been 
supported by further studies, including those evaluating magnetic resonance imaging 
(MRI) and histopathological findings (Hall, 2005; Muscolo, et al., 2006; Nakamura, et 
al., 2002; Norman & Baker, 1978; Takeda, et al., 2008). In addition to osteoporosis, the 
development of such subchondral fractures has also been related to abnormal loading 
across the knee joint secondary to meniscal injury, malalignment or underlying 
degenerative changes (Robertson, et al., 2009).  
The definitive pathogenesis of SONK, however, remains debated and may indeed be 
multi-factorial in nature, evolving from a combination of underlying pathological 
abnormalities described in these theories.  
 
1.4. Clinical Presentation 
SONK is a relatively uncommon disease, most frequently occurring in middle-aged to 
elderly patients. It affects females up to three times more often than males (Aglietti, et 
al., 1983; Ahlbäck, et al., 1968; Karim, et al., 2015; Rozing, et al., 1980). There is 
limited epidemiological data published regarding the incidence and prevalence of 
SONK; one study described an incidence of 3.4% in patients under 50 years old, rising 
to 9.4% in those over 65 (Pape, et al., 2002).  
 
The condition frequently presents with acute onset of severe pain, often localised to the 
affected area, usually without history of trauma (Karim, et al., 2015). Patients often 
complain of increased pain on weight-bearing, along with persistent rest pain (Forst, et 
al., 1998). Examination of the knee may reveal evidence of an effusion with localised 
tenderness over the affected area, usually the medial femoral condyle (Karim, et al., 
2015; Lotke P A, 1982). During the initial, acute stages of disease, patients may have a 
restricted range of motion compared to the normal knee. In more long-standing cases, 
a fixed flexion deformity may occur (Patel, et al., 1998). 
1.5. Diagnosis 
The diagnosis of SONK can often be made based on clinical history and radiographic 
changes alone. However, plain radiographs are often normal in the first stages of the 
disease. Further magnetic resonance imaging (MRI) may be needed (Zywiel, et al., 
2009), which can detect early subtle changes in the bone marrow as early as 72 hours 
after symptom onset (Yates, et al., 2007).  It can provide more detailed information on 
the degree and distribution of bone marrow involvement and the presence of cartilage 
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damage due to bone collapse, which relates to prognosis (Fotiadou & Karantanas, 
2009; Yates, et al., 2007). MRI has greatly improved early diagnosis of the disease, 
and is the imaging modality of choice for diagnosis, staging and disease monitoring 
(Dogan, et al., 2012; Lotke, et al., 2000; Yates, et al., 2007).  
 
1.6. Differential Diagnosis  
Osteonecrosis of the knee can be broadly divided into four groups: spontaneous 
osteonecrosis of the knee (SONK, also described as primary osteonecrosis), 
secondary osteonecrosis (also called idiopathic, ischaemic or atraumatic 
osteonecrosis), post-arthroscopic and post-traumatic osteonecrosis (Mont, et al., 2000; 
Zywiel, et al., 2009). SONK is the most common type of osteonecrosis and affects an 
older age group (Pape, et al., 2002), in comparison to secondary osteonecrosis, which 
is associated with other underlying medical problems or medication. Alcohol, steroid 
use, sickle cell disease, myeloproliferative disorders and renal disease have all been 
implicated in the development of secondary osteonecrosis (Karim, et al., 2015). Post-
arthroscopic osteonecrosis is thought to be the rarest form, with an onset following 
arthroscopic knee surgery, more specifically, after meniscectomy (Cetik, et al., 2009; 
Karim, et al., 2015). In post-traumatic osteonecrosis, as the name suggests, there is a 
history of trauma or surgery preceding symptom onset, leading to bone death, usually 
in an isolated area of the knee (Mont, et al., 2000).  
 
In addition to the different forms of osteonecrosis, there are other intra-articular 
pathologies of the knee to be considered when diagnosing SONK: osteochondritis 
dissecans, transient osteoporosis and traumatic bone marrow lesions must be ruled out 
as they often share common clinical and pathological findings (Mont, et al., 2000).  It 
can sometimes be difficult to differentiate these conditions from the history and clinical 
examination alone and radiological findings can also be misleadingly similar. Certain 
characteristics, such as the age of the patient, location of the lesion, clinical symptoms, 
histology, general lack of intra-articular loose bodies and relatively delayed appearance 
of changes on plain radiographs may help to differentiate SONK from other conditions 
(Marcacci, et al., 2016).  
 
Osteochondritis dissecans (OD) is a condition affecting articular cartilage and 
subchondral bone. It results in varying pathological abnormalities, beginning with 
softening of the articular cartilage, early cartilage separation and partial or, in some 
cases, complete separation of an osteochondral fragment (Pape, et al., 2010). It affects 
the posterolateral aspect of the medial femoral condyle in most cases. OD often affects 
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adolescents and young adults, whereas SONK is most common in middle-aged and 
elderly patients (Williams, et al., 1998).  
 
Transient osteoporosis is another differential diagnosis. It is an uncommon, usually 
self-limiting syndrome of unknown aetiology, characterised by joint pain and osteopenia 
(Sastre, et al., 2007). Unlike SONK, it is more commonly located in the lateral femoral 
condyle and gives a characteristic appearance of focal osteopenia within eight weeks 
of symptom onset (Crespo, et al., 2001; Hayes, et al., 1993).  
 
Lesions and bone marrow oedema following trauma also sometimes need to be 
considered as a possible diagnosis; this can either be associated with acute trauma, or 
with more subacute injuries related to overload, such as stress fractures (Roemer, et 
al., 2009).   
 
Specific features on imaging can be used as an aid to diagnose SONK. One of the 
most important differences between early SONK and bone marrow oedema (as seen 
with transient osteoporosis or trauma) is the presence of a focal subchondral lesion on 
MRI (Björkengren, et al., 1990; Lecouvet, et al., 1998). The focal nature of the lesion in 
early stage SONK suggests that a pathological process is taking place at this site, 
rather than a more diffuse disease process throughout the femoral condyle, as seen in 
bone marrow oedema related to transient osteoporosis or trauma (Yates, et al., 2007). 
The location of the disease also helps to differentiate between conditions; the lateral 
femoral condyle is the most commonly affected site in transient osteoporosis, the 
lateral side of the medial femoral condyle is commonly affected in OD, whereas the 
medial aspect of the femoral condyle and the tibial plateau are most commonly 
involved in SONK (Mont, et al., 2000). Contour flattening is also seen more often in 
SONK. (Gil, et al., 2006). A comparison of SONK and other conditions to be considered 
in the differential diagnosis are summarised in table 1.1. 
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 Spontaneous 
Osteonecrosis 
Osteochondritis 
dissecans 
Transient 
osteoporosis 
Secondary 
osteonecrosis  
Patient age 
group 
>55 years Young-middle 
age 
Young-middle 
age 
<55 years 
Associated 
co-
morbidities  
None  None  None  Corticosteroid 
use, renal 
disease, alcohol 
excess 
Other joint 
involvement  
Rare  Uncommon Common (in a 
migratory 
pattern) 
60-90% 
Condylar 
involvement 
Usually medial side 
of medial femoral 
condyle)  
Posterolateral 
aspect of medial 
femoral condyle 
in 70% 
Usually lateral 
femoral condyle 
Multiple  
Laterality  99% unilateral  Bilateral in ~30% Usually unilateral >80% bilateral  
Clinical 
features 
Usually sudden 
onset of severe pain  
Insidious onset. 
Prior knee 
trauma in 40% 
Progressive 
mechanical pain  
Usually insidious 
onset of pain  
Radiological 
features 
Dependent on 
stage, see table 1.2 
Well 
circumscribed 
area of 
subchondral 
bone separated 
from femoral 
condyle by 
crescent shaped 
radiolucent line.  
Diffuse 
osteopenia, 
preservation of 
joint space. 
Absence of 
necrosis on MRI 
Lesions much 
larger and area of 
osteonecrosis 
more diffuse than 
in SONK  
Table 1.1: A comparison of SONK and similar pathologies affecting the knee. 
Information adapted from: Clanton & DeLee, 1982; Mont et al, 2000; Soucacos, et al, 1997 
 
1.7 Staging of Disease  
Koshino et al (1982) described a four-tiered radiological classification of SONK based 
on plain radiographic appearances, which was later modified by Aglietti et al (1983) to 
include a fifth stage of disease, describing the appearance of degenerative changes of 
the knee (table 1.2, figure 1.2). This is the classification system still widely in use to 
stage SONK.  
In stage 1 disease, also described as the incipient stage, patients usually describe 
significant knee pain which can last for several weeks. Plain radiographs are usually 
normal. After a variable period, the pain may spontaneously resolve, and patients 
become asymptomatic, or the disease may progress to subsequent stages (Koshino, 
1982). 
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Stage  Radiographic changes  
1 No changes on plain radiographs 
2 Flattening of the weight bearing portion of the femoral condyle  
3 Flattening of the femoral condyle with sclerotic halo around area of disease  
4  Sclerotic ring becomes more defined, with associated subchondral collapse 
5 Narrowing of the joint space, osteophyte formation ± tibial subchondral sclerosis 
Table 1.2: Stages of SONK as described by Koshino (1982) & later modified by Aglietti (1983). 
 
 
Figure 1-2: Original illustrations of medial femoral condyles with Koshino stage 2, 3 and 4 SONK as 
they would appear on radiographs (Koshino, 1982). Permission granted for reproduction from Wolters 
Kluwer (appendix 11).  
 
Stage 2 disease is characterised by the appearance of flattening of the medial femoral 
condyle on plain radiographs, with MRI scanning being able to provide further 
information regarding the overall size of the area of osteonecrosis (Soucacos, et al., 
2004).  
The onset of stage 3 disease is defined by the appearance of a sclerotic ring on plain 
radiographs. This lesion represents segmental necrosis of the subchondral bone with 
detachment of the overlying articular cartilage (Soucacos, et al., 2004).  
Further sclerosis along with articular cartilage destruction and subchondral collapse 
represents the progression to stage 4 disease, which may extend across the width of 
the femoral condyle resulting in loss of joint congruity and articular collapse. This may 
lead to significant malalignment of the knee (Soucacos, et al., 2004).  
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Patients with stage 5 disease demonstrate characteristic features of degenerative 
disease of the joint. Plain radiographs show narrowed joint space, osteophyte 
formation with subchondral sclerosis in some cases (Aglietti, et al., 1983).  
For cases of SONK which have progressed to degenerative changes, the arthritis 
grading systems, described by Ahlbäck (1968) or Ficat and Arlet (1980) can also be 
used to grade the severity of disease (table 1.3). 
Stage  Ahlbäck classification Ficat & Arlet classification  
0 No signs of arthrosis   
I Diminished joint space Knees with normal appearance  
II Obliteration of joint space  Cystic or sclerotic lesions, or both. 
Normal joint contour, no subchondral 
fractures  
III Erosion <5mm  Crescent sign & subchondral collapse 
IV Erosion between 5-10mm Reduced joint space, subchondral cysts 
and osteophytes 
V Erosion >10mm and lateral 
subluxation  
 
Table 1.3: Classification systems used to describe degenerative changes associated with SONK 
(Ahlbäck, et al., 1968; Ficat & Arlet, 1980).  
 
1.8 Natural History and Prognosis 
The clinical course of SONK is variable. Some cases spontaneously resolve after a 
period of rest, analgesia and physiotherapy, whereas others can rapidly progress to 
joint collapse and subsequent osteoarthritis (Nelson, et al., 2014). This is largely 
dependent on the stage of disease at presentation, with earlier-disease being more 
likely to resolve spontaneously (Al-Rowaih, et al., 1993; Mont, et al., 2000). Prognosis 
has also been linked to the size of the lesion, measured by taking the largest width in 
the antero-posterior radiograph and the largest length in the lateral radiograph (Lotke & 
Ecker, 1988). It is thought that small lesions measuring less than 3.5 centimetres 
squared will typically resolve; intermediate sized lesions (3.5 to 5 cm2) are less 
predictable and may or may not progress, whereas large lesions involving more than 
5cm2  of the femoral condyle are more likely to progress to severe disease with 
condylar collapse, subsequent knee malalignment and secondary arthritis (Muheim & 
Bohne, 1970; Soucacos, et al., 2004).  A second prognostic indicator has been 
described, using the ratio of the width of the lesion to the width of the affected femoral 
condyle; if this is more than 40%, patients will often have a poorer outcome, requiring 
surgical intervention (Ahuja & Bullough, 1978). 
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1.9 Treatment 
Several treatment modalities have been described for SONK, depending on the site, 
size and progression of osteonecrosis. They represent a wide spectrum, varying from 
non-operative measures to joint-preserving and joint replacement surgery. For the 
purposes of this thesis, the term ‘joint-preserving treatment’ will be used to describe 
any treatment not involving arthroplasty, both non-operative and operative measures. 
Regardless of treatment type, the overall aim is to provide a pain-free, mobile knee with 
good function (Pape, et al., 2010; Patel, et al., 1998). 
1.9.1 Non-operative, joint-preserving interventions  
Several non-operative treatments have been described for small, early lesions, not 
affecting the contour of the joint. (Karim, et al., 2015; Mont, et al., 2000). Measures 
include a combination of symptomatic control with non-steroidal anti-inflammatory 
medication with or without restriction in weight-bearing. Physiotherapy is also used to 
strengthen quadriceps, hamstrings and modify forces across the knee (Strauss, et al., 
2011).  
 
Medical therapy with bisphosphonates has also been described. Bisphosphonates 
inhibit bone resorption and are already widely used for various metabolic bone 
diseases (Russell, 2006).  In osteonecrosis, structural defects and failure are thought to 
result from resorption of the necrotic area of bone during the period of 
revascularisation, before new bone is formed (Yamamoto & Bullough, 2000). It has 
been proposed that reducing bone resorption with the use of bisphosphonates during 
the phase of revascularisation may decrease the incidence of structural failure and joint 
collapse associated with SONK (Kraenzlin, et al., 2010). 
  
1.9.2 Surgical options for joint preservation  
Varying indications for progression from non-operative measures to surgical 
management have been described, including persistent severe pain, a large lesion, 
collapse of the femoral condyle and the presence of varus deformity of the knee (Patel, 
et al., 1998). Surgery aims to provide symptomatic relief and halt disease progression 
to avoid joint collapse and secondary arthritis (Karim, et al., 2015). 
Numerous joint-preserving surgical treatments have been described, including 
arthroscopy with drilling, perforation and decompression of the lesion; resurfacing the 
lesion either with microfracture or transplant techniques and high-tibial osteotomy with 
or without bone grafting (Flynn, et al., 1994; Karim, et al., 2015; Mont, et al., 1997; 
Mont, et al., 2000).  
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1.9.2.1 Core Decompression/Drilling of the lesion  
Core decompression or drilling of the area of osteonecrosis aims to relieve the 
increased pressure within the lesion, which is thought to contribute to the local 
ischaemia (Mont, et al., 1997). It is also thought that this technique will provide a 
vascular channel into the area of osteonecrosis to promote healing (Zywiel, et al., 
2009). 
1.9.2.2 Biological Resurfacing: Microfracture  
Arthroscopic microfracture of the subchondral bone is a bone-marrow stimulation 
technique, which was initially developed for the treatment of chondral defects but has 
since been used in small studies for SONK (Steadman, et al., 2001). This technique 
involves making small intra-articular holes through the affected area of the joint under 
direct vision using an arthroscope; the underlying bone marrow brings blood and 
associated factors into the area of the defect to promote healing (Zywiel, et al., 2009). 
1.9.2.3 Biological Resurfacing: Transplant  
Osteochondral transplantation into knee defects has also been described; this is 
commonly known as OATS (osteochondral autograft transfer system). This technique 
provides autologous hyaline cartilage to resurfacing the defect within the knee and 
reconstruct the joint surface using a graft with similar biomechanical properties 
(Karataglis, et al., 2006). A graft consisting of articular cartilage and subchondral bone 
is harvested from a non-weight bearing portion of the knee, usually the lateral or medial 
edge of the trochlea, or notch and transplanted to fill the defect (Zywiel, et al., 2009).  
 
1.9.2.4 Unloading Techniques 
High tibial osteotomy is a procedure used to offload to affected knee compartment and 
is often used in the setting of varus or valgus deformity, to realign the knee and 
redistribute the forces across the joint (Preston, et al., 2005). This technique aims to 
provide pain relief, while preserving the knee joint itself (Saito, et al., 2014). A wedge of 
bone is either removed from the proximal tibia, or an opening cut is made, depending 
on the deformity to offload the affected area and realign the knee. This procedure can 
be performed alone, or with the addition of intra-articular procedures described above 
(Koshino, 1982). 
1.9.3 Summary of Treatments 
There are multiple treatment options available depending on the site, size and 
progression of osteonecrosis; they represent a wide spectrum, varying from both non-
operative and operative joint-preserving measures, to joint replacement surgery. The 
multitude of treatments available can make it difficult to decide which treatment options 
to use and when. There is some evidence in the literature describing indications and 
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outcomes for patients with severe SONK and joint collapse requiring total knee 
arthroplasty (Bergman & Rand, 1991; Mont M, 2002; Radke, et al., 2005). The difficulty 
lies with the group of patients who have significant symptoms but do not warrant total 
knee arthroplasty; there is no consensus or established evidence-base regarding which 
the most effective joint-preserving treatment is to use in such cases, or 
recommendations for treatment depending on specific disease stage. 
Although there are many potential treatment modalities described in the literature’ with 
the publication of some treatment algorithms (Karim, et al., 2015; Mont, et al., 2000; 
Zywiel, et al., 2009), a review undertaken at the onset of this study of the British and 
American Orthopaedic Associations as well as the National Institute for Health and 
Care Excellence did not reveal any evidence-based guidelines for the treatment of 
SONK (AAOS, 2015; BOA, 2015; NICE, 2015). 
 
Clinical practice guidelines exist to provide advice on treatment for clinicians, as well as 
improve care and outcomes for patients with specific conditions (Woolf, et al., 1999). 
Usually, the initial stages in guideline development involves analysis of existing 
relevant systematic reviews, or a new systematic review is undertaken if none already 
exist (Woolf, et al., 2012). At the time of writing, no systematic reviews or consensus 
studies evaluating both operative and non-operative joint-preserving treatments for 
SONK were found on a search of the literature. This thesis has therefore set out to 
identify existing treatments and the evidence to support them using a systematic 
review, followed by a consensus study to provide further information on which 
treatments are most suitable for different stages of disease. The thesis then evaluates 
the findings of these studies in and considers the implications for clinical practice and 
further research.  
1.10 Thesis Aims & Objectives 
 
The aim of this thesis was to evaluate both non-operative and operative joint-
preserving treatments for Spontaneous Osteonecrosis of the Knee, to guide clinicians, 
who may only treat a small number of cases of SONK in making a more informed, 
evidence-based decision on which treatment is best for their patient.  
The objectives of the thesis are as follows:  
Research Objective 1 
To evaluate the indications and effectiveness of both non-operative and operative 
treatments for SONK, through assessment of clinical and radiological outcomes.  
12 
 
Research Objective 2 
To assess complications and failure rates of joint-preserving treatments, particularly the 
need for patients to undergo further procedures or joint arthroplasty during the follow-
up period. 
Research Objective 3 
To evaluate existing evidence for the effectiveness of different treatment modalities, 
both surgical and non-surgical according to severity of disease and establish whether 
certain treatments are more commonly utilised for specific disease stages.   
Two studies were conducted to achieve these research objectives; a systematic review 
and Delphi study. The combined results of these will be used, where possible, to make 
recommendations for management and assess the value of future research into the 
treatment of SONK. 
 
1.11 Outline of the Thesis 
This thesis contains four chapters, of which this introduction is the first. Chapter two 
presents the aims, methodology and results of the systematic review evaluating the 
effectiveness of joint-preserving treatments for SONK. A discussion of the findings, 
implications and recommendations for future research then follows.  Chapter three 
gives the Delphi consensus study and includes aims, objectives, and justification for 
this choice of methodology, results and discussion.  Chapter four gives a summary of 
the overall findings of the thesis and presents the overall conclusions.  
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2 CHAPTER TWO: SYSTEMATIC REVIEW OF JOINT-PRESERVING 
TREATMENTS FOR SPONTANEOUS OSTEONECROSIS OF THE 
KNEE  
 
Chapter one gave an overview of the underlying pathology of SONK, the diagnosis, 
staging and potential treatments. It has highlighted that, despite numerous joint-
preserving treatments being available, there are currently no clear management 
pathways or guidelines about which treatment to use when.  Before beginning to 
develop guidelines, it is necessary to review existing evidence for the treatments used 
for SONK and evaluate their efficacy for different stages of disease.  In this chapter, the 
methods and findings of a systematic review of both operative and non-operative joint-
preserving treatments for the treatment of SONK are presented. There is then a 
discussion regarding the findings of the review, as well as the strengths and 
weaknesses of the review process, implications and recommendations for future 
research.  
2.1 Aims and Objectives 
The systematic review set out to assess the level of existing evidence for joint 
preserving treatments (both surgical and non-surgical) of SONK. The systematic review 
objectives are as follows:  
1. To identify which joint-preserving treatments for SONK have been evaluated in 
the literature. 
2. To assess the effectiveness of different non-operative treatments for SONK in 
improving clinical and radiological outcomes and reducing the need for operative 
intervention.  
3. To evaluate the effect of joint-preserving surgery on clinical and radiological 
outcomes. 
4. To review complication and failure rates of both non-operative and operative 
treatments.  
5. To assess the efficacy of treatments according to disease stage.  
 
2.2 Methods  
2.2.1 Study Design   
The study design was a systematic review; this was chosen over other techniques as 
the most appropriate method to gather such information. Using pre-defined inclusion 
criteria reduces the risk of selection bias and individual assessment of included 
research ensures correct weighting is applied to the most valid research, therefore 
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producing more reliable findings to inform decision-making (Higgins & Green, 2011; 
Katikireddi, et al., 2015).   
2.2.2 Eligibility Criteria 
Condition  
Ahlbäck’s (1968) definition of SONK, described in section 1.2, was used to identify 
studies, as this is the most well-known description used in the literature. Descriptions of 
SONK were analysed in each study to ensure that they were in line with the recognised 
definition. Studies describing a combination of SONK and post-arthroscopy 
osteonecrosis of the knee were included as the underlying pathological process, lesion 
size, location and affected patient population are somewhat similar (Strauss, et al., 
2011). Studies with a mixed population, for example, those describing a specific 
treatment for patients with both spontaneous and secondary osteonecrosis, were only 
included if it was possible to differentiate the outcomes of the two groups in the results.  
 
Studies solely describing patients with secondary osteonecrosis of the knee were 
excluded given the differing underlying pathological process, patient population and 
lesion characteristics (table 1.1).  
Types of Participants 
All studies with adult patients (over 18 years of age) with SONK were included with no 
gender or age restrictions. Studies describing patients with all or any of the disease 
stages as defined by Koshino (table 1.2, section 1.7), Ficat and Arlet (1980) or Ahlbäck 
(1968) (table 1.3, section 1.7) were eligible for inclusion. 
Types of interventions 
Studies describing non-operative treatments for SONK, such as lifestyle or activity 
modification, the use of insoles, physiotherapy, simple analgesia and medical treatment 
with bisphosphonates were included. Joint-preserving surgical treatments were 
included for review. This includes, but was not limited to, arthroscopic microfracture, 
core decompression and drilling, grafting of the lesion (OATS) and offloading 
procedures, specifically, high tibial osteotomy.  
Studies on joint-sacrificing surgery (knee arthroplasty, both uni-compartmental and 
total knee replacement) were excluded. Studies focusing on alternative and 
complementary therapies were also excluded, as these are not commonly considered 
in routine clinical practice. 
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Comparators  
Both studies with comparators and those without were eligible for inclusion in the study, 
as it was anticipated, from the literature review in the previous chapter, that there would 
be relatively few comparative studies available.  
Research comparing arthroplasty with joint-preserving surgical measures was included, 
provided the outcomes of the groups were differentiated. In these situations, only the 
outcomes of the patients undergoing joint-preserving surgery were included. Research 
comparing non-operative and operative joint-preserving treatments for SONK were 
sought, along with comparison between different surgical or non-surgical treatments.  
Studies with arms comparing treatment with placebo or no intervention were also 
included.  
Types of Outcomes  
Clinical outcomes were assessed by either improvement or resolution in symptoms or 
change in function. This was quantified using pre- and post-operative scoring systems 
assessing pain, functional outcomes and quality of life, either through generic quality-
of-life scores, for example, EQ5D (Brooks, 1996), or more specific tools for the knee, 
for example, the Oxford Knee score (Dawson, et al., 1998).  No specific scoring 
systems were sought, as it was anticipated from the outset that numerous tools would 
be used, which is often dependent on the country in which the research took place. The 
focus was on improvement in overall patient and clinical parameters, rather than the 
type of scoring system used.  
Radiological outcomes were recorded; changes in plain radiographs or MRI images 
before and after interventions were assessed. Any change in the radiological grading of 
severity of disease, using the different staging classifications (tables 1.2 and 1.3), or 
change in the size of the osteonecrotic lesion were of interest (Lotke P A, 1982). 
Failure was defined as the need for additional intervention following the described 
treatment. This was further separated into additional joint-preserving surgical 
intervention, or knee arthroplasty. Other complications were also recorded.  
2.2.3 Follow-up  
There was no exclusion based on duration of follow-up of the patient cohort.  For 
publications involving the same patient group, but describing different durations of 
follow-up, the outcomes of each study were reviewed. If these were the same, data 
from the paper with the longer follow-up time was included. 
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2.2.4 Types of Studies  
Randomised controlled trials were the main focus for inclusion, as these often provide 
the highest levels of evidence. However, it was anticipated from the outset that few (if 
any) of these would be available. Comparative methods, such as cohort studies and 
case-control studies, and non-comparative studies, were therefore also sought.  Case 
series, whether data was collected prospectively or retrospectively, were only included 
if they described more than five patients for each intervention, as smaller series would 
be of limited value.  
2.2.5 Types of Reports  
Articles from peer-reviewed journals were considered; abstracts from conference 
presentations were excluded, as were PhD theses. Only studies with full texts 
published in English were included, as resources were not available to accurately 
translate medical literature to English within reasonable time and costs.  
For publications describing different population sizes of the same study, the outcomes 
of each study were reviewed. If these were the same, data from the paper with the 
larger population was included. If different outcomes were described, the study 
information would be collated together and included. 
2.3 Search Strategy  
The following databases were searched: MEDLINE (OVID); Embase (OVID); Cochrane 
Library (including CENTRAL, DARE and HTA) and AMED. These databases were 
chosen as they specifically include orthopaedic and related fields in their subject 
coverage, are internationally recognised, regularly updated, and they have a 
longstanding history covering articles as far back as the 1950s (Kluwer, 2017; EBSCO, 
2017). The combination of these databases was used to capture the most relevant and 
up-to-date information related to SONK.  
Prior to undertaking the final search, keywords were trialled together to give the most 
relevant results (for example, knee; knee joint; lower extremity and osteonecrosis; 
avascular necrosis; aseptic necrosis; bone necrosis respectively). The criteria used in 
the final search, shown in table 2.1, were found to be the best combination, as this 
gave the most numerous, but most relevant results from the provisional search. 
EBSCO was used to search articles in AMED; Embase and MEDLINE were searched 
together on OVID to minimise duplicate results. There were no limits applied on 
publication year. 
The electronic search strategy shown in table 2.1 was used for MEDLINE, Embase and 
AMED. The Cochrane Library database was searched using the terms “osteonecrosis” 
and “knee”.  
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Keyword 
Knee (SH exploded); Knee joint (SH exploded); Knee 
(keyword) 
Osteonecrosis (SH exploded); Osteonecrosis 
(keyword) 
 
 
OR  
Avascular necrosis (keyword) 
Bone necrosis (keyword)  
Aseptic Necrosis (keyword) 
Knee (SH exploded); Knee joint (SH exploded); Knee 
(keyword) 
 
AND 
Osteonecrosis (SH exploded); OR Osteonecrosis 
(keyword); OR Avascular necrosis (keyword); OR 
Bone necrosis (keyword); OR Aseptic Necrosis 
(keyword) 
Table 2.1: Example of search strategy using OVID combined MEDLINE and Embase* search. 
Abbreviations: SH = subject heading (*search terms amended as appropriate for Embase/Emtree subject 
headings)  
 
2.4 Study Selection  
 
Screening was performed in three stages independently by two reviewers (MC Killen 
and CP Charalambous, a supervisor). Titles were screened initially to exclude studies 
which were not relevant, followed by abstracts against eligibility criteria and then full 
texts of selected abstracts. Finally, references of included papers were screened to 
identify any additional texts. It was planned to involve a third reviewer if a decision 
could not be reached after the full text was reviewed.  
Duplicate results between databases were screened using a combination of auto and 
manual searching.  Initially, the tool within OVID for removing duplicates was utilised 
whilst searching MEDLINE and Embase. Following this, the author and then titles were 
ordered alphabetically and manually reviewed for duplicates.  
 
2.4.1 Data Extraction  
Data was extracted from the included studies using a standardised data collection form 
(appendix 2); this was developed to ensure that all necessary data was obtained from 
the selected studies accurately, without introducing reporting bias. The form was 
designed to obtain general information about the publication, as well as more specific 
information about the study. An overview of the information gathered is shown in table 
2.2.  
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Study characteristics  Patient characteristics/Treatment/Outcomes  
Title  Number eligible and included 
Study ID (Author/Year)  Number excluded/withdrawn/lost to follow-up 
Study Setting (e.g. Tertiary referral 
centre) 
Number randomised to each group (if 
applicable)  
Aim of Study  Mean age (& range)  
Study Design Gender distribution  
Level of Evidence  Stage of disease  
Recruitment Method  Details of intervention  
Inclusion/Exclusion Criteria Details of control (if applicable)  
Informed Consent  Timing of intervention  
Ethical Approval  Primary outcome measure used  
Power calculation & statistical methods 
used 
Secondary outcome measure(s) used  
 Timing of follow-up (frequency & overall 
duration)  
Details of results  
Quality assessment/Risk of bias tools  
Table 2.2: Summary of data captured from included studies (full data capture proforma in appendix 
2). 
 
Each study was reviewed with respect to the type of intervention described, 
classification system used and disease stage of included patients (where available). 
Clinical and radiological outcomes and the method of quantifying treatment effect were 
recorded. The number of patients lost to follow-up was documented and used as part 
of the risk of bias assessment (discussed below). 
 
A study was considered prospective if it commenced prior to enrolment of the first 
patient. The relevant data was extracted using the data collection form independently 
by two reviewers (M Killen and MP Dey, a supervisor), compared and then transferred 
over to an Excel spreadsheet. A third reviewer was available if there were any 
conflicting opinions that could not be resolved by discussion.  
2.4.2 Quality Assessment & Risk of Bias  
 
Assessment of methodological quality for each included study was undertaken to 
ensure the results were given appropriate weight according to the strength and 
reliability of the presented evidence. Level of evidence was assigned in keeping with 
established criteria (table 2.3), (Phillips, et al., 2009) . This hierarchy was chosen as it 
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is the most well recognised and utilised in medical literature. For the purposes of this 
systematic review, only evidence levels 1 to 4 were included.   
Level Type of evidence 
1A Systematic review of randomised controlled trials  
1B Individual RCT (with narrow confidence intervals) 
1C All or none study 
2A Systematic review (with homogeneity) of cohort studies 
2B Individual Cohort study (including low quality RCT, e.g. <80% follow-up) 
2C “Outcomes” research 
3A Systematic review (with homogeneity) of case-control studies 
3B Individual case-control study 
4 Case series (and poor-quality cohort and case-control study) 
5 Expert opinion without explicit critical appraisal, or based on physiology, bench 
research or “first principles” 
Table 2.3: A summary of levels of evidence for therapeutic studies and example of each study, 
from the Centre for Evidence-Based Medicine, http://www.cebm.net. 
Abbreviation: RCT=randomised controlled trial 
 
For any randomised controlled trials eligible for inclusion, criteria outlined in the 
Cochrane Handbook for systematic reviews and interventions (Higgins & Green, 2011) 
were used to assess quality and risk of bias. The following methodological areas were 
assessed, with each domain being rated as high, low, unclear (if there was lack of 
information or uncertainty regarding the risk of bias) or not used:  
▪ “Selection bias: methods of randomisation and concealment of allocation 
sequence. 
▪ Performance bias: blinding of participants, researchers and outcome 
assessments.  
▪ Attrition bias: number of participants lost to follow-up (either through 
withdrawals, drop-outs or changes to protocol)  
▪ Sample size/power calculation: whether performed or adequate explanation of 
sample size used.   
▪ Results: incomplete outcome data; selective outcome reporting” (Higgins & 
Green, 2011). 
Level of risk of bias within each category was then assigned using the criteria in table 
2.4.  
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Risk of 
bias 
Selection bias Performance 
Bias 
Attrition 
Bias 
Sample size  Results  
Low  Appropriate 
concealment of 
allocation 
Blinding of 
participants, 
researchers 
and outcome 
measures 
< 5% 
loss to 
follow-
up 
Appropriate 
explanation 
of sample 
size 
calculation 
Full outcome 
data presented  
Moderate Concealment 
allocation unclear 
or inadequate  
Blinding 
unclear  
5-20%  Unclear or 
inadequate 
sample size 
calculation 
Some minor 
deficiencies in 
presentation of 
outcomes  
High  Concealment 
allocation not 
used  
Blinding not 
used 
>20% 
lost to 
follow-
up or not 
recorded  
Calculation 
not recorded 
or used 
Selective 
reporting of 
outcomes, 
incomplete 
data presented  
Table 2.4: Criteria used to determine risk of bias for randomised controlled trials, from the 
Cochrane Handbook (Higgins & Green, 2011).  
 
For non-randomised studies, criteria outlined by the Methodological Index for Non-
Randomised Studies (MINORS) were used to assess quality (table 2.5). MINORS is a 
validated tool which has a set of criteria to be scored; each domain scores either zero 
(not reported); 1 (reported inadequately) or 2 (fully reported). An overall global ideal 
score would be 16 for non-comparative studies or 24 for comparative studies (Slim, et 
al., 2003). Studies reaching such scores were assessed as having low risk of bias; 
research with lower scores had increasing risk of bias.   
Clearly stated aim? For comparative studies:  
Inclusion of consecutive patients? An adequate control group? 
Prospective data collection? Contemporary groups?  
Endpoints appropriate to study aim? Baseline equivalence of groups  
Unbiased assessment of the study endpoint? Adequate statistical analysis  
Follow-up period appropriate?  
Loss to follow-up <5%  
Prospective calculation of study size?  
Table 2.5: MINORS assessment for non-randomised studies (Slim, et al., 2003). 
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2.4.3 Data Analysis  
It was anticipated from the outset that meta-analysis would not be possible from a 
preliminary search of the available evidence, with limited numbers of randomised 
controlled trials. Therefore, findings were presented in narrative form including multiple 
tables and figures to aid in data presentation, where appropriate. 
After initial analysis of the results, studies were grouped and sub-analysed according to 
the treatment type, then stage of disease (using the Koshino or other formal staging 
systems), if the data was available. This was an important step in working towards 
evaluating the efficacy of different treatments depending on the severity of disease.  
 
2.5 Systematic Review results 
2.5.1 Results of Search  
A total of 3501 records were identified from the database searches performed in 
September 2015. From this initial search, 921 records were removed as duplicates and 
searches of the references of the included research revealed an additional 7 records, 
giving a total of 2587 records.  Table 2.6 presents the search strategy and number of 
results for the combined MEDLINE and Embase search; the results of the AMED and 
Cochrane search are shown in appendix 1. 
Keyword Number of 
results  
Knee (SH exploded); Knee joint (SH exploded); Knee 
(keyword) 
120655 
Osteonecrosis (SH exploded); Osteonecrosis 
(keyword) 
 
 
OR  
 
 
18224 
Avascular necrosis (keyword) 
Bone necrosis (keyword)  
Aseptic Necrosis (keyword) 
Knee (SH exploded); Knee joint (SH exploded); Knee 
(keyword) 
 
AND 
3457 
 
Osteonecrosis (SH exploded); OR Osteonecrosis 
(keyword); OR Avascular necrosis (keyword); OR 
Bone necrosis (keyword); OR Aseptic Necrosis 
(keyword) 
Table 2.6: Search strategy and number of results using OVID MEDLINE and Embase* search. 
Abbreviations: SH = subject heading (*search terms amended as appropriate for Embase/Emtree subject 
headings). 
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Titles were screened for relevance and those obviously not relevant were excluded at 
this stage. The most common reason for exclusion was due to the cohort relating to 
osteonecrosis of the hip only, or from stating they were a single case report in the title. 
Following screening of titles and duplicate removal, 187 were considered potentially 
relevant and the abstracts were reviewed. There were 41 abstracts considered 
potentially eligible (or more information was needed) for inclusion by both reviewers on 
independent review, and after discussion, a further 6 were considered potentially 
eligible. A total of 47 full manuscripts relating to these abstracts were then reviewed by 
both reviewers. In total, 21 were considered eligible following review independently, 
and 20 were included following discussion. A third reviewer was not needed throughout 
the process. Figure 2.1 shows a summary of the search findings and the exclusions at 
each stage. Appendix 3 gives information on 27 studies that were excluded following 
review of the full text. 
In summary, 4 were excluded as there were no clinical or radiological outcome 
measures to quantify their results, 9 were excluded as they only included patients with 
secondary or steroid-associated osteonecrosis, or other knee pathologies. A further 9 
were excluded as they included mixed populations (for example, osteoarthritis and 
SONK), with no separation of outcomes. Four were excluded as the full text was not 
available in English. One article was excluded as most of the patient cohort were 
treated with arthroplasty (figure 2.1). 
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27 excluded:  
No outcome measures= 4 
Secondary ON = 9 
Mixed population, results not separated=9 
Full text not in English=4 
Majority treated with arthroplasty=1 
3501 identified through database searching 
(AMED, Embase, Cochrane, MEDLINE) 
7 identified through reference searches  
921 duplicates removed  
2400 excluded  
IDENTIFICATION  
SCREENING   
Titles screened= 2587 
Abstracts screened= 187 
Full texts articles assessed for eligibility= 47 
ELIGIBILITY 
20 studies included in analysis   
140 excluded  
Figure 2.2: Summary of search findings and exclusion at each stage, adapted from PRISMA (Moher, et 
al., 2009) 
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2.5.2 Study Characteristics  
Twenty studies met the inclusion criteria and were included in the final analysis. There 
was one unblinded randomised controlled trial (Uchio, et al., 2000). Seven studies were 
prospective; one was an open-label prospective observational study (Kraenzlin, et al., 
2010), the second was a non-randomised comparative prospective study (Marti, et al., 
2000) and five were case series with prospective identification of patients (Aglietti, et 
al., 1983; Johnson, et al., 2014; Jureus, et al., 2012; McDermott, et al., 1985; Miller, et 
al., 1986) . The remaining twelve studies were either retrospective case series (Akgun, 
et al., 2005; Valentí Nín, et al., 1998; Yates, et al., 2007), or the nature of the data 
collection was not stated and so assumed to be to be retrospective (Breer, et al., 2013; 
Deie, et al., 2008; Duany, et al., 2010; Forst, et al., 1998; Koshino, 1982; Kotani, et al., 
2003; Marcheggiani Muccioli, et al., 2013; Takeuchi, et al., 2009; Tanaka, et al., 2009) . 
The included studies and interventions involved are summarised in table 2.7.  
The twenty included studies described outcomes of a total of 465 knees in 442 
patients. The mean number of patients included in each study was 22.1 (SD 18.6; 
range 5-105). The mean age of the patient population (using the mean of the published 
mean values) was 59.8 years (SD 8.02; range 18-91). All but two studies gave 
information regarding the gender distribution of included patients (Kraenzlin, et al., 
2010; McDermott, et al., 1985); there were 152 males and 250 females, giving a male 
to female ratio of 1:1.64.   
Eleven out of the twenty studies used a combination of plain radiographs and MRI to 
reach a diagnosis of SONK. The remaining studies used either plain radiographs alone 
(Johnson, et al., 2014; Koshino, 1982; Miller, et al., 1986; Uchio, et al., 2000),  MRI 
alone (Breer, et al., 2013; Yates, et al., 2007), a combination of MRI findings and 
histological analysis of tissue (Forst, et al., 1998) or radiographs with scintigraphic 
studies if needed (Aglietti, et al., 1983). One included study did not describe the 
method of diagnosis (McDermott, et al., 1985). 
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Author, Year Study Design; Level of Evidence  Intervention Described  
 
N= Knees Mean age 
(range)  
Mean follow-
up (months) 
Akgun et al, 2005 Case Series; IV Arthroscopic microfracture  26 26 48 (16-67)  27 
 
 
Aglietti et al, 1983 
 
 
Prospective case Series; IV 
Various treatments: protected weight-bearing, 
analgesia and physiotherapy; arthrotomy and 
curettage; HTO or TKR  91 
 
 
105 66 (38-85)  
 
 
48 
Breer et al, 2013 Case Series; IV Bisphosphonate (Ibandronate) & Vitamin D  5 5 51.8 (±6) 2 
Deie et al, 2008 Case Series; IV Core decompression & artificial bone grafting  12 12 69.6 (59-84) 24.6 
Duany et al, 2009 Case Series; IV  Arthroscopic core decompression; OATS  15 15 50 (18-76) 40 
Forst et al, 1998 Case Series; IV Extra-articular drilling  16 16 64.6 (55-81) 35.4 
Johnson et al, 2014 Prospective case Series; IV Autogenous bone grafting  25 26 58 (26-74) 156-228 
Jureus et al, 2012 Prospective case series, IV Bisphosphonate (alendronate)  17 17 68 (48-82) 12 
Koshino, 1982 Case Series; IV High tibial osteotomy ± drilling/bone grafting 36 37 58 (43-78)  61 
Kotani et al, 2003 Case Series; IV OATS 16 16 64.9 (58-74)  67  
Kraenzlin et al,2010 Prospective observational study; IV Bisphosphonates (Pamidronate, Alendronate)  28 28 57.7 (±2.7)  6 
Marcheggiani 
Muccioli et al, 2013 
 
Case Series, IV 
 
Pulsed electromagnetic therapy  28 
 
28 49.8 (46-74) 
 
24.9 
 
Marti et al, 2000 
Prospective non-randomised 
comparative, III 
 
High tibial osteotomy  10 
 
10 59.5 (44-80) 
 
17.5 
McDermott et al, 
1984 
 
Prospective case Series, IV 
 
Osteochondral allograft  11 
 
11 48 
 
72 
Table 2.7: Summary of study design, intervention and patient demographics of included studies 
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Author, Year Study Design; Level of Evidence  Intervention Described  
 
N= Knees Mean age 
(range)  
Mean follow-
up (months) 
Miller et al, 1986 Prospective case Series, IV Arthroscopic debridement  5 5 69.2 (61-80) 31 
Takeuchi et al, 
2009 
 
Case Series, IV 
 
High tibial osteotomy 30 
 
30 71 (58-82)  
 
37 
Tanaka et al, 2008 Case Series, IV OATS 6 6 54.2 (50-57) 27.7 
Uchio et al, 2000 RCT (unblinded) II Lateral wedge insole  30 31 69 (46-78) 53.5 
Valentí Nín et al, 
1998 
Case Series; IV Various Treatments: protected weight bearing, 
analgesia & physiotherapy; arthroscopic washout; 
arthroscopic drilling; high tibial osteotomy; TKR  21 
 
 
21 66 (46-91) 
 
 
41 
 
Yates et al, 2007 
 
Case series, IV 
Analgesia, protected weight-bearing or activity 
restriction 
 
14 
 
20 52 (42-64) 
 
Not stated 
Table 2.7:  Summary of study design, intervention and patient demographics of included studies (ctd)  
Abbreviations: HTO= high tibial osteotomy; OATS=osteochondral autograft transfer system; RCT= randomised controlled trial; TKR=total knee replacement;
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Time from diagnosis to treatment was widely variable. One study described that 
treatment was commenced within 7 days (Marcheggiani Muccioli, et al., 2013). Eleven 
studies gave numerical values for time from diagnosis to treatment with a range of 
0.75-60 months.   
Treatments are summarised in table 2.7. With regard to non-operative measures, 3 
studies reported outcomes following analgesia with or without physiotherapy and 
restricted weight bearing (Aglietti, et al., 1983; Valentí Nín, et al., 1998; Yates, et al., 
2007),  3 studies described outcomes following bisphosphonate therapy (Breer, et al., 
2013; Jureus, et al., 2012; Kraenzlin, et al., 2010), one described results of pulsed 
electromagnetic field therapy (Marcheggiani Muccioli, et al., 2013) and one reported 
outcomes following treatment with a lateral wedge insole (Uchio, et al., 2000).  
The majority of studies described outcomes following joint-preserving surgical 
treatment: two described results following either arthroscopic or open joint debridement 
(Aglietti, et al., 1983; Miller, et al., 1986); four reported outcomes with 
drilling/decompression of the lesion (Deie, et al., 2008; Duany, et al., 2010; Forst, et al., 
1998; Valentí Nín, et al., 1998); one study reviewed results of microfracture (Akgun, et 
al., 2005) and five reported outcomes after osteochondral transplantation or bone 
grafting (Duany, et al., 2010; Johnson, et al., 2014; McDermott, et al., 1985; Kotani, et 
al., 2003; Tanaka, et al., 2009) . Five studies reported results following high tibial 
osteotomy (Aglietti, et al., 1983; Koshino, 1982; Marti, et al., 2000; Takeuchi, et al., 
2009; Valentí Nín, et al., 1998). 
Most studies were case series and did not have any comparators. One study was a 
randomised controlled trial and compared the use of a lateral wedge insole with usual 
treatment of analgesia and physiotherapy (Uchio, et al., 2000). Three further studies 
involved some form of comparator: Aglietti et al (1983) described outcomes of various 
operative and non-operative treatments; Marti et al (1999) compared high tibial 
osteotomy with a period of partial weight bearing. Koshino (1982) compared outcomes 
in patients undergoing high tibial osteotomy with or without the use bone grafting. The 
findings of these different groups have been discussed separately in the appropriate 
sub-section. 
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2.5.3 Study Outcome Measures  
 
A variety of tools were used in the included studies to measure outcomes, which can 
be broadly divided into clinical and radiological outcome measures. The clinical scoring 
systems can further be sub-divided into general health or quality of life assessments 
(for example, EQ-5D), assessments specific to pain (for example, Visual Analogue 
Scale) or more specific knee scores, focusing on knee function and how knee 
symptoms impact on activities of daily living (for example, Hospital for Special Surgery 
knee score, American Knee Society Score). Table 2.8 shows each included study and 
the specific scoring tools used.  One study used a scoring tool specific to the type of 
treatment used, the Fresh Small-Fragment Osteochondral Allografts-Score, which 
combines a subjective and objective assessment of knee function (McDermott, et al., 
1985).  A summary of the scoring systems and their parameters is in appendix 5. 
 
A variety of methods were also used to measure radiological parameters. Most 
included research involved a measurement of the size of the lesion both pre- and post-
intervention as a minimum. Some employed more specific measurements to assess 
joint alignment (for example, femoro-tibial angle), or the Lotke index, which is a ratio 
expressed as a percentage of joint surface involvement of SONK in relation to the total 
joint surface of the affected medial or lateral femoral condyle (Lotke P A, 1982).
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Author, Year Clinical outcomes  Radiological Outcomes  
Akgun et al, 2005 
Lysholm score, activity level of 
Cincinnati, pain, ROM, effusion, 
instability, muscle atrophy, satisfaction 
level 
- 
Aglietti et al, 1983 Knee evaluation & score; HSS Radiographic staging 
Breer et al, 2013 VAS Absence of MRI changes 
Deie et al, 2008 VAS, JOA scores  Radiographic & MRI changes  
Duany et al, 2009 
 
KSS 
Radiographic & MRI size of 
lesion; survival of native knee  
Forst et al, 1998 KSS MRI changes  
Johnson et al, 
2014 
Summary of common complaints 
Subsequent surgical interventions 
- 
Jureus et al, 2012  Clinical examination Lotke index & MRI changes 
Koshino, 1982 Ranawat knee score Radiographic changes 
Kotani et al, 2003 JOA score; clinical findings; arthroscopic 
changes 
Radiographic & MRI change 
Kraenzlin et 
al,2010 
VAS MRI ± radiographic staging  
Marcheggiani 
Muccioli et al, 
2013 
VAS, KSS, Tegner, EQ-5D MRI staging (WORMS score) 
Marti et al, 1999 
KSS Radiographic staging & MRI 
Changes 
McDermott et al, 
1984 
Fresh Small-Fragment Osteochondral 
Allografts-Score, Survival of native knee 
-  
Miller et al, 1986 HSS  Radiographic changes  
Takeuchi et al, 
2009 
KSS & functional score Radiographic changes: FTA, WBL 
%.  
Tanaka et al, 2008 Lysholm score, histological evaluation - 
Uchio et al, 2000 HSS Radiographic changes; FTA  
Valenti Nín et al, 
1998 
Ordoñez classification  Radiographic staging 
Yates et al, 2007 - MRI changes  
Table 2.8: Clinical and radiological outcome measures used for included studies.  
Abbreviations: VAS= visual analogue scale; HSS: hospital for special surgery rating system; KSS= 
American Knee Society Score; FTA= femorotibial angle; WBL %= weight bearing line percentage; ROM= 
range of motion; JOA=Japanese Orthopaedic Association.  
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2.5.4 Risk of Bias  
The randomised controlled trial was assessed using the criteria outlined by the 
Cochrane handbook (Higgins & Green, 2011) and scored as having a high risk of bias 
in 3 out of the 5 domains; it is an un-blinded trial with no concealment of allocation or 
power calculation (Uchio, et al., 2000). Given the nature of the intervention, it would not 
have been possible to blind the participants, but it is not reported whether the 
assessors were blinded. However, there were no patients lost to follow-up and the 
results were fully presented, so this study had low risk of bias for these areas.  The 
outcomes and ratings are summarised in table 2.9; as 3 out of 5 areas scored as high, 
it can be concluded that the overall risk of bias for this study is high.   
Domain Assessed Outcome Level of risk  
Selection bias Concealment allocation not used  High risk  
Performance Bias Blinding not used for either participants or assessors High risk 
Attrition bias 0% loss to follow-up Low risk 
Sample size Sample size calculation not reported High risk 
Results  Full outcome data presented Low risk 
Table 2.9: Risk of Bias assessment for the included randomised controlled trial evaluating use of 
lateral wedge insole compared with analgesia and physiotherapy (Uchio, et al., 2000).  
 
Non-randomised controlled trials were assessed for their risk of bias using the 
MINORS criteria (summarised in table 2.5). For non-comparative studies, an ideal 
score would be 16, whereas, for comparative research, an ideal score would be 24 to 
demonstrate a low risk of bias (Slim, et al., 2003).  The scoring for comparative studies 
is summarised first in table 2.10, followed by non-comparative studies in table 2.11. 
Author, Year Study Design  Treatment Described MINORS 
score 
Aglietti et al, 1983 
Case Series 
(prospective) 
Various treatments 9/24 
Marti et al, 1999 
Prospective, non-
randomised comparative 
study 
High tibial osteotomy versus 
non-operative treatment with 3 
months partial-weight bearing 
18/24 
Koshino, 1982 
Case series  High tibial osteotomy with or 
without drilling/bone grafting 
10/24 
Table 2.10: MINORS scoring for included comparative studies.  
As demonstrated in table 2.10, none of the included comparative studies reached a 
score of 24, with values ranging from 9 to 18, demonstrating high risk for all the 
included studies. A full breakdown of the scoring for each domain in shown in appendix 
4.  
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Author, Year Study Design  Treatment Described MINORS 
score 
Akgun at al, 2005 Case Series Arthroscopic microfracture  10/16 
Breer et al, 2012 Case Series Bisphosphonate  9/16 
Deie et al, 2008 
Case Series Core decompression & artificial bone 
grafting  
9/16 
Duany et al, 2009 Case Series Arthroscopic core decompression; OATS  7/16 
Forst at al, 1998 Case Series Extra-articular drilling  7/16  
Johnson et al, 
2014 
Case Series 
(prospective) 
Autogenous bone grafting  8/16 
Jureus et al, 2012 
Case series 
(prospective) 
Bisphosphonates (alendronate) 12/16 
Kotani et al, 2003 Case Series OATS 8/16 
Kraenzlin et al, 
2010 
Prospective non-
comparative 
observational 
study 
Bisphosphonates  11/16 
Marcheggiani et al, 
2012 
Case Series Pulsed electromagnetic therapy  16/16 
McDermott et al, 
1984 
Case Series 
(prospective) 
Osteochondral allograft  11/16 
Miller et al, 1986 
Case Series 
(prospective) 
Arthroscopic debridement  10/16 
Takeuchi et al, 
2009 
Case Series High tibial osteotomy 8/16 
Tanaka et al, 2009 Case Series OATS 9/16 
Valentí Nín 
et al, 1998 
Case Series Various Treatments  7/16 
Yates et al, 2007 Case series Analgesia, protected weight-bearing 7/16 
Table 2.11: MINORS scores for included non-comparative studies.  
 
Only one of the non-comparative studies achieved an ideal score of 16 (Marcheggiani 
Muccioli, et al., 2013). The retrospective nature and lack of calculation of study size in 
most of the included studies automatically led to a reduced score, and very few 
discussed whether consecutive cases were included. In addition to this, only one study 
used an independent assessor to evaluate outcomes of the patient cohort 
(Marcheggiani Muccioli, et al., 2013). The remaining studies have only involved the 
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authors to assess the endpoints, potentially increasing bias and resulting in a lower 
than ideal global score in the 16 non-comparative studies.  
2.5.5 Effect of intervention on outcome  
This section sub-analyses included research, firstly by treatment type, then by stage of 
disease to try and evaluate if certain treatments are more effective depending on the 
severity of SONK.  
 
2.5.5.1 Clinical outcome by treatment type: Non-operative measures  
Six studies reported outcomes following non-operative measures (table 2.12), either 
with insoles or electromagnetic therapy (Uchio, et al., 2000; Marcheggiani Muccioli, et 
al., 2013), or with medical treatment using different bisphosphonates (Breer, et al., 
2013; Jureus, et al., 2012; Kraenzlin, et al., 2010). Three studies have treated patients 
with analgesia, with or without weight-bearing restriction and physiotherapy (Aglietti, et 
al., 1983; Valentí Nín, et al., 1998; Yates, et al., 2007).  
Lateral wedge insole     
One un-blinded randomised controlled trial evaluated a lateral wedge insole for patients 
with early disease (Uchio, et al., 2000). Thirty participants were randomised to either a 
patient-specific insole or no insole. Both groups were treated with a period of non-
steroidal anti-inflammatory medication and physiotherapy. There was a significant 
improvement in the clinical scores of the treatment group compared to the placebo 
group (HSS score). Radiological improvement in the treatment group was also 
observed (size of the necrotic area), compared to the placebo group, whose 
radiological parameters worsened. The authors therefore concluded that the use of a 
lateral wedge insole is a useful treatment for early stage disease. Complications and 
treatment failures were not reported in this study. 
 
Pulsed electromagnetic therapy  
One case series evaluated self-administered pulsed electromagnetic therapy in the 
treatment of 30 consecutive patients with early stage SONK (Marcheggiani Muccioli, et 
al., 2013). Authors found a significant improvement in VAS, KSS and EQ-5D scores at 
6 months. Radiological parameters also improved, with significant reduction of total 
WORMS score and mean femoral bone marrow lesion area on MRI. Four patients 
required knee arthroplasty at the end of the study (24 months), giving a failure rate of 
14.3%. 
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Bisphosphonate treatment 
Three case series evaluated the effectiveness of bisphosphonates (Breer, et al., 2013; 
Jureus, et al., 2012; Kraenzlin, et al., 2010). Breer et al (2012) reviewed ibandronate 
with high dose vitamin D supplementation in 5 consecutive patients with early stage 
disease. Remission of MRI findings was observed in all cases and there was a 
statistically significant improvement in VAS scoring at both 4 and 8 weeks; the study 
follow-up was limited to 8 weeks. 
 
Jureus et al (2012) evaluated the outcomes of 17 patients with SONK after 
administration of weekly oral alendronate for either minimum of 6 months, or until the 
lesion regained bone density on plain radiography or MRI. Outcomes were divided into 
three groups; 10 out of 17 patients did not go on to develop arthritis, 4 developed 
arthritis without joint collapse and 3 developed arthritis and joint collapse. Of the group 
with joint collapse, 2 out of 3 stopped their treatment prematurely due to side effects 
and both required knee arthroplasty, the final patient progressed to joint collapse during 
treatment but had mild symptoms so did not require any further intervention. Clinical 
outcomes and Lotke ratio (Lotke P A, 1982) evaluating the lesion size were measured 
as part of the methodology but are not fully reported.  
 
Kraenzlin et al (2010) evaluated intravenous pamidronate followed by oral alendronate 
in 28 patients. Anti-inflammatory and other analgesics were given throughout. There 
was a rapid reduction in VAS scoring after 4-6 weeks, with a decrease of 80% by 6 
months. Complete symptom resolution was observed in 15 out of 28 patients at 6 
months. Bone marrow oedema either resolved (18 patients) or substantially reduced on 
MRI scan. Treatment failed in 2 patients, who required knee arthroplasty. 
 
In summary, bisphosphonate treatment appears to be effective in reducing symptoms 
and improving radiological changes in these small studies. From the two studies 
reporting complications, four patients went on to require knee arthroplasty during the 
study period, giving an overall failure rate of 8.9%.  
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Intervention 1st author, 
study design  
Comparator (if 
applicable) 
N= Main clinical 
outcome used 
Pre- treatment value 
(mean) 
Post- treatment 
value (mean) 
Need for additional 
intervention/surgery n= (%) 
Lateral wedge 
insole 
Uchio 
Unblinded RCT  
Analgesia and 
physiotherapy  
18* HSS  Treatment: 58.6 
No treatment: 60.8 
Treatment: 69.9 
No treatment: 57.8 
Not reported  
Pulsed EM 
therapy 
Marcheggiani 
Case series  
n/a  28 VAS 7.3 2.7 4 (14.3%)  
Bisphosphonates Breer 
Case series  
n/a 5 VAS 7.4 0.8 Not reported 
Jureus  
Case series  
n/a  17 Radiographic outcomes only  2 (11.8%)  
Kraenzlin 
Observational 
study 
n/a  28 VAS 8.2 2.0 2 (7.1%)  
Supportive 
measures: 
analgesia, 
physiotherapy  
Aglietti  
Case series  
Various 
treatments** 
22 HSS 70 82 Not reported 
Valentí Nín 
Case series  
Various 
treatments** 
6 Ordoñez 
 
See text  1 (16.7%) 
Yates 
Case series  
n/a 14 Radiographic outcomes only 0 
Table 2.12: Summary of included studies evaluating non-operative measures for the treatment of SONK. 
Abbreviations: EM- electromagnetic; HSS- Hospital for Special Surgery Knee Score; VAS- visual analogue scale; *=number in treatment group; **=comparators discussed in their 
respective sections.
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Patients treated with supportive measures  
Three studies described patients undertaking a period of supportive measures either as 
their entire cohort (Yates, et al., 2007), or as part of larger case series (Aglietti, et al., 
1983; Valentí Nín, et al., 1998), the results of the control arm of the randomised 
controlled trial is also discussed here (Uchio, et al., 2000).  
Yates et al (2007) evaluated the MRI outcomes of 14 patients with early-disease 
treated with a period of analgesia (paracetamol and non-steroidal anti-inflammatory 
medication) and either weight-bearing relief or activity restriction with full weight-
bearing until their symptoms resolved. All patients made complete symptomatic 
recovery at a mean period of 4.8 months (range 3-8 months), with full resolution of MRI 
changes in all cases (mean time to resolution 8 months, range 3-18 months).  
Aglietti et al (1983) described long-term results of 105 knees in 91 patients, treated with 
different measures. Twenty-two underwent a period of weight-relief, analgesia and 
isometric quadriceps exercises. The Hospital for Special surgery (HSS) knee score 
(appendix 5) improved from a mean of 70 (range 48-87) to 82 (range 41-98) following 
treatment, which was just statistically significant (p<0.05). Radiologically, the lesion 
resolved in 1, reduced in size in 8, remained unchanged in 7 and worsened in 6 
patients.  Arthritis was present in eleven patients prior to treatment; it remained 
unchanged in 9, but worsened in 2. Arthritis developed in the remaining 11 knees, 
giving an overall deterioration of 59%. Failure of treatment requiring further intervention 
was not reported. 
 
Valentí Nín et al (1998) described outcomes of a subgroup of 6 patients undertaking a 
period of weight-relief, anti-inflammatory medication and straight leg raises, as part of a 
larger case series. According to the Ordoñez classification (appendix 5), one patient 
had a poor outcome, one was fair, and four had good outcomes. One patient required a 
uni-compartmental knee replacement at a later stage, giving a complication rate of 
16.7%, higher than the other patients in this study (0% for arthroscopic washout and 
high tibial osteotomy, 12.5% for drilling).  
The control arm of the study by Uchio et al (2000) described outcomes of patients 
treated with analgesia and physiotherapy only. There was a slight deterioration in their 
HSS score, along with an increase in the size and percentage ratio of the lesion, 
compared to the group treated with an insole, who demonstrated improvements in all 
domains.  
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Summary of Failures of Non-Operative Measures  
Failure of described treatment was defined by progression of disease and need for 
further intervention, either additional joint-preserving procedures or knee arthroplasty. 
Table 2.13 gives a summary of the overall failure rates described for the non-operative 
measures discussed above. Five out of the 8 studies describing non-operative 
measures specifically stated their failure rates, the remaining 3 did not describe any 
need for further surgery nor did they explicitly state no failures occurred. Need for 
additional joint-preserving surgical procedures was not required in any patients, 
whereas total knee replacement was required in 9 out of 93 cases where failure was 
described, giving an overall failure rate of 9.7% (range 0-16.7%).  
First author, year 
study design  
N= Treatment Need for further 
surgery (native 
joint) (%) 
Need for 
TKR (%) 
Aglietti, 1983 
Case series 
22 Supportive measures None described 
Breer, 2013 
Case series  
5 Ibandronate & 
vitamin D 
None described 
Jureus, 2012 
Case series  
17 Bisphosphonates 0 2 (11.8%) 
Kraenzlin, 2010 
Case series 
28 Bisphosphonate  0 2 (7.1%) 
Marcheggiani, 2013 
Case series 
28 Pulsed EM therapy  0 4 (14.3%) 
Uchio, 2000 
RCT  
18 vs 13 Lateral wedge insole 
vs no insole  
Not described 
Valentí Nín, 1998 
Case series  
6 Supportive measures 0 1 (16.7%) 
Yates, 2007 
Case series 
14 Supportive measures 0 0 
Table 2.13: Summary of overall failure rates for non-operative measures 
 
Summary of non-operative measures 
This section has described the results of eight studies describing non-operative 
treatments. An initial period of conservative treatment with weight-bearing relief, 
analgesia and physiotherapy appears to be effective in the described case series. 
However, the control arm of the randomised controlled trial does not show the same 
positive outcomes, with this group having poorer outcomes than the group treated with 
a lateral wedge insole (Uchio, et al., 2000).  
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2.5.5.2 Clinical outcomes by treatment type: arthroscopic Interventions, drilling 
and grafting procedures  
There were eleven studies investigating outcomes following arthroscopic or open 
interventions, along with various debridement, drilling or grafting techniques. Table 
2.14 summarises the study designs and clinical outcomes of these studies. 
Arthroscopy with washout, debridement/currettage or drilling  
Valentí Nín et al (1998) described arthroscopic washout for 4 patients and arthroscopy 
and drilling for 8 patients as part of a larger series. In the washout group, one patient 
had an excellent, two had good and one had a fair outcome according to the Ordoñez 
classification; no further procedures were needed. Radiographic outcomes (Koshino 
staging) remained static in 3; one deteriorated, but still had a good outcome. 
For arthroscopy and drilling, outcomes were excellent in 2, good in 4, fair in 1 and poor 
in 1. Two out of 8 patients demonstrated radiographic progression, but both had 
excellent outcomes. One patient required further surgery in the form of high tibial 
osteotomy.  
The outcomes of 5 patients treated with arthroscopic debridement were described by 
Miller et al (1986). The Hospital for Special surgery scores improved from 52 (50-55) to 
81.4 (53-95) post-operatively. Two patients required further surgery; one had a repeat 
arthroscopy and debridement due to recurrence of pain and one underwent high tibial 
osteotomy for persisting symptoms.  
Aglietti et al (1983) described outcomes of 11 patients undergoing arthrotomy and 
curretage as part of a larger case series. There was a clinical improvement, but this 
was not  statistically significant (table 2.14). Radiologically, the osteonecrotic lesion 
disappeared in 1 patient, improved in 1, remained unchanged in 8 and worsened in 
one. No adverse outcomes or need for further surgery was reported throughout this 
study for any of the treatment groups.  
Arthroscopic Microfracture 
Akgun et al (2005) presented outcomes of 26 patients treated with arthroscopic 
microfracture after 4 months of non-operative measures; 3 patients also underwent 
high tibial osteotomy due to associated varus malalignment. Both Lysholme scores and 
the activity level of Cincinatti showed significant improvements post-operatively 
(p<0.001) (table 2.14). Radiographic outcomes (Koshino classification) remained static 
in 16, 4 worsened and 6 improved. The authors found no correlation between the pre-
operative size of the lesion and the functional outcome. No adverse outcomes or 
failures were reported.  
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Intervention 1st Author, study design  N= Main clinical outcome  Pre-op  
value, (mean) 
Post-op value, (mean) Additional 
surgery, n= (%)  
Arthroscopic Washout Valentí Nín, case series 4 Ordoñez N/A Excellent (n=1); good (n=2); 
fair (n=1) 
0 
Arthroscopic debridement Miller, case series 5 HSS  52  81.4  2 (40%) 
Arthrotomy & curettage Aglietti, case series 11 HSS 69 79 Not described 
Arthroscopy & drilling Valentí Nín, case series 8 Ordoñez N/A Excellent (n=2); good (n=4); 
fair (n=1); poor (n=1) 
1 (12.5%) 
Arthroscopic microfracture Akgun, case series 26 Lysholme score 
Activity level of Cincinnati   
57  
6  
90  
13.54  
0 
Core decompression ± 
bone grafting  
Deie, case series 12 VAS 
JOA 
8.4  
43  
1.5  
80  
2 (16.7%)  
Duany, case series 7 KSS 61.7 76 2 (28.6%) 
Forst, case series  16 KSS 74 187.2 Not reported 
Autogenous bone grafting Johnson, case series 25 Summary of common 
complaints 
See text  13 (52%) 
Osteochondral autograft 
transfer 
(OATS)/Osteochondral 
Allograft 
Duany, case series 9 KSS 57.9 80.2  2 (22.2%) 
Kotani, case series 16 JOA 68.1  88.8  0 
McDermott 
Case series 
11 Fresh Small-Fragment 
Osteochondral Allografts-Score 
3 (27%) classified as successful  8 (73%) 
Tanaka, case series 6 Lysholme score 54.7 92.3 Not reported 
Table 2.14: Summary of included studies evaluating arthroscopic measures, drilling and grafting for the treatment of SONK.  
Abbreviations: HSS=hospital for special surgery knee score; JOA= Japanese orthopaedic association knee score; KSS= American knee society score; VAS=visual analogue score. 
39 
 
 
Core decompression with bone grafting or Osteochondral Autograft Transfer (OATS) 
Deie et al (2008) described clinical and radiological outcomes in 12 patients following 
core decompression and bone grafting. There was a significant improvement in both 
JOA scores (p<0.001) and VAS (p<0.05) post-operatively. Two patients underwent 
repeat arthroscopy, the indication being persisting swelling in one and not reported in 
the other. There was radiological progression according to the Kellegren-Lawrence 
classification in 4 patients, the others remained static (Kellegren & Lawrence, 1957).  
Duany et at (2009) reported a series of 15 patients who had failed period of non-
operative management. Seven underwent arthroscopy and extra-articular core 
decompression, with a mean improvement in KSS from 61.7 to 76 post-operatively. 
Five out of 7 cases were sucessful (71.4%).  Two patients demonstrated radiological 
deterioration; 1 patient underwent OATS at one year due to persistent symptoms and 
one patient required knee arthroplasty for disease progression. 
Nine patients had the OATS procedure (1 patient was included in both groups after 
poor result with decompression); KSS improved from 57.9 to 80.2 post-operatively. 
Seven out of 9 cases were successful (77.8%) and one patient demonstrated 
radiological progression. One patient required a repeat arthroscopy for mensical tear 
and the other underwent knee arthroplasty for disease progression. The OATS group 
was therefore very slightly more sucessful with a lower rate of disease progression 
compared to the core decompression group.   
Forst et al (1998) described outcomes of extra-articular core decompression in 16 
patients, all of whom had failed a course of non-operative mangement. Mean KSS 
improved from 74±38.2 to 187.2± 52.1 post-operatively. One patient had a post-
operative pulmonary embolus; this was the only complication reported. Radiologically, 
there was complete normalisation of bone marrow signal on repeat MRI in all but one 
patient at 6 months; the remaining patient had progression of disease with desctruction 
of the femoral condyle, but it is not reported whether further intervention was needed.  
Autogenous bone grafting, Osteochondral Autograft (OATS) and Osteochondral 
Allograft  
Johnson et al (2014) reported the outcomes of 25 patients (26 knees) following 
autogenous bone grafting; 15 of the 26 knees also had high tibial osteotomy (HTO). 
Nine patients were available for long-term clinical follow-up and their outcomes were 
reported as improved (7), worse (1) or no response (1). Seven patients in the HTO with 
grafting group and 3 patients in the grafting only group went on to have a total knee 
replacement; 1 patient required a second arthroscopy and 1 patient adhesiolysis giving 
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an overall reoperation rate of 48%.  
 
The outcomes of 16 patients treated with osteochondral autografting were presented 
by Kotani et al (2003); 4 patients in this group also had HTO. The Japanese Orthopedic 
Association (JOA) clinical scores improved from a mean of 68.1 (60-75) to 88.8 (80-
100) post-operatively. All patients had planned repeat arthroscopy at 18-21 months 
following index procedure. Both repeat arthroscopy and post-operative radiographs 
demonstrated graft acceptance in all cases. No adverse outcomes or failures were 
reported in this series.   
McDermott et al (1985) presented the long-term results of fresh osteochondral 
allografts for different knee pathologies. There were 11 patients with SONK. Patients 
also had realignment surgery if necessary but the authors do not state how many, if 
any of the SONK group required this. The procedure was deemed to be successful in 
the absence of re-operation and if the fresh osteochondral allograft clinical scoring tool 
was ≥75 (appendix 5). Using these parameters, 3 out of 11 (27%) were sucessful, but 
the number of re-operations is not presented.  
Tanaka et al (2008) reported outcomes of 6 patients undergoing autogenous 
osteochondral grafting; 5 out of 6 patients also had an arthroscopic mensicectomy. 
Lysholme scores improved from a mean of 54.7 (47-70) to 92.3 (85-100) at final follow-
up. No radiological outcomes, complications or failures were reported.  
Failures of Arthroscopic treatments, drilling and grafting  
Table 2.15 gives an overall summary of the re-operation rate and failures requiring 
arthroplasty. Eight out of eleven studies described complications and failures; rates 
were widely variable ranging from zero to 40% for both further joint-preserving surgery 
and arthroplasty. The highest failure rate was 73% described my McDermott et al 
(1985), but the authors did not define what constituted failure and it is unclear how 
many of these patients had further interventions. In total, 22 out of the 112 patients with 
complications described required further intervention, giving an overall failure rate of 
19.7% for this group.  
Summary of arthroscopic interventions, drilling and grafting  
Over half of the studies included in the systematic review are described in this section, 
with widely variable techniques. Aside from the outcomes described by Johnson et al 
(2014), who reported a re-operation rate of 48% and the failure rate of 73% described 
by McDermott et al (1985), the majority of the arthroscopic techniques and grafting 
procedures provided reasonably promising results, with overall improvements in clinical 
outcomes. It is important to note, however, that despite this section including the 
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highest number of included studies, they are limited to case series only without any 
higher level evidence to support the results.  
Author, study 
design  
N= Treatment Need for further surgery (native 
joint) (%) 
Need for 
TKR (%) 
Akgun 
Case series  
26 Microfracture 0 0 
Aglietti 
Case series  
11 Arthrotomy and 
curettage  
None described 
Deie 
Case series 
12 Decompression & bone 
grafting 
2 (16.7%) repeat arthroscopy 0 
Duany  
Case series 
 
7 Core decompression 1 (14.3%) OATS 1 (14.3%) 
9 OATS 1 (11.1%) arthroscopy and 
meniscal debridement 
1 (11.1%) 
Forst 
Case series 
16 Extra-articular drilling  Not described 
Johnson 
Case series   
25 Autogenous bone 
grafting  
3 (12%): 2 arthroscopy± 
debridement,  
1 manipulation & adhesiolysis  
10 (40%) 
Kotani 
Case series 
16 Osteochondral autograft  0 0 
McDermott 
Case series  
11 Osteochondral allograft 8 (73%) overall failure, not specific to re-
operations  
Miller  
Case series  
5 Arthroscopic 
debridement  
2 (40%): 1 repeat arthroscopy, 1 
HTO 
0 
Tanaka  
Case series  
6 Osteochondral autograft Not described 
Valentí Nín 
Case series  
 
4 Arthroscopic washout 0 0 
8 Arthroscopy and drilling  1 (12.5%) HTO 0 
Table 2.15: Summary of failure rates of arthroscopic interventions, drilling and grafting of lesions 
 
2.5.5.3 Clinical outcomes by treatment type: Realignment surgery (high tibial 
osteotomy) 
Aglietti et al (1983) described the outcomes of 31 patients undergoing HTO; 21 also 
had an arthrotomy, with either fragment removal and drilling (n=18) or drilling alone 
(n=3). Hospital for Special surgery scores significantly improved (p<0.001, table 2.16). 
Radiologically, the lesion disappeared in 3, improved in 15, remained unchanged in 11 
and worsened in 2. Arthritis was present pre-operatively in 22 patients; it remained 
unchanged in 17, worsened in 5 and developed in 4 patients, giving a deterioration in 
29%. Radiographs were also analysed to determine alignment correction using the 
femorotibial angle (FTA). Knees with a mean correction of 170 degrees (range 165-
42 
 
174⁰) had statistically significant improved outcomes compared to those whose FTA 
was either greater than 174 or less than 165 degrees (p<0.01). Two patients in this 
group had failure of treatment requiring knee arthroplasty.  
First author, 
study design  
Comparator  N
= 
Main clinical 
outcome 
Pre-op value 
(mean)  
Post-op 
value (mean) 
Total re-
operations 
Aglietti 
Case series 
N/A 31 HSS 58  79  2 (6.5%) 
Koshino 
Case series 
HTO vs HTO 
with grafting 
± drilling 
36 Ranawat score  HTO: 53 
Graft: 58 
Drilling: 56 
HTO 87 
Graft: 96 
Drilling: 88 
4 (11.1%) 
Marti 
Non-
randomised 
comparative 
study 
HTO vs PWB 10 KSS HTO:132  
PWB:139  
HTO:163  
PWB:140  
Not reported 
Takeuchi 
Case series 
N/A 30 KSS 51 93 0 
Valentí Nín 
Case series 
Various 
treatments 
2 Ordoñez N/A Both excellent  0 
Table 2.16: Study design, clinical outcomes and failure rates of studies describing outcomes of 
HTO.  Abbreviations: HTO: high tibial osteotomy; HSS= Hospital for special surgery score; KSS= American 
knee society score; PWB=partial weight-bearing.  
 
Koshino (1982) presented 36 patients (37 knees) undergoing HTO alone (n=14), HTO 
with drilling (n=17) or HTO with bone grafting (n=6). There was a statistically significant 
difference between pre- and post-operative scores for each type of surgical procedure 
and for each stage of osteonecrosis (table 2.16). The scores for those treated with 
HTO and bone grafting were significantly higher than the other groups. Radiologically, 
the lesion disappeared in 13, improved in 17 and remained unchanged in 7. There was 
a statistically significant increased score in patients who had a FTA between 164 and 
173 degrees, compared to those outside this range (p<0.05). Three patients required 
additional procedures on their native knee and one patient underwent knee 
arthroplasty.  
Marti et al (2000) conducted a non-randomised comparative study evaluating outcomes 
of HTO versus partial-weight bearing and analgesia for 3 months. Patients were given 
the option of which treatment modality they would prefer; 6 opted for HTO and 4 for 
conservative treatment. There was a statistically significant increase in KSS in the HTO 
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group (p=0.031) compared to the conservatively managed group (table 2.16). There 
was also a statistically significant difference in reduction of oedema, but not area of 
necrosis between the two groups on MRI post-treatment. No complications or failures 
were described for either group.  
Takeuchi et al (2009) described the outcomes of 30 patients following HTO, combined 
with removal of damaged cartilage and drilling of the lesion. A bone substitute 
(Tomofix™) was used to fill the osteotomy defect to permit early weight-bearing. There 
was a statistically significant increase in KSS post-operatively (p<0.01). Radiologically, 
the FTA improved from 181±2.9⁰ pre-operatively to 170±1.8⁰ post-operatively. There 
was evidence of healing of the articular cartilage in 24 out of 30 patients during repeat 
arthroscopy. No patients required any additional surgery.  
Valentí Nín (1998) described the outcomes of 2 patients undergoing HTO as part of a 
larger case series. Both patients were reported to have excellent clinical outcomes 
(Ordoñez classification), despite radiological progression in one of the patients.  
Summary of overall failures of High Tibial Osteotomy 
A summary of overall complication rates for HTO is given in table 2.17. Four out of 5 
studies reported the number of patients requiring either additional surgery or knee 
arthroplasty, with a mean total re-operation rate of 6.1%, this ranged from zero to 8.1% 
for further native joint surgery and zero to 6.5% need for total knee replacement. These 
results represent some of the lowest complication rates of all the treatment modalities. 
Summary of High Tibial Osteotomy 
Overall, the included studies describing outcomes of HTO show positive results for 
disease of varying stages, with some of the lowest complication rates of all the 
treatment types. There is large variation in techniques, fixation methods and 
rehabilitation protocols between authors, along with the use of additional intra-articular 
procedures in some patients. Most authors, however, highlight the overall importance 
of adequate alignment correction, to sufficiently offload the affected compartment, 
aiming for a FTA of approximately 170⁰ to achieve the best outcomes. 
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Author, study design  N= Treatment Need for further surgery (native 
joint) n=, (%) 
Need for 
TKR n=, 
(%) 
Aglietti 
Case series 
31 HTO 0 2 (6.5%) 
Koshino 
Case series 
37 HTO ± drilling/ 
bone grafting  
3 (8.1%); 1 arthrotomy for loose 
body, 2 metalwork removal  
1 (2.7%) 
Marti 
Non-randomised 
comparative study 
6 vs 4 HTO vs PWB None described 
Takeuchi 
Case series  
30 HTO 0 0 
Valentí Nín 
Case series 
2 HTO  0 0 
Table 2.17: Summary of overall failure rates described for high tibial osteotomy.  
Abbreviations: HTO= high tibial osteotomy; PWB= partial weight-bearing; TKR= total knee replacement.  
 
Summary of clinical outcomes for all treatment types  
In summary, the 20 studies demonstrate a huge spectrum of techniques with variable 
outcomes.  Eight studies presented outcomes of non-operative measures, either 
observation, bisphosphonate treatment, electromagnetic therapy or insoles, one of 
which was a randomised controlled trial (Uchio, et al., 2000). Five of these eight studies 
described the need for additional surgical treatment with a mean operation rate of 9.7% 
(range 0-16.7%). A further seven studies, all of which were case series, described 
washout of the knee, with either debridement, curettage with or without microfracture, 
drilling or core decompression; the mean re-operation rate in this group was 11.3% 
(range 0-40%). Various forms of grafting were described in 5 studies, 3 out of 5 
described re-operation rates with a mean of 19.6% (range 0-73%). Finally, five studies 
demonstrated their outcomes of high tibial osteotomy, four of which presented their re-
operation rates, which were the lowest of all the treatment groups with a mean of 6.1% 
(range 0-11.1%). Table 2.18 gives an overall summary of clinical, radiological 
outcomes and failure rates of the different treatment groups.  
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Intervention 1st author, study design  N= Overall improvement 
in clinical scoring? 
Overall improvement in radiological outcome? Need for 
further 
surgery n=, 
(%) 
Bisphosphonates Breer, case series  5 Yes  Remission of disease in all cases Not reported 
Jureus, case series  17 Radiographic outcomes 
only  
24% developed arthritis, further 18% arthritis and joint collapse  2 (11.8%)  
Kraenzlin 
Observational study 
28 Yes Resolution or improvement in all cases 2 (7.2%)  
Pulsed EM therapy Marcheggiani, case series  28 Yes  Overall improvement in WORMS scoring and size of lesion  4 (14.3%)  
Lateral wedge insole Uchio, RCT  18* Yes  Overall improvement in lesion size  Not reported  
Supportive measures: 
analgesia, physiotherapy  
Aglietti, case series  22 Yes  Resolution/improvement in 41%, unchanged in 32%, worse in 27% Not reported 
Valentí Nín, case series  6 67% good No change in stage for 83%, remaining 17% progressed 1 (16.7%) 
Yates, case series 14 Resolution in all Remission of disease in all cases 0 
Arthroscopic Washout Valentí Nín, case series 4 Excellent, good or fair 
outcome in all 
No change in stage for 75%, remaining 23% progressed  0 
Arthroscopic debridement Miller, case series 5 Yes  No change in stage for any patient 2 (40%) 
Arthrotomy & curettage Aglietti, case series 11 Yes  Resolution/improvement in 18%, unchanged in 73%, worse in 9% Not described 
Arthroscopy & drilling Valentí Nín, case series 8 Excellent 25%; good 
50%; fair 12.5%; poor 
12.5% 
No change in stage for 75%, progression in 25% 1 (12.5%) 
Table 2.18: Summary of clinical, radiological outcomes and failure rates of all included studies 
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Intervention 1st author, study design  N= Overall improvement 
in clinical scoring? 
Overall improvement in radiological outcome? Need for 
further 
surgery n=, 
(%) 
Arthroscopic microfracture Akgun, case series 26 Yes   Improvement in 23%, unchanged in 62%, progression in 15% 0 
Core decompression ± bone 
grafting  
Deie, case series 12 Yes  Unchanged in 67%, progression in 33% 2 (16.7%)  
Duany, case series 7 Yes  Progression of disease in 29% 2 (28.6%) 
Forst, case series  16 Yes  Resolution in 94%, 6% progression Not reported 
Autogenous bone grafting Johnson, case series 25 No  None described 13 (52%) 
Osteochondral autograft 
transfer/Osteochondral 
Allograft 
Duany, case series 9 Yes Progression of disease in 11% 2 (22.2%) 
Kotani, case series 16 Yes Graft acceptance in 100%, 0 
McDermott, case series 11 No  None described   8 (73%) 
Tanaka, case series 6 Yes  None described  Not reported 
High Tibial Osteotomy  Aglietti, case series 31 Yes  Resolution/improvement in 58%, unchanged in 35.5%, progression in 
6.5% 
2 (6.5%) 
Koshino, case series 36 Yes  Resolution/improvement in 81%, unchanged in 19% 4 (11.1%) 
Marti 
Non-randomised 
comparative study 
10 Yes  Reduction in necrotic area in 83%, reduction in oedema in 100% Not reported 
Takeuchi, case series 30 Yes  Improvement in radiolucent area  0 
Valentí Nín, case series 2 Excellent in 100% Improvement in 50%, progression in 50%  0 
Table 2.18: Summary of clinical, radiological outcomes and failure rates of all included studies (ctd). *=number in treatment arm of study. 
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2.5.6 Clinical results by stage  
Although disease staging has been briefly discussed above, this section gives a further 
summary of the outcomes for early-stage disease with normal joint contour (equivalent 
to Koshino 1 and 2) and late-stage disease with altered joint architecture and collapse 
(equivalent to Koshino stage 3 and 4). Table 2.19 summarises the method of staging 
used, the number of patients in each stage and whether results were presented 
according to disease stage. Four studies are not included in the table as no staging 
was recorded for their patients (Johnson, et al., 2014; Jureus, et al., 2012; Kraenzlin, et 
al., 2010; McDermott, et al., 1985).  Outcomes according to stage could only be 
extracted for 9 of the 16 studies with staging included: 3 studies were restricted to one 
disease stage (Breer S, et al 2013; Marcheggiani Muccioli, et al 2013; Yates, et al., 
2007)) and 6 presented outcome data for each disease stage (Duany, et al., 2010; 
Forst, et al., 1998; Koshino, 1982; Tanaka, et al., 2009; Uchio, et al., 2000; Valentí Nín, 
et al., 1998).  
Early stage with normal joint contour (Koshino Stages 1 & 2) 
Five studies exclusively described outcomes of patients with early-stage SONK (i.e. 
normal joint contour and no collapse of the involved femoral condyle). As shown in 
table 2.20, all treatment modalities resulted in clinical and/or radiological improvement.  
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 Number of Patients   
1st Author 
and year 
Method of Staging Stage 
1 
Stage 
2 
Stage 
3 
Stage 
4  
Stage 
5 
Outcomes 
described 
per stage?   
Akgun, 2005 Koshino 0 13 10 3  No 
Breer, 2013 5 0 0 0  Yes  
Deie, 2008 0 5 7 0  No  
Koshino, 
1982 
0 10 16 11  Yes 
Marcheggiani, 
2013  
28 0 0 0  Yes  
Miller, 1986 0 2 3 0  No 
Takeuchi, 
2009 
0 5 10 15  No 
Tanaka, 2009 0 0 3 3  Yes  
Forst, 1998 
15 1 0 0  Change in 
stage 
recorded  
Yates, 2007 14 0 0 0  Yes 
Uchio, 2000 
Koshino  Treatment 3 6 7 2  Change in 
stage 
recorded  Control 2 7 1 3  
Valentí Nín, 
1998 
Koshino 7 8 1 5  Yes  
Aglietti, 1983 
Insall modification of 
Koshino 
0 12 40 31 18 No 
Marti, 2000 
Insall 
modification 
of Koshino 
HTO  2 2 0 2 0 No 
Control 2 0 1 0 1 No  
Duany, 2010 
Ficat & 
Arlet  
Core 
Decompre
ssion 
1 5 1 0  Yes 
OATS 0 0 8 0 
Kotani, 2003 
Lotke 1b=1
2 
1c=4 
0 0 0 0 Partially  
Table 2.19: Method of disease staging and number of patients in each stage for included research. 
Abbreviations: HTO= high tibial osteotomy, OATS= osteochondral autograft transfer system. 
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1st Author, year Intervention N= Results  
Yates, 2007 Supportive 
measures 
14 ▪ Complete resolution of symptoms and MRI 
changes 
Marcheggiani 
Muccioli, 2013 
Pulsed EM 
therapy 
28 ▪ Significant improvement in KSS, EQ-5D & 
Tegner activity scale 
▪ Pain reduction in 75% 
▪ Significant reduction in WORMS score at 6 
months 
Breer, 2013 Bisphosphonates 
& vitamin D 
5 ▪ All patients’ symptom free at 4 weeks 
▪ Remission of bone marrow oedema in all cases 
Forst, 1998 Extra-articular 
drilling 
16 ▪ Pain resolved in all patients  
▪ Normalisation of bone marrow signal at a mean 
of 35.8 months  
▪ KSS improved from 74 to 187.2 
Kotani, 2003 OATS ± HTO 16 ▪ JOA improved from 68.1 to 88.8 
▪ Radiological and arthroscopic confirmation of 
graft acceptance in all cases  
Table 2.20: Summary of included studies specifically evaluating early-stage disease.  
Abbreviations: EM=electromagnetic, KSS= American Knee Society score; OATS= osteochondral autograft 
transfer system, HTO=high tibial osteotomy, JOA= Japanese orthopaedic association score, 
WORMS=whole organ MRI score.  
 
Three further studies described outcomes for a mixed population, with their results and 
outcome measures separated for early and late-stage disease (Duany, et al., 2010; 
Koshino, 1982; Valentí Nín, et al., 1998):  
 
Duany et al (2010) described arthroscopy and decompression for 6 patients with early-
disease. The patient with stage 1 disease had radiological progression and underwent 
an OATS procedure at 13 months following the initial surgery, with an improvement in 
KSS from 62 to 100 at final follow-up. The 5 patients with stage 2 disease 
demonstrated an increase in KSS from 59 (range 50-70) to 74 (range 45-100) post-
operatively. One patient had radiological progression, requiring total knee arthroplasty 
4 months after the index procedure, giving a total re-operation rate of 33% in this 
group. One patient with stage 2 disease underwent OATS as their primary procedure; 
their KSS increased from 52 to 80 post-operatively. (Duany, et al., 2010). 
 
Valentí Nín et al (1998) published outcomes of 7 patients with Koshino stage 1 disease 
and 8 patients with stage 2 disease, treated with various modalities, depending on their 
symptom severity. Although 4 patients had evidence of radiological progression 
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following intervention, 75% still had an excellent clinical outcome despite worsening 
radiological features and did not require any further intervention (table 2.21). Only one 
patient with a poor clinical outcome (but no radiological progression) following 
arthroscopy and drilling required further treatment in the form of HTO. 
 
Koshino  
Stage 
N= Treatment 
modality  
Clinical 
outcome 
(Ordoñez) 
Change in 
radiological stage 
Further 
treatment 
1 3 Weight-bearing 
relief, analgesia, 
physiotherapy 
Good n=2 
Fair n=1 
No change: n=2 
Progressed to stage 
2: n=1 
- 
1 2 Arthroscopic 
washout 
Excellent n=2 No change: n=1 
Progressed to stage 
4: n=1 
- 
1 2 Arthroscopy & 
drilling  
Excellent n=2 No change: n=1 
Progressed to stage 
2: n=1 
- 
2 1 Weight-bearing 
relief, analgesia, 
physiotherapy 
Good n=1 No change: n=1 - 
2 1 Arthroscopic 
washout 
Fair n=1 No change  - 
2 5 Arthroscopy & 
drilling  
Good n=4 
Poor n=1 
No change  HTO n=1  
(poor outcome)  
2 1 HTO Excellent n=1 Progressed to stage 
4: n=1 
-  
Table 2.21: Outcomes of treatment for early disease described by Valentí Nín et al (1998). 
Abbreviations: HTO= high tibial osteotomy  
 
Koshino described 37 patients with varying stages of disease who had been treated 
with HTO. He found that treatment of stage 2 disease had a higher statistically 
significant improvement in clinical outcomes compared to stage 3 (p <0.05) and stage 
4 disease (p<0.01). There was also a statistically significant improvement in those who 
had stage 3 disease, compared to stage four disease (p <0.05) (table 2.22).  
 
Koshino Stage Number of Patients Pre-op knee score Post-op knee score  
II 10 56±9 95±2 
III 16 56±6 90±7 
IV 11 54±6 81±11 
Table 2.22: Outcomes as described by Koshino following HTO (Koshino, 1982) 
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Late disease with abnormal joint contour (Koshino stage III & IV)  
Four studies isolated and presented their results for late-stage disease (Duany, et al., 
2010; Koshino, 1982; Tanaka, et al., 2009; Valentí Nín, et al., 1998). The results of 
Koshino (1982) are shown above in table 2.22, suggesting that the clinical outcomes of 
HTO are better with earlier disease.  
 
Tanaka et al (2009) evaluated the short-term effects of osteochondral autografting in 3 
patients with Koshino stage 3 disease. The Lysholme score increased from 54.7 (range 
47-69) to 95.3 (90-100) post-operatively. Three patients with stage 4 disease also 
demonstrated an increase in their Lysholme score, but to a lesser extent, increasing 
from 54.7 (range 47-69) to 89.3 (85-94) post-operatively.  
 
Duany et al (2010) described the results of one patient with Ficat and Arlet stage III 
disease undergoing arthroscopy and decompression; their KSS increased from 75 to 
90 post-operatively with no change in disease stage. There were 8 patients with stage 
III disease treated with OATS; their mean KSS increased from 58 (range 39-75) to 80 
(range 43-80) post-operatively. One patient progressed to stage IV disease and 
required knee arthroplasty 11 months after their index procedure, giving an overall 
failure rate of 12.5% (Duany, et al., 2010). 
 
Valentí Nín et al (1998) described one patient with stage 3 disease managed non-
operatively, with a good outcome and no change in radiological stage. There were 5 
patients with stage 4 disease treated with different modalities; 1 was managed with 
conservative measures and had a poor outcome.  There were 3 treated with 
arthroscopy, HTO, or total knee replacement; all had excellent outcomes at final follow-
up. One patient was treated with arthroscopy and drilling had a fair outcome. (Valentí 
Nín, et al., 1998). 
 
Summary of results according to disease stage 
Several studies exist evaluating conservative treatment, decompression, grafting or 
high tibial osteotomy for intermediate to late-stage disease. Although outcomes mostly 
improved, it appears, as stated by Koshino (1982) that treatments may lead to a better 
clinical outcome if intervention is employed earlier, before joint-collapse.  
Despite there being twenty studies eligible for inclusion in this systematic review, less 
than half detailed their results in such a way as to be able to differentiate the results of 
the proposed treatment according to stage of disease. For the studies that did, there 
were often several different interventions described in the cohort, leaving individual 
numbers of patients in each treatment group small.  
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2.6  Systematic review: Discussion 
 
This section summarises the main findings from the systematic review evaluating joint 
preserving treatments for SONK. The strengths and limitations of the methodology are 
then discussed followed by the clinical implications and conclusions of the review.  
 
Summary of Main Findings  
The systematic review identified numerous different treatment modalities for SONK, 
both non-operative and operative joint-preserving measures, with widely varying 
techniques. There was one randomised controlled trial, but this had high a risk of bias 
(Uchio, et al., 2000). The remaining included evidence consisted of multiple case series 
limited by relatively small numbers, inherently increasing the risk of possible selection, 
reporting and publication bias (O’Neil, et al., 2014). 
 
Non-operative joint-preserving treatments  
Supportive measures included a period of rest, analgesia and physiotherapy, the use of 
insoles, electromagnetic therapy and medical intervention with bisphosphonates. All 
case series demonstrated promising results in their small patient groups.  
The randomised controlled trial describing a lateral wedge insole versus placebo 
showed positive results, but a power calculation was not included, patient numbers 
were relatively small and given the nature of the intervention, participants could not be 
blinded, questioning the overall strength of evidence (Uchio, et al., 2000).   
The study describing the effect of pulsed electromagnetic therapy showed beneficial 
outcomes in stage 1 disease. However, patients in this study also received regular anti-
inflammatory medication and recommendations on restricted weight-bearing; it is 
possible that these additional measures may influence outcomes (Marcheggiani 
Muccioli, et al., 2013). Studies evaluating analgesia with or without a period of weight-
bearing restriction and physiotherapy alone have also shown similar improvements in 
results, making it difficult to formally conclude that electromagnetic therapy alone 
results in additional beneficial effects in early-stage disease (Aglietti, et al., 1983; 
Valentí Nín, et al., 1998; Yates, et al., 2007).  
The role of bisphosphonates in the treatment of SONK is limited to evidence presented 
in small case series only, which have shown a beneficial effect (Breer, et al., 2013; 
Jureus, et al., 2012; Kraenzlin, et al., 2010).  A double-blind randomised controlled trial 
evaluating bisphosphonates compared to placebo was excluded from this systematic 
review as it had a population with mixed pathologies (Meier, et al., 2014). This trial 
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provided conflicting evidence to the included studies and failed to demonstrate any 
additional benefit of ibandronate over placebo.  A recent systematic review including 8 
studies, specifically focussing on the use of bisphosphonates for SONK has been 
published following the conclusion of the review for this thesis. Despite several 
additional studies being included, the review comes to similar conclusions; 
bisphosphonates may have a role, but as their efficacy has not been validated by a 
randomised controlled trial (Meier, et al., 2014) further research is needed to identify 
whether they should continue to be a treatment option for SONK (Jordan, et al., 2016).  
 
Several studies describing joint-preserving surgical interventions reported that their 
included patients had failed a period of non-operative treatments, usually for a period of 
up to 3 months (Akgun, et al., 2005; Duany, et al., 2010; Forst, et al., 1998; Miller, et 
al., 1986; Takeuchi, et al., 2009). It would suggest that conservative measures are 
therefore an acceptable first-line treatment, but without knowing the ratio of patients 
who were successfully treated by these means compared to those who went on to 
require further intervention it is impossible to evaluate the true effectiveness. Only one 
of these studies stated that 80 patients had symptomatic improvement following a 
period of analgesia and protected weight-bearing compared to 18 requiring further 
surgical intervention, suggesting a possible overall success rate of 82% for supportive 
treatment (Duany, et al., 2010). The efficacy, as well as the duration of treatment using 
these measures is an area that requires further research.  
Joint-preserving surgery  
Although this group of treatments makes up most of the included research, it consists 
of a selection of low level evidence, with high risk of bias.  
Aside from earliest included studies by McDermott et al (published in 1985), who 
reported a failure rate of 73%, and the small study by Miller et al from 1986, where 2 of 
5 patients (40%) required further intervention, the majority of the arthroscopic 
techniques and grafting procedures have provided reasonably promising results, with 
overall improvements in clinical outcomes. However, these from relatively small case 
series, for patients with widely variable disease presentations, and were often 
performed concominantly with realignment procedures. For those with positive 
outcomes, it is impossible to state whether this was due to the realignment or the 
grafting alone, or due to the combination of interventions. Larger scale studies or trials 
with more standardised techniques and the use of control groups to provide 
comparison would provide a useful contribution to this area of treatment.  
 
The studies describing outcomes of high tibial osteotomy for SONK also show positive 
results for disease of varying stages. There is large variation in techniques, fixation 
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methods and rehabilitation protocols between authors, along with the use of additional 
intra-articular procedures in some patients. Most authors, however, highlight the overall 
importance of adequate alignment correction, to sufficiently offload the affected 
compartment, aiming for a femorotibial angle of approximately 170⁰ to achieve the best 
outcomes. 
Following on from the planning and completion of this systematic review, two 
systematic reviews have since been published evaluating the use of bisphosphonates 
for SONK (Jordan, et al., 2016) and joint-preserving surgical procedures (Lieberman, et 
al., 2014) for the treatment of both SONK and secondary ON. Lieberman et al (2014) 
found that core decompression was successful for small pre-collapse lesions and bone 
grafting is effective for pre- and post-collapse lesions. Osteochondral grafting was also 
found to be effective. Jordan et al (2016) concluded that bisphosphonates may have a 
role in the treatment of SONK, but this has not been supported by a single randomised 
controlled trial (Meier, et al., 2014). The results both systematic reviews present similar 
conclusions and support the results of this review, that further larger trials are needed 
to determine the true efficacy and make recommendations for treatment.  
Complication rates and overall failure  
The systematic review set out to review failure of treatment with need to progress to 
additional surgery or joint arthroplasty. Fourteen of the included studies (70%) provided 
information on patients needing further surgical intervention. Rates were highly 
variable, ranging from zero to 40% of patients needing further joint-preserving 
intervention, as well as zero to 40% of patients requiring total knee arthroplasty after 
their initial joint-preserving treatment. The varying follow-up periods described in the 
included research ranging from a few months to many years, makes a definitive 
comparison of overall failure rates inaccurate. It could be argued that the complication 
rate is relatively high for the various techniques, with one in ten patients in the included 
studies requiring further joint preserving surgery and 11% of patients ultimately 
requiring total knee arthroplasty.  However, the small numbers involved and the 
uncertainty regarding complications in the studies excluded from this calculation make 
it difficult to fully appreciate the true success of the described interventions. 
 
Efficacy of treatments according to disease stage.  
Overall, less than half of the included studies detailed their results in such a way as to 
be able to differentiate the results of the proposed treatment per stage of disease. For 
the 45% of included studies which did provide some information regarding this, there 
were often several different interventions described in the cohort, leaving individual 
numbers of patients in each treatment group small. This, along with the numerous 
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different outcome measures used across the included research makes it difficult to 
provide comparison and come to any firm conclusions regarding the efficacy of specific 
treatments for each stage of disease. Presenting results across the spectrum of 
disease may also result in inaccuracies; individual treatments may successful for early 
disease, for example, but if the patient cohort is presented together, rather than specific 
to stage of disease, it may reduce the apparent effectiveness. This highlights the need 
for future research to be sub-grouped according to disease stage.    
 
Strengths and Limitations  
Despite the weaknesses in available evidence, there are several strengths to the 
methodology used to undertake this systematic review. Both the Cochrane handbook 
and PRISMA checklists were used for guidance throughout the development and 
execution of the review, results were presented according to the PRISMA flowchart to 
minimise bias while conducting the review and ensure clear and transparent reporting 
of results (Higgins & Green, 2011; Liberati, et al., 2009; Moher, et al., 2009).  
Numerous databases were utilised, followed by a search of the references of included 
studies to identify and include as much relevant research as possible. Two reviewers 
were involved throughout the process to try and avoid introducing selection and 
reporting bias; studies were independently reviewed and selected for inclusion by two 
reviewers (MC Killen and CP Charalambous), data was then extracted from included 
research using a standardised proforma, by two reviewers (MC Killen and MP Dey), 
ensuring the same information was obtained, or any deficits in methodology or results 
were identified (Moher, et al., 2009). All included studies were screened using a risk of 
bias checklist included within the data extraction proforma (appendix 2).   
Potential weaknesses of the methodology used include the decision to exclude any 
papers not available in English, potentially introducing an element of selection bias and 
risking missing important studies which may impact the overall results. However, a 
systematic review evaluating the effect of English language restriction has failed to 
show evidence of this, with none of the included studies finding major differences 
between summary treatment effects in English-language restricted meta-analyses 
(Morrison, et al., 2012) .  In addition, there were several conference proceedings 
identified in the initial search which were relevant to the review, but no full texts were 
published in the literature for formal inclusion and analysis, the decision to exclude 
such literature may have introduced a degree of publication bias (Blackhall & Ker, 
2007), but it is unclear whether inclusion of such data would influence overall results 
and may in fact result in overestimation of treatment effectiveness (McAuley, et al., 
2000). There may be further limitations, present with all systematic reviews in terms of 
an element of both publication and reporting bias of the included studies, whereby only 
56 
 
series with positive results are written up and selected for publications (Dwan, et al., 
2008); the availability of further higher-level evidence would hopefully limit such factors, 
by reporting outcomes of either randomised trials or comparative studies showing 
whether one treatment is superior to another.  
 
Overall, the body of evidence describing joint preserving treatments for SONK is 
limited. The included randomised controlled trial had a high risk of bias, and the 
remaining evidence is limited to small studies, mostly in the form of case series. The 
nature of the evidence itself results in an introduction of possible reporting bias, and 
further analysis of the individual studies found that all but one scored as high risk of 
bias from deficiencies in their methodology and results.  
Limitations in drawing conclusions from the studies has also arisen from the use of 
numerous different classification systems to stage disease (Ficat, 1985; Koshino, 1982; 
Lotke PA, 1982), as well as an even larger number of outcome measures used to 
quantify outcomes, making direct comparison of results almost impossible. There are 
currently no recommendations for the most appropriate method of staging for SONK, 
but it does appear from review of the literature that the Koshino classification remains 
the most commonly utilised (Koshino, 1982). Regarding clinical scoring systems, it is 
unclear from the literature whether any of these scoring tools are validated specifically 
for SONK, as most of the knee-specific scoring tools were initially designed for 
evaluating outcomes related to either osteoarthritis of the knee or ligamentous 
instability, which may affect the relevance and strength of the results (appendix 5).  
There is no existing research evaluating the ceiling effects of the scoring tools used; if 
maximum scores are easily attained, it may give an overestimation of the efficacy of 
the treatment described, affecting the validity of the results (Wang, et al., 2008). 
Evaluation whether a ceiling effect exists for each scoring system would be worthwhile 
when deciding on the best score to use for measurement of clinical outcomes for 
SONK.  
 
There is very little in the way of ‘new evidence’ included in this systematic review, with 
publication dates of included research ranging from 1982 to 2014; only 35% of studies 
have been published in the last 10 years. Giving the ever-advancing surgical 
techniques, particularly in arthroscopy, these results may not provide a true 
representation of treatments currently being performed, and the potentially improved 
outcomes that often come with developments in procedures (Carr, et al., 2015). At the 
time of writing, there were currently no ongoing trials related to SONK registered with 
either ISRCTN (ISRCTN, 2017) or Cochrane Central Register of Controlled Trials 
(Cochrane Library, 2017); although these resources are mostly limited to UK and 
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European trials, the lack of any ongoing research further emphasises the need for 
some more up to date evidence.  
 
Implications for clinicians  
At the time of writing this is the first available systematic review to evaluate both 
medical and surgical joint-preserving treatment for SONK. Although it has not been 
able to provide conclusive evidence, it has been able to present the outcomes and 
failure rates of 20 studies, which met the inclusion criteria. From these studies, it is 
difficult to come to any conclusion as to whether bisphosphonate treatment has a role 
in treatment of SONK, over and above the traditional conservative measures of rest, 
physiotherapy and analgesia, as these measures alone have also shown to be 
beneficial (Aglietti, et al., 1983; Valentí Nín, et al., 1998). Most studies reporting the 
numerous joint-preserving surgical measures have demonstrated relatively promising 
results, ranging from simple arthroscopic debridement to joint re-alignment with high 
tibial osteotomy, but they vary widely in overall study design and quality, along with 
differences in surgical techniques. The included research has also demonstrated 
widely variable in complication rates and ultimate need for joint replacement, with some 
research showing much higher failure rates than with non-operative measures alone 
(Miller, et al., 1986; Johnson, et al., 2014; McDermott, et al., 1985; Valentí Nín, et al., 
1998). Although the results of the systematic review have provided some guidance on 
the success and failure rates of various treatments, both medical and surgical, the 
combined evidence is not strong enough to make formal recommendations to influence 
current practice. 
 
Implications for further research 
This review has identified the need for larger, well designed and appropriately powered 
randomised controlled trials with formal comparison of joint-preserving treatments with 
each other or placebo to determine the true effectiveness of the available treatment 
options. There is a need for comparison of the different drilling and grafting techniques 
with each other as this is an area with the most limited evidence. Given the uncommon 
nature of SONK it is likely that such trials would require multi-centre collaboration either 
on a national or international scale (McCulloch, et al., 2002; Solomona & McLeod, 
1995). It may also be that high quality, non-randomised methods are needed as an 
alternative, due to small patient numbers; well-designed observational studies may 
provide a suitable alternative to give important information on differences between 
various interventions (Silverman, 2009). It is also imperative that future trials are set-up 
to analyse outcomes according to disease stage, along with standardisation of disease 
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grading and outcome scoring, to try and determine which treatment is best to use for 
each patient group. 
A quarter of the included studies stated that their cohort had undertaken a period of 
non-operative management before proceeding to surgical intervention (Akgun, et al., 
2005; Duany, et al., 2010; Forst, et al., 1998; Miller, et al., 1986; Takeuchi, et al., 
2009). Additional important information to gather from future research would include 
whether all patients undergo a provisional trial of non-operative measures with 
analgesia and physiotherapy and if so, in what proportion of patients is this successful. 
Complication rates and failures should be clearly defined and stated to aid in evaluating 
treatment effectiveness compared to non-operative measures.  
One of the main difficulties in synthesising the results for this review was the huge 
variation in measures used to assess outcomes. It is unclear from the literature 
whether any of these outcomes used have been validated for use in SONK, and most 
tools employed were initially developed for other knee conditions, particularly knee 
osteoarthritis and ligamentous instability (appendix 5). In addition to this, there is no 
evidence evaluating ceiling effects of the scores used, further questioning the overall 
validity of results. There is therefore a need to either develop or validate an existing 
tool for use in SONK to provide some standardisation and aid in future interpretation of 
clinical results.  
2.7 Conclusion and recommendations of the Systematic Review  
The systematic review has identified 20 studies describing treatments ranging from 
analgesia and physiotherapy to realignment surgery using high tibial osteotomy. 
Although the evidence to support the overall efficacy of a period of analgesia and 
physiotherapy is limited, 25% of included studies stated that their entire patient 
population underwent a trial of such measures prior to proceeding with further 
intervention, suggesting that this may be a commonly employed initial treatment 
(Akgun, et al., 2005; Duany, et al., 2010; Forst, et al., 1998; Miller, et al., 1986; 
Takeuchi, et al., 2009). One study suggested that 82% of their entire cohort were 
successfully treated with non-operative measures alone (Duany, et al., 2010). In the 
event of failure of non-operative treatment, there is no good evidence to advise on 
which is the best treatment to consider next; currently available research is limited to 
case series and small randomised trials, the majority of which have a high risk of bias.   
There is no doubt that further, up-to-date research evaluating the treatment of SONK 
would be worthwhile, to reflect evolving technology and surgical practice. 
Recommendations from the outcome of this systematic review are as follows:  
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1. Non-operative treatment with rest, analgesia and physiotherapy appears to be an 
acceptable initial strategy for treatment. For authors presenting a cohort of patients 
who have failed non-operative measures, it would be worthwhile to know the 
proportion of patients who have been treated overall, to gain better knowledge of 
the overall success rates of this treatment modality.  
2. A minimum follow-up period should be employed for studies, to determine the true 
success of interventions. Limiting overall follow-up to 8 weeks, as utilised in one 
study (Breer, et al., 2013), is insufficient to determine whether a treatment is 
effective in the long-term.  
3. Where possible, studies should utilise a control group, particularly for those where 
interventions are being used concomitantly with analgesia and physiotherapy, to 
give a better understanding of treatment efficacy.  
4. An effort should be made to minimise bias in future research, using appropriate 
study designs and guidance for the reporting of studies, for example, CONSORT or 
STROBE, alongside risk of bias tools while planning and developing studies 
(Moher, et al., 2010; (von Elm, et al., 2008).  
5. There should be clear and transparent reporting of failure rates and complications 
experienced with reported treatments. It is often unclear whether there were no 
complications experienced, or whether this has simply not been reported.  
6. There should be a standardised disease staging used for studies relating to SONK, 
and results should be presented per disease stage.  
7. Outcome reporting also needs to be standardised, with a view to validation of either 
an existing clinical scoring tool, or formulation of a new score with a low ceiling 
effect to improve overall validity of outcomes reporting.  
Given the inconclusive nature of the results of the systematic review, further methods 
were considered to provide additional evidence and work towards understanding which 
treatments are considered most appropriate to use for different stages of disease. It 
was decided that the use of consensus methodology would be the most appropriate 
way to proceed; such techniques have been increasingly used and have demonstrated 
effectiveness in providing agreement on topics that do not yet have strong empirical 
evidence to support them. Following on from this review, a Delphi consensus study 
was therefore undertaken, involving an international group of knee experts to try and 
provide further information to reach the objectives that were not addressed from the 
systematic review.  
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3. CHAPTER THREE: DELPHI STUDY OF JOINT-PRESERVING 
TREATMENTS FOR SPONTANEOUS OSTEONECROSIS OF 
THE KNEE   
 
3.1 Introduction 
The systematic review was conducted as an initial phase in working towards the 
formulation of recommendations for the treatment of SONK, through evaluation of 
currently available evidence. Research has shown the success rates of various medical 
and surgical treatments for patient groups of differing sizes, but it has failed to 
demonstrate which treatment is most effective for patients overall or with different 
disease stages 
In such situations where good quality evidence is lacking, consensus methods can be a 
helpful tool to provide further information and guide clinical practice (Jones & Hunter, 
1995).  A Delphi consensus method was therefore undertaken to gather opinions on 
best practice from an international group of experts. Various scenarios were presented, 
relating to different disease stages, to try and establish which treatment is best for 
patients throughout the spectrum of SONK, as this was one of the main areas where 
the systematic review failed to provide any good quality evidence. A second area 
highlighted from the systematic review was that several studies stated that their cohort 
undergoing surgical intervention had failed a period of non-operative management 
(Akgun, et al., 2005; Duany, et al., 2010; Forst, et al., 1998; Miller, et al., 1986; 
Takeuchi, et al., 2009); this was explored further in the Delphi study to determine 
whether this is standard practice before proceeding with any surgical treatment. It is 
unclear from the evidence reviewed whether surgeons perform specific first-line, less 
invasive treatments, such as medical treatment or arthroscopic measures, to try and 
improve symptoms before proceeding with more major alternatives, such as high tibial 
osteotomy in the event of failure of initial treatment; this is also explored in the 
scenarios presented.  
This chapter will give an overall introduction to why a Delphi study design was chosen 
and provide details on the aims, objectives and methods of the study. Following on 
from this, the two rounds of the Delphi study will be described in detail along with the 
results, a discussion and conclusion.  
3.2 Aims & Objectives  
The aim of this Delphi study was to identify commonly utilised treatment modalities for 
SONK and to reach an agreement on most appropriate first and second-line 
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management of different stages of disease. The specific objectives of this Delphi study 
are detailed below.   
Delphi Objective 1: 
To identify if specialists give a standard period of observation with adjuncts such as 
analgesia, physiotherapy and/or restricted weight-bearing before proceeding with 
surgical intervention.  
Delphi Objective 2: 
To establish whether experts consider that there is a role for medical treatment of 
SONK with bisphosphonates. 
Delphi Objective 3: 
To establish whether specialists regularly perform arthroscopic drilling or microfracture, 
or grafting procedures, and, if so, establish a consensus on what stage in the disease 
process it should be used. 
Delphi Objective 4: 
To establish if experts agree on whether high tibial osteotomy has a role as either a 
primary treatment or secondary intervention after failure of less invasive methods. 
Delphi Objective 5: 
To achieve a consensus on first-line treatment of patients with SONK but normal joint 
architecture (no collapse of the femoral condyle or tibial plateau) and preferred second-
line treatment in the event of persisting symptoms following intervention.  
Delphi Objective 6: 
To achieve consensus on both first and second-line treatment of patients with SONK 
with collapse of the femoral condyle and knee malalignment. 
The combination of outcomes from the systematic review and Delphi study will aim to 
provide a foundation for evidence-based guidance for treatment of patients with 
different stages of disease, as well as assessing ongoing deficits in evidence and the 
value of further research into the management of SONK.  This will be discussed in the 
final chapter of the thesis.  
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3.3 Delphi Study Methodology 
A two-round Delphi study was chosen to gather evidence from an international group of 
knee specialists regarding commonly utilised joint-preserving treatments for patients 
with various stages of SONK. The Delphi technique was initially developed for the 
military in 1948 to aid in forecasting events (Dalkley & Helmer, 1962). Since then, 
Delphi studies have long been used in the setting of healthcare and medical related 
research (Fearon, et al. 2011; McKenna, 1994; Powell, 2003; Rayens & Hahn, 2000). 
The Delphi method has been defined as a structured process for collecting knowledge 
and opinion from a group of experts using a series of questionnaires, in order to 
determine commonly used treatments to aid in the development of clinical 
assessments or guidelines and provide recommendations for future research 
(Hutchings, et al., 2006; Jordan, et al., 2003; Ziglio, 1996).  
Using a Delphi technique has the advantage of being open to a wide range of potential 
participants, is not limited by location and has a potentially low time commitment for 
those involved. It permits anonymous responses, eliminating the possibility for the 
group to become dominated by individuals, which can sometimes occur in face-to-face 
groups (Jairath & Weinstein, 1994; Critcher & Gladstone, 1998). The Delphi method 
also allows participants to refine their opinions in response to the views of the group 
between rounds (Skulmoski, et al., 2007).  It does, however, rely on an adequate 
number of willing participants and carries a possibility that consensus may never be 
reached.  
There are three main consensus techniques that are used in the field of medicine; a 
consensus development panel, the nominal group technique and a Delphi consensus 
(Waggoner, et al., 2016). A consensus development panel is commonly used to aid 
formulation of healthcare policies, whereas, a nominal group process is often used to 
evaluate appropriateness of interventions in healthcare; both techniques can ultimately 
result in changes to the decision-making process involved in treating patients 
(Waggoner, et al., 2016; Jones & Hunter, 1995). Although both these techniques have 
their advantages, they involve face-to-face meetings with the involved participants. 
Given the planned international nature of the consensus in this thesis, this would have 
been logistically very difficult, costly and would have involved relatively large time 
commitments, potentially reducing the number of interested and available experts. For 
this reason, it was decided that a Delphi consensus would be the most appropriate 
method to use for this study. 
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There are wide variations in the description of the Delphi technique in the literature 
(Boulkedid, et al., 2011; Dalkley & Helmer, 1962; Diamond, et al., 2014). In its 
traditional form, three rounds are used. The first round begins with an initial 
questionnaire or brainstorming session to generate ideas and form a basis for the 
issues that need to be raised in future rounds (Fearon, et al., 2011). Feedback from 
round one is presented in the form of a second-round questionnaire, which aims to 
gather opinions on the issues raised. Subsequent rounds usually consist of the 
presentation of the opinions of the panel, with members being asked to reconsider their 
opinions considering the information presented from other members until a consensus 
is reached (Hsu & Sandford, 2007; Keeneya, et al., 2001; Sumsion, 1998).  
3.4 Delphi Study Method 
For this thesis, the systematic review had already provided a basis for the issues that 
needed to be raised in questionnaires. For this reason, a modified two-round Delphi 
technique was used, an adaptation which has already been described in the literature 
(Mullen, 2003). It was also proposed that reducing the number of rounds from three to 
two would hopefully lead to increased response rates from the chosen panel. An 
overview of the Delphi process used is shown in figure 3.1.  
 
Figure 3-1: A diagrammatic representation of the Delphi process used 
 
 
 
Round 1
•Demographic data collected 
•Treatments previously used by individuals for all cases of SONK established 
•Clinical scenarios presented with all possible treatment options listed
Round 2
•Demographic data collected
•Same clinical scenarios presented (with minor adaptations using comments 
given in round 1)
•Limited options for responses using up to 5 most popular answers from round 
1 
Analysis of 
Round 2
•Consensus reached if ≥60% agreeing on treatment for a specific scenario
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3.4.1 The Panel & Sample Size  
Before undertaking the first round of the Delphi study, panel members were identified. 
To be eligible to take part and contribute to the study, participants were required to 
have ‘expert’ knowledge of SONK. There are no established set criteria for ‘experts’ but 
is largely dependent on the subject area (Keeney, et al., 2006). It has been stated that 
invited participants should have sufficient knowledge and experience of the area under 
investigation, capacity and willingness to participate, sufficient time to permit 
participation and have effective communication skills (Adler & Ziglio, 1996). Selection 
of panel members does have the theoretical risk of introducing bias, as those agreeing 
to participate often have a particular interest in the field being examined and may have 
a vested interest in a specifc treatment related to personal involvement in research 
(Murry & Hammons, 1995; Sandrey & Bulger, 2008). It is therefore important to select 
individuals that can be relatively impartial so that the results of the study reflect a true 
representation of current opinion and knowledge (Goodman, 1987).  A group of 
practicing clinicians who regularly manage cases of SONK were selected as well as a 
group of authors, to try and minimise any bias towards the treatments published by the 
author group.  
The first group of experts contacted were members of the “20/20 knee group”, a special 
interest group of 21 fellowship-trained knee surgeons working in different centres 
throughout England.  Members of this group have experience in managing patients 
with SONK and may have a higher than average case load of this condition compared 
to other practicing knee surgeons.  Contact with this group was made through one of its 
members, who was willing to aid in facilitation and distribution of emails, in the absence 
of contact details being available in the public domain.   
The second group in the Delphi panel were selected using a PubMed search to identify 
those who have recently published on the topic of SONK and are working as a knee 
surgeon, with no limit on country of practice, provided they have published in English. 
The keywords ‘spontaneous, osteonecrosis and knee’ were used to search for relevant 
publications. Consecutive publications, ordered from most recent first, including a 
reasonable population of SONK (no case reports) were reviewed to identify surgeons 
who were most likely to still be practicing. This process was continued, until sufficient 
authors were identified. One author per article was invited to take part in the study, in 
keeping with the publication of contact details for a single author in the publication. 
Usually, this was the most senior author of these publications, when possible, as it was 
presumed that this author would have the most experience in treating patients with 
SONK and would therefore be most suited to being involved in the study; if there was 
any uncertainty, a further search was performed of the authors’ other publications to 
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establish that the person to be contacted was a practicing clinician. Although initially 20 
authors were sought, further authors were identified following dissemination of initial 
round 1 emails due to several of the listed email addresses being undeliverable and a 
lower than expected response from the first group contacted. In total, 40 authors were 
identified and contacted to take part in the study.  
3.4.2 Defining consensus  
There is no absolute figure on what constitutes consensus in a Delphi study; the gold 
standard would be 100% agreement in all statements (Keeney, et al., 2006). However, 
when presenting clinical scenarios where the best option is not known, this is often not 
achievable and differing opinions will almost always be present between experts. It is 
therefore accepted in the literature that agreement anywhere between 50% to 80% of 
cases can be used as an acceptable consensus end-point (KG & Moore, 1979; Green, 
et al., 1999). For this study, a value of 60% was used to define consensus; this is 
above the minimum described in the literature, but any higher percentage was thought 
to be difficult to achieve given the possible large variation in clinical practice between 
surgeons.  
3.4.3 Ethical Approval, Data Protection & Confidentiality 
Prior to the onset of the study, the proposal was submitted, reviewed and approved by 
the STEM research ethics committee at the University of Central Lancashire (appendix 
10). Issues detailed in the submission for ethical approval included participant 
information leaflets, consent to participate, withdrawal procedure, anonymity of 
respondents as well as storage of contact details and responses to the study.   
 
The email addresses obtained from the author group were available online publicly, 
unlike those of the 20/20 knee group. It was therefore agreed that a single member of 
this second group would co-ordinate dissemination of the questionnaire to overcome 
confidentiality and consent issues; at no point were the email addresses of the group 
disclosed. Only authors with publications in English were contacted to overcome any 
communication problems. The participant information leaflet distributed with the initial 
contact email is given in appendices 6 and 7. The initial invitation was sent out to all 
participants, with the purpose of the study and the anticipated timetable, at least one 
week prior to the distribution of the first-round of questionnaires to give participants 
sufficient time to decide whether to take part. Implied informed consent was judged to 
be enacted on completion and return of the questionnaires and participants were made 
aware that they were free to withdraw from the study prior to its onset or at any point 
throughout by email request. Participants were made aware of these facts from the 
initial email and information leaflet (appendices 6 and 7); this information was also re-
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emphasised in the email when the link to round 1 of the study was distributed. 
Feedback was given in the form of amended answer options or minor changes to 
question stems if necessary, and participants were made aware that the multiple-
choice answer selection in round 2 was made up of the most popular answers from 
round 1.  
 
To ensure anonymity was upheld, an online survey was chosen (SmartSurvey), with no 
request for any personal details and automatic anonymisation of the responses by the 
software used. More specifically, the survey website had UK-based servers in keeping 
with data protection regulations. The data involved in this Delphi study was stored in 
keeping with university policy, in password protected files, which were only accessed 
by the researcher, and supervisory team when necessary. Emails and email addresses 
were deleted following completion of the study.  Data will be kept for 5 years following 
completion of the study, then destroyed.  
3.4.4 Development of Questionnaire  
A two-round Delphi process was designed for this study. Each round was separated 
into two parts; the first section aimed to capture demographic data of the participants 
regarding their level of experience and the treatments they use in their current practice. 
The second section involved the presentation of several descriptive scenarios of 
patients presenting with different stages of SONK. The development of scenarios and 
potential answers were put together using information highlighted in the systematic 
review; the survey development did not involve the participants.  
The first section of the questionnaire was used as a tool to capture the demographic 
data of those responding to the survey. This was composed of four questions to gauge 
their level of experience as a knee surgeon, as well as their previous experience with 
the different treatments, using an extensive list of modalities described in the literature. 
The questions used to capture this information are shown in table 3.1.   
Question Answer modality  
Where is your country of practice? Free text 
Approximately how many years have you been practicing as a knee 
specialist? 
Free text 
On average, how many cases of Spontaneous Osteonecrosis of the 
Knee do you treat per year? 
Free text  
Please indicate which of the following treatments for Spontaneous 
Osteonecrosis of the Knee you have personally performed 
Multiple choice (select 
all that apply) 
Table 3.1: Questions used to capture demographic data in Round 1. 
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The second section of round 1 presented patient scenarios. The systematic review 
demonstrated that there was a significant lack of existing evidence regarding treatment 
outcomes for disease stages, therefore, patient scenarios were presented to establish 
opinion, and work towards developing consensus on which treatment to use for 
different disease stages and presentations. Most, but not all, research included in the 
systematic review used the Koshino classification to grade the severity of SONK 
(Koshino, 1982). For this Delphi study, descriptive terms were used instead of specific 
classifications to limit the ambiguity of the scenario being presented and to avoid the 
possibility of participants not being immediately familiar with the staging system used. 
Three separate patient scenarios were developed using descriptive terms used to 
broadly describe different stages of disease in keeping with the Koshino classification:  
1. A patient with normal radiographs but MRI changes in keeping with SONK 
(equivalent to Koshino stage 1); 
2. A patient with sclerotic changes on plain radiographs, but normal knee 
alignment (equivalent to Koshino stage 2/3);                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
3. A patient with collapse of the femoral condyle and associated knee 
malalignment (Koshino stage 4).  
Each patient scenario was further broken down into two sections. Participants were 
firstly asked to specify what their likely initial treatment would be for each case, then 
identify which second-line treatment they would use, should their initial management 
fail (with treatment failure being defined as ongoing symptoms, but no radiological 
progression). The scenarios were structured in this way to aid clinicians in deciding 
which treatment to use for patients at first presentation, as well as those patients 
returning who did not respond to their initial treatment, but who radiologically had 
remained at the same disease stage. For all scenarios, participants were given a list of 
treatment modalities described in included research and asked to choose their most 
likely treatment but were permitted to select more than one if they felt necessary. There 
was also the option to state ‘other’ with free text to describe an alternative treatment 
choice, which may not be covered. The answer options for each scenario are shown in 
table 3.2.  A full copy of the questionnaire is included in appendix 8. 
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A period of rest, analgesia and full weight-bearing (please state duration)  
A period of rest, analgesia and partial weight-bearing (please state 
duration) 
A period of rest, analgesia and non-weight bearing (please state duration) 
Arthroscopic Debridement 
Arthroscopic drilling/microfracture: trans-chondral  
Arthroscopic drilling/microfracture: extra-articular  
Osteochondral transplantation: allograft  
Osteochondral transplantation: autograft 
High tibial osteotomy  
Metal button resurfacing of the lesion  
Unicompartmental knee replacement  
Total knee replacement 
Other (please specify)  
Table 3.2: Treatment options given as possible answers for round 1 of the survey. 
 
Prior to widespread email dissemination to selected participants, several colleagues 
with knowledge of the condition, were asked to pilot the study to ensure there were no 
areas of ambiguity in the questions, or difficulty understanding certain statements. This 
also provided an opportunity to trial the software on the website to ensure there were 
no technical issues. Following this initial pilot, no issues with the software or 
questionnaire layout were raised, but several minor changes were made to the 
question structure and the possible answers listed for each scenario. A treatment not 
described in the included research from the systematic review, but raised from the pilot 
was the option of metal button resurfacing, which was added in as an additional answer 
option, as it was thought that this may be a more recent treatment option without 
published data (Hobbs, et al., 2013). Aside from these amendments, the remaining 
aspects of round 1 were unchanged.  
3.4.5 Dissemination of Questionnaire  
An initial invitation was sent out via email to all participants with a brief overview of the 
purpose and anticipated timeline (appendix 6). Attached to this email, a participant 
information sheet was included containing more detailed information of the purpose of 
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the study, confidentiality, data protection along with the process of opting out of the 
study either from the outset or at any time during the process (appendix 7). Following 
on from this initial contact email, as no requests were received to be excluded from the 
study, all participants were sent an invitation to complete the first round of the Delphi 
study. Contained in this email, the purpose of the study was again detailed, the 
expected time taken to fill out the first round and the hyperlink to the survey website 
was given (appendix 6). A full version of round 1 of the study is shown in appendix 8.  
Emails were sent out to several participants at a time over a period of 48 hours, to 
ensure no technical problems were encountered with the software.   
Each round of survey was initially available for two weeks. Timely response to each 
round was important as it was required to adapt the content for the following round. To 
facilitate this, all participants were contacted well in advance of the first round with 
personalised emails sent from a university email account with the anticipated time 
required to complete the survey and planned deadline detailed in each email. One 
reminder email was sent to participants at a week interval, to maximise the number of 
respondents.  
 
All responses to round 1 were collected using the survey website and were 
subsequently entered into an Excel spreadsheet. Any additional comments put forward 
by participants were also used to develop and amend the round 2 questionnaire, 
particularly if it was expressed that certain areas of the scenarios require re-phrasing or 
further explanation to improve the clarity. At the end of round 1, all comments had been 
addressed and included in the round 2 questionnaire if necessary.  
 
3.4.6 Development of Round 2 
Round 2 was developed using feedback and results from round one and sent out to all 
potential participants, regardless of whether they had responded to the initial round. 
Given the anonymous nature of the responses from round 1, demographic data was 
collected at the beginning of round 2, to ensure a similar group of participants were 
involved. This was composed of three questions regarding their experience as a knee 
surgeon, but with multiple choice answers, instead of free text responses using the 
most common answers from round 1, to try and reduce the time taken to complete this 
section.  
The same questionnaire format was used for round 2 and the statements were mostly 
unchanged. Participants were informed in the round 2 invitation email that only up to 
five of the most popular answers from round 1 were possible answers to the scenarios. 
This gave participants the opportunity to understand the most popular treatment 
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modalities chosen in round 1 and use this information to aid in their decision making 
while answering the round 2 scenarios. Instead of being able to select as many 
answers as possible, participants were asked to only select one treatment modality that 
they would be most likely to use in each scenario, with a final option included as ‘none 
of the above’ should they not agree with any of the options listed. A full copy of the 
round 2 questionnaire is shown in appendix 9.  At the end of this round, responses 
were entered onto a second excel spreadsheet and the percentage of respondents 
selecting each treatment modality was calculated. If the final percentage of agreement 
for one treatment per clinical scenario reached 60%, then it was established that a 
consensus had been reached.  
3.5 Analysis  
A percentage agreement was calculated for each scenario and was used to evaluate 
the level of consensus for each round. The data captured was then presented using a 
series of tables, graphs and descriptive text to demonstrate the results. Any additional 
free text comments or suggestions gathered from round 1 participants were used to 
amend round 2 questions and responses where necessary.  
 
In this section, the methodology has been outlined and the reasoning behind the choice 
of a Delphi study over other consensus methods. The rationale behind the scenarios 
used has been described, with the overall emphasis on achieving consensus from 
research participants on the content of the best treatment for patients with various 
stages of SONK. 
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Delphi Study Results  
3.5.1 Round 1 participant demographics  
Initially, round 1 was distributed to all members of the 20/20 group and the group of 20 
authors simultaneously. Of the 21 members of the 20/20 group contacted, 8 responded 
(38%). Out of the 20 authors contacted using email addresses publicly available in the 
published literature, 4 emails were invalid and were returned undelivered. One potential 
participant contacted to state they did not wish to be involved but supplied an email 
address of a suitable colleague. Of the 16 delivered email invitations, 4 responses were 
received following the initial email and one reminder (25% response rate). Given this 
lower than expected response rate, the decision was taken to gather a further group of 
authors using the same search techniques and restart round one. A further 20 authors 
were identified and contacted. Again, 3 of the published emails were returned 
undelivered. Of the 17 emails delivered, 7 responses were received to round 1 from the 
second group of authors contacted. This gives an overall response rate of 33% for the 
author group. Overall, there were 19 responses to round 1 between the two groups and 
a total response rate of 35%.  
Demographic data from round 1 participants is summarised in figures 3.2, 3.3 and 3.4.  
Most participants were from the UK or USA, with the remaining being practicing 
surgeons in other European countries. The majority (n=18, 95%) had at least 10 years’ 
experience practicing as a knee surgeon. When it came to the number of cases of 
SONK treated per year, the results were more varied, with participants treating from 
two, up to 30 cases per year (mean 9.8 cases/year, SD 9.06).  
 
Figure 3-2: Chart summarising country of practice for all round 1 participants N=19 
UK, 9
USA, 5
Germany , 3
Luxembourg, 
1
Spain , 1
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Figure 3-3: Graph summarising the number of years of experience, n= 19 
 
 
Figure 3-4: Graph summarising average case load of SONK treated per year, n=19 
 
3.5.2 Round 1 range of treatments 
Following collection of the round 1 demographic data, participants were then asked to 
indicate which, out of a list of treatments they have used at any time in their practice for 
the treatment or SONK. If a treatment was not listed in the multiple-choice list, a free 
text option was available; the results are summarised in table 3.3. By far the most 
commonly utilised treatments were knee arthroplasty, followed by high tibial osteotomy. 
The remaining arthroscopic treatments, along with grafting and decompression 
methods were utilised less frequently.  
0
1
12
4
1 1
2 to 5 5 to 10 10 to 20 20 to 30 30-40 >50
Years Practicing as a Consultant
9
5
1
3
1
0
2 to 5 5 to 10 10 to 20 20 to 30 30-40 >50
Number of cases of SONK/Year
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Treatment used  No. of 
respondents  
Uni-compartmental knee replacement 14 
Total knee replacement 12 
High tibial osteotomy  9 
Arthroscopic debridement 6 
Arthroscopic drilling/microfracture: extra-articular 4 
Arthroscopic drilling/microfracture: trans-chondral 3 
Osteochondral transplantation: allograft 2 
Osteochondral transplantation: autograft 1 
Coagulation studies and anticoagulation  1 
Conservative non-weight bearing 1 
Antiresorptive Medication 1 
Unloader brace  1 
Conservative partial weight bearing and NSAIDs for 6 weeks 1 
BioPoly after bony issue improved  1 
Fine wire drilling 1 
Extra-articular bone grafting when chondral surface intact  1 
Table 3.3: A summary of different treatment modalities used by respondents at any stage of their 
practice for the treatment of SONK (treatments shown in italics were not in the multiple-choice list and 
were given as free text answers). 
 
3.5.3 Round 2 Participant Demographics 
Round 2 was distributed to all members of the 20/20 group and the whole cohort of 
authors contacted in round 1 (excluding those with undeliverable email addresses), 
regardless of whether a response was received to the initial round. A total of 14 out of 
54 (26%) responses were received, lower than the 19 (35%) received in round 1. In 
terms of country of practice, both rounds had a majority of over 70% from the UK and 
USA, with the remaining minority practicing throughout Europe. Experience and annual 
SONK case load also showed similar spread between rounds, with most participants 
having at least 10 years’ experience as a knee surgeon, but mostly treating 2 to 10 
cases of SONK per year. A comparison of demographics of participants in round 1 and 
2 is shown in table 3.4.  
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Demographic  Round 1 
(n) 
% Round 2 
(n) 
% 
County of practice UK 9 47 7 50 
USA 5 26 3 21 
Germany  3 16 2 14 
Switzerland 0 0 1 7 
Spain 1 5 1 7 
Luxembourg  1 5 0 0 
Total 19  14  
Years practicing as a 
knee specialist  
5 to 10 1 5 1 7 
10 to 20 12 63 7 50 
20 to 30 4 21 4 29 
30-40 1 5 2 14 
>50  1 5 0 0 
Total 19  14  
Number of cases of 
SONK treated per 
year  
2 to 5 9 47 6 43 
5 to 10 5 26 5 36 
10 to 20 1 5 1 7 
20 to 30 3 16 0 0 
30-40 1 5 1 7 
>40  0 0 1 7 
Total 19  14  
Table 3.4: Comparison of demographics of participants involved in round 1 and 2. 
3.5.4 Scenario 1 (Koshino Stage 1 disease) 
The first scenario, representative of early-stage disease (Koshino 1) is shown in table 
3.5, there were no changes to the wording of the question stem between rounds 1 and 
2. The results of round 1, scenario 1a are shown in figure 3.5 and 1b in figure 3.6.  
A 60-year-old, active patient, with no other medical problems presents with significant 
knee pain despite regular analgesia. Plain radiographs of the knee are normal, but MRI 
changes are in keeping with isolated spontaneous osteonecrosis of the weight bearing 
portion of the medial femoral condyle (no other degenerative changes or pathology) 
Scenario 1a:  What would be your first-line treatment? 
Scenario 1b: Following failure of your first-line treatment, with ongoing pain but no 
radiological progression, what would be your usual second-line management? 
Table 3.5: First scenario presented to participants, representative of early disease (equivalent to 
Koshino stage 1). 
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Figure 3-5: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment options for round 1, scenario 1 equivalent to early-stage disease (Koshino 1), n=19  
(*= answers given as a free text option and not listed in the multiple choice).  Participants permitted to 
select more than one answer. 
 
Figure 3-6: Bar chart demonstrating the number of participants selecting their preferred second-
line treatment options for round 1, scenario 1, equivalent to early-stage disease (Koshino 1), n=19 
(*= answers given as a free text option and not listed in multiple choice), participants permitted to select 
more than one answer.  
 
 
 
0 2 4 6 8 10 12
Evaluate and consider anticoagulation*
Stabilisation of calcium homeostasis*
Pain management*
A period of rest, analgesia and non-weight bearing
A period of rest, analgesia and full-weight bearing
Bisphosphonate treatment
A period of rest, analgesia and partial-weight
bearing
0 1 2 3 4 5
Weight bearing as tolerated*
Repeat MRI*
Fine-wire retrograde drilling*
Arthroscopy with grafting of the affected area:
osteochondral allograft
High tibial osteotomy
Bisphosphonate treatment
A period of rest, analgesia and non-weight
bearing
Total knee replacement
Arthroscopy with drilling/microfracture of the
lesion: extra-articular
Uni-compartmental knee replacement
A period of rest, analgesia and partial-weight
bearing
A period of rest, analgesia and full-weight bearing
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For participants indicating that their treatment would entail non-operative measures, 
with analgesia with or without restricted weight-bearing, the intended duration of such 
treatment was requested; the mean duration was 11.5 weeks (range 6-24 weeks).  
Analysis of the duration of such non-operative measures from round 1 clearly 
demonstrated three specific time periods (up to 6 weeks, up to 3 months, more than 3 
months), so this was given as a separate question with a multiple-choice answer 
option, rather than a free text. Additional comments had also raised the treatment of 
functional bracing during a period of non-operative treatment, so this was added in as 
an additional yes/no answer as part of scenario 1.   
Following review of the free text comments, the wording of the options for conservative 
treatment were adjusted. For round 2, the options were given as either ‘a period of rest, 
analgesia and full-weight bearing/weight bearing as tolerated’ or ‘a period of rest, 
analgesia and partial or non-weight bearing’ to limit the number of answer options.    
Table 3.6 shows the most popular responses and percentage agreement from round 1, 
scenario 1; up to 5 of the top answers were used as possible multiple-choice options 
for scenario 1 in round 2 with the final option being ‘none of the above’. For scenario 
1b, several answers scored equally, bisphosphonates therapy was carried forward to 
round 2 as it was most popular in scenario 1 from both scenarios combined. The 
results from round 2, scenario 1 are shown in figures 3.7 and 3.8.  
Scenario  Treatment Option Percentage 
agreement  
n 
1a A period of rest, analgesia & partial-weight bearing 57.8% 9 
A period of rest, analgesia and full-weight bearing 15.8% 3 
Bisphosphonate treatment 15.8% 3 
A period of rest, analgesia and non-weight bearing 10.5% 2 
1b A period of rest, analgesia and full-weight bearing 21% 4 
A period of rest, analgesia and partial-weight bearing 15.8% 3 
Uni-compartmental knee replacement 15.8%  3 
Arthroscopy with drilling/microfracture of the lesion: 
extra-articular 
10.5% 2 
Bisphosphonate treatment 5% 1 
Table 3.6: Most popular answers from round 1, carried forward into round 2 (Scenario 1). 
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Figure 3-7: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment options for round 2, scenario 1, equivalent to early-stage disease (Koshino 1), n=14. 
 
Out of the 14 responses to round 2, scenario 1a, 12 participants (86%) stated they 
would consider a period of rest and analgesia as their preferred first-line treatment; 
50% would restrict the patients to partial-weight bearing, 25% would initiate a period of 
non-weight bearing, and the remaining 25% would allow their patients to fully weight-
bear or weight-bear as tolerated. In terms of duration of such measures, the majority 
(n=8, 66.7%) would continue this treatment for a period of up to 3 months, 16.7% 
would treat for over 3 months and 16.7% for a period of up to 6 weeks. All 12 of the 
participants who selected a period of observation stated that they would not consider 
bracing of the knee during this time.  
It was therefore determined that a consensus had been reached for first-line treatment 
in early-stage disease and the duration of such treatment; 86% of participants would 
treat with a period of rest and analgesia, with 66.7% of this group persisting with this 
treatment modality for a period of up to 3 months; 75% of participants selecting this 
treatment would restrict their patients to either partial or non-weight bearing during this 
time.  
Scenario 1b presented the same information and asked for a preferred second-line 
treatment for early-stage disease following failure of initial treatment, with persisting 
symptoms but no radiological deterioration; the results are shown in figure 3.8.  
0 1 2 3 4 5 6 7
None of the above
Bisphosphonate ± correction of calcium
homeostasis
A period of rest, analgesia and full weight
bearing/weight bearing as tolerated
A period of rest, analgesia and non-weight
bearing
A period of rest, analgesia and partial weight
bearing
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Figure 3-8: Bar chart summarising preferred second-line treatment for round 2, scenario 1, 
equivalent to early-stage disease (Koshino 1) n= 14. 
In contrast to scenario 1a, there was a wider spread of answers for preferred second-
line management following failure of initial measures; no single option reached a 
consensus of more than 60%. Non-operative treatment (with a period of rest and 
analgesia), regardless of weight bearing status reached a percentage of agreement of 
43%.  
From this scenario, representing early disease (Koshino stage 1) it can clearly be 
stated that a period of non-operative measures with analgesia and restriction in weight-
bearing is an appropriate first line-treatment for a duration of up to 3 months. In terms 
of second-line treatment following failure of initial measures, a consensus has not been 
reached, with several different treatments options scoring almost equally (figure 3.8).  
3.5.5 Scenario 2 (Koshino stage 2/3 disease) 
Scenario 2 was then presented to represent intermediate-stage disease (Koshino 2/3) 
and is shown in table 3.7. This was also split into two sections, asking participants for 
their preferred first-line treatment (scenario 2a) and their second-line management 
(scenario 2b) should their initial measures fail; responses from round 1 are shown in 
figure 3.9 and 3.10 respectively.  
0 1 2 3 4
None of the above
Bisphosphonate ± correction of calcium
homeostasis
Arthroscopy with drilling/microfracture of the lesion
A period of rest, analgesia and full weight
bearing/weight bearing as tolerated
Knee arthroplasty (either uni-compartmental or
total knee replacement)
A period of rest, analgesia and partial or non-
weight bearing
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A 60-year-old, active patient with no other medical problems presents with significant 
knee pain despite regular analgesia. Plain radiographs of the knee show a sclerotic 
lesion in the weight-bearing portion of the medial femoral condyle. MRI scan 
demonstrates a lesion with appearances consistent of spontaneous osteonecrosis, 
isolated to the medial femoral condyle (no other degenerative changes or pathology). 
 
Scenario 2a: What would be your first line treatment? 
Scenario 2b: Following failure of your first line treatment, with ongoing pain but no 
radiological progression, what would be your usual second line management? 
Table 3.7: Scenario 2 presented to participants, representative of intermediate-stage disease 
(equivalent to Koshino 2/3).  
 
 
Figure 3-9: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment for round 1, scenario 2, equivalent to intermediate-stage disease (Koshino 2/3). n=19. 
Participants permitted to select more than one answer (*= answers given as a free text option and not 
listed in the multiple choice). Abbreviations: HTO= high tibial osteotomy, TKR= total knee replacement. 
0 1 2 3 4 5 6 7
Unloader brace to determine HTO vs TKR*
Additional correction of calcium homeostasis*
BioPoly resurfacing if localised*
Weight-bearing as tolerated
Total knee replacement
Uni-compartmental replacement
Arthroscopy with drilling/microfracture of the
lesion: transchondral
Bisphosphonate treatment
A period of rest, analgesia and non-weight bearing
A period of rest, analgesia and full-weight bearing
A period of rest, analgesia and partial-weight
bearing
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Figure 3-10: Bar chart demonstrating the number of participants selecting their preferred second-
line treatment for round 1, scenario 2, equivalent to intermediate-stage disease (Koshino 2/3) n=19. 
Participants permitted to select more than one answer (*= answers given as a free text option and not 
listed in the multiple choice). 
 
As with scenario 1, participants indicating that their treatment would entail non-
operative measures were asked to state the intended duration of such treatment; the 
mean duration was 12.9 weeks (range 6-24 weeks).  
In round 1, several participants commented that they would need additional clinical 
information regarding knee alignment prior to reaching a decision on treatment options 
for this scenario; this information was therefore added into the scenario for round 2, 
stating that the patient had normal knee alignment, otherwise the question stem was 
kept the same. One comment that was not addressed from round 1 stated that the 
treatment chosen would partly depend on the size of the lesion; it was felt that this 
would require numerous additional question stems, so was not taken forward.  
The most popular answers from round 1, scenario 2 are shown in table 3.8, these 
answers were taken forward to be used for the multiple choice in round 2. For scenario 
2b, there were 2 popular answers, but the remaining options were equally unpopular. 
Where possible, the treatment options with the best combined popularity across the 
0 1 2 3 4 5 6 7 8 9
Fine-wire drilling*
Possibly BioPoly resurfacing if localised defect*
Weight-bearing as tolerated*
Arthroscopy with drilling/microfracture of the lesion:
transchondral
Arthroscopy with drilling/microfracture of the lesion:
extra-articular
Arthroscopy with grafting of the affected area:
osteochondral allograft
High tibial osteotomy
Bisphosphonate treatment
A period of rest, analgesia and full-weight bearing
A period of rest, analgesia and partial-weight
bearing
A period of rest, analgesia and non-weight bearing
Arthroscopy with debridement of the lesion
Total knee replacement
Uni-compartmental knee replacement
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scenario were chosen to take forward to round 2. The results for round 2, scenario 2a 
are shown in figure 3.11.   
Scenario  Treatment Option Percentage 
agreement  
n 
2a A period of rest, analgesia and partial-weight bearing 31.5% 6 
A period of rest, analgesia and full-weight bearing 21% 4 
Arthroscopy with drilling/microfracture 10.5% 2 
Bisphosphonate treatment  10.5% 2 
Uni-compartmental knee replacement  10.5% 2 
2b Uni-compartmental knee replacement  42% 8 
Total knee replacement  15.8% 3 
Arthroscopy with debridement of the lesion 5% 1 
Arthroscopy with drilling/microfracture  5% 1 
High tibial osteotomy  5% 1 
Table 3.8 Most popular answers from round 1, carried forward into round 2, scenario 2.  
 
Figure 3-11: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment for round 2, scenario 2, equivalent to intermediate stage disease (Koshino 2/3) n=14.  
Most participants stated that their first-line treatment for patients with intermediate-
disease would be a period of rest, analgesia and either full weight-bearing, weight-
bearing as tolerated or non-weight bearing; 78.6% of respondents selected one of 
these options. Out of the group selecting these measures, 63.6% would allow patients 
to fully weight-bear or weight-bear as tolerated, whereas the remaining 36.4% of the 
group would restrict the patients to partial or non-weight bearing. In terms of duration of 
0 1 2 3 4 5 6 7 8
None of the above
Arthroscopy with drilling/microfracture of the
lesion
Bisphosphonate ± correction of calcium
homeostasis
Knee arthroplasty (either uni-compartmental or
total knee replacement)
A period of rest, analgesia and partial or non-
weight bearing
A period of rest, analgesia and full weight
bearing/weight bearing as tolerated
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such measures, a consensus was reached, with 63.6% of participants stating that they 
would treat in this way for a period of up to 3 months (27.3% would treat for up to 6 
weeks and 9.1% for a period of greater than 3 months). The remainder of participants 
stated they would treat with knee arthroplasty (14.3%) or would not treat with any of the 
available options (7.1%).   
Scenario 2b was then presented, requesting a preferred second-line treatment, 
following failure of initial treatment for intermediate-disease, with persisting symptoms 
but no radiological deterioration; the results to this scenario are shown in figure 3.12. 
Seven participants (50%) would proceed with knee arthroplasty, the remaining group 
would either perform arthroscopy with drilling or microfracture (21.4%), undertake a 
period of rest, analgesia and partial or non-weight bearing (14.3%), or not use any of 
the possible options given (14.3%). 
Figure 3-12: Bar chart demonstrating the number of participants selecting their preferred second-
line treatment options for round 2, scenario 2, equivalent to intermediate stage disease (Koshino 
2/3), n=14.  
 
From this scenario, it can be concluded that a period of rest and analgesia for a period 
of up to 3 months is an acceptable first-line treatment for intermediate disease; 63.6% 
of participants selecting this option would allow their patients to either fully weight-bear 
or weight-bear as tolerated during this time. In terms of second-line treatment, knee 
arthroplasty was by far the most popular option, but with 50% of participants selecting 
this, it is not enough to reach consensus.  
 
0 1 2 3 4 5 6 7 8
None of the above
Grafting of the lesion
High tibial osteotomy
A period of rest, analgesia and partial or non-weight
bearing
Arthroscopy with drilling/microfracture of the lesion
Knee arthroplasty (either uni-compartmental or total
knee replacement)
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3.5.6 Scenario 3 (Koshino stage 4 disease) 
The third and final scenario was presented to represent late-stage disease (Koshino 4) 
and formatted in the same way as the two previous scenarios. Scenario 3 is shown in 
table 3.9 and the results of round 1 in figures 3.13 and 3.14.  
A 60-year-old, active patient with no other medical problems presents with significant 
knee pain despite regular analgesia. Plain radiographs of the knee show a sclerotic 
lesion with associated collapse of the weight-bearing portion of the medial femoral 
condyle. MRI confirms appearances in keeping with spontaneous osteonecrosis, 
isolated to the medial femoral condyle (no other degenerative changes or pathology) 
with associated collapse of the weight bearing portion. 
 
Scenario 3a: What would be your first line treatment? 
Scenario 3b: Following failure of your first line treatment, with ongoing pain but no 
radiological progression, what would be your usual second line management? 
Table 3.9: Third and final scenario presented to participants, representative of late-stage disease 
(equivalent to Koshino stage 4). 
 
Figure 3-13: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment options for round 1, scenario 3, equivalent to late-stage disease (Koshino 4), n=19. 
Participants permitted to select more than one answer (*= answers given as a free text option and not 
listed in the multiple choice). 
0 1 2 3 4 5 6 7 8 9 10
Arthroscopy with grafting of the affected area:
osteochondral allograft
High tibial osteotomy
Bisphosphonate treatment
Metal button resurfacing of lesion
A period of rest, analgesia and full-weight bearing
A period of rest, analgesia and partial-weight
bearing
A period of rest, analgesia and non-weight bearing
Arthroscopy with drilling/microfracture of the lesion:
extra-articular
Arthroscopy with debridement of the lesion
Arthroscopy with drilling/microfracture of the lesion:
transchondral
Total knee replacement
Uni-compartmental knee replacement
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Figure 3-14: Bar chart demonstrating the number of participants selecting their preferred second-
line treatment options for round 1, scenario 3, equivalent to late-stage disease (Koshino 4), n=19. 
Participants permitted to select more than one answer (*= answers given as a free text option and not 
listed in the multiple choice). 
 
The percentage agreement for each treatment option was calculated and the top 4 or 5 
answers were selected from each scenario to use as the multiple-choice answers for 
round 2; the percentage agreements for each scenario are shown in table 3.10.  
Scenario  Treatment Option Percentage 
agreement  
n 
3a Uni-compartmental knee replacement 47.3% 9 
Arthroscopy with drilling/microfracture (extra-articular or 
transchondral)  
26.3% 5 
Total knee replacement 21.1% 4 
Arthroscopy with debridement 10.5% 2 
A period of rest, analgesia and non-weight bearing 10.5% 2 
3b Uni-compartmental knee replacement 57.8% 11 
Total knee replacement 15.8% 3 
Arthroscopy with drilling/microfracture of the lesion 10.5% 2 
High tibial osteotomy  5.2% 1 
Table 3.10: Most popular answers from round 1, carried forward into round 2 (scenario 3)  
 
As in scenario 2, several participants commented in round 1 that they would need 
additional clinical information regarding knee alignment prior to reaching a decision on 
0 2 4 6 8 10 12
Aggressive stablilisation of calcium homeostasis*
BioPoly resurfacing*
Weight-bearing as tolerated*
High tibial osteotomy
Bisphosphonate treatment
Arthroscopy with debridement of the lesion
Arthroscopy with drilling/microfracture of the
lesion: transchondral
Total knee replacement
Uni-compartmental replacement
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treatment options for this scenario; this information was therefore added for round 2, 
stating that the patient had varus malalignment of the knee associated with condylar 
collapse. Otherwise, the scenario was kept the same as in round 1. The results to 
round 2 with the preferred first and second-line treatments for late disease are shown 
in figure 3.15 and 3.16 respectively.   
Figure 3-15: Bar chart demonstrating the number of participants selecting their preferred first-line 
treatment options for round 2, scenario 3, equivalent to late-stage disease (Koshino 4) n=14 
 
Figure 3-16: Bar chart demonstrating the number of participants selecting their preferred second-
line treatment options for round 2, scenario 3, equivalent to late-stage disease (Koshino 4) n=14 
 
For scenario 3a, representing first-line treatment for late disease, the treatment option 
of arthroplasty (either uni-compartmental or total knee replacement) was by far the 
most popular first line treatment option, but with 50% of participant selecting this 
modality is insufficient to achieve consensus. For scenario 3b, representing second-line 
0 1 2 3 4 5 6 7 8
None of the above
A period of rest, analgesia and non-weight bearing
Arthroscopy with drilling/microfracture
High tibial osteotomy
A period of rest, analgesia and partial-weight
bearing
Knee arthroplasty (either uni-compartmental or
total knee replacement)
0 2 4 6 8 10 12
N/A (selected arthroplasty in scenario 3a)
Arthroscopy with drilling/microfracture
Grafting of the lesion
High tibial osteotomy
Knee arthroplasty (uni-compartmental or total knee
replacement)
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treatment, 78.6% of participants selected arthroplasty as their preferred treatment 
option, with 1 selecting high tibial osteotomy and the remaining 2 selecting the ‘not 
applicable’ option as they had chosen arthroplasty as first-line treatment.  
From this scenario, it is appropriate to state that arthroplasty is considered a preferable 
treatment modality for both first and second-line treatment for patients with SONK and 
associated joint collapse. However, a consensus regarding the use of such surgery has 
only been reached for second-line treatment in this scenario.  
3.5.7 Summary of Delphi Results  
A summary of round 2 results and whether consensus has been reached for each 
scenario is shown in table 3.11. This 2-round Delphi study has reached a consensus 
for first-line treatment of early and intermediate-stage disease, with a period of rest and 
analgesia, with or without restriction in weight bearing being deemed appropriate for a 
period of up to 3 months. Consensus was also reached for treatment of patients with 
osteonecrosis and collapse of the medial femoral condyle, when initial measures have 
failed; 78.6% would proceed with knee arthroplasty. For the remaining scenarios, with 
the exclusion of scenario 1b, describing second line-treatment for early stage disease, 
a percentage agreement for a single treatment has reached 50%, which would be 
accepted as consensus in some literature, but did not reach the 60% that was set as 
the value for consensus in this study.  
Scenario Most popular choice (percentage agreement) Consensus 
reached?  
1a: early disease, first-line 
treatment  
A period of rest, analgesia ± restriction of weight-
bearing (85.7%) 
Yes 
1b: early disease, 
second-line treatment 
A period of rest, analgesia ± restriction of weight-
bearing (42.9%)  
No  
2a: intermediate disease, 
first-line treatment 
A period of rest, analgesia ± restriction of weight-
bearing (78.6%) 
Yes 
2b: intermediate disease, 
second-line treatment  
Knee arthroplasty (50%) No  
3a: late disease, first-line 
treatment  
Knee arthroplasty (50%) No  
3b: late disease, second-
line treatment  
Knee arthroplasty (78.6%) Yes  
Table 3.11: Summary of answers and percentage agreement to round 2 scenarios. 
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3.6 Delphi Study Discussion & Conclusion  
This section summarises the main findings from the Delphi study evaluating joint 
preserving treatments for SONK. The strengths and limitations of the methodology are 
then discussed followed by the implications for both clinical practice and further 
research and conclusions of the review. 
Summary of main findings 
The main aim of the Delphi study was to engage orthopaedic knee experts in a formal 
consensus exercise to hopefully reach an agreement on the commonly utilised, and 
most appropriate treatments for different stages of SONK. An international group of 
surgeons have been involved throughout the study, with experience varying from 5 to 
over 50 years practicing as a consultant or international equivalent. From the collection 
of initial data in round 1, it became clear than numerous treatments, both operative and 
non-operative had been used at some stage in the practice of the respondents, with 17 
different modalities being identified during initial data collection.  
This study also set out to establish whether there is a role for non-operative 
management in the treatment of SONK. From the responses to the study, it has been 
demonstrated that a period of rest analgesia, with or without restriction of weight-
bearing status has a role, throughout the spectrum of disease, but is most often utilised 
for patients in the early or intermediate-stages. A standard period of up to 3 months 
was the consensus for duration of this form of treatment. It is less clear from the results 
whether weight-bearing during this time should be restricted, with participants being 
more likely to enforce restriction in earlier disease.  
Despite the supporting evidence of a randomised controlled trial evaluating the use of 
lateral wedge insoles for early stage disease (Uchio, et al., 2000), this is not a modality 
that was used by participants. Alternative medical management, particularly 
bisphosphonates, was rarely selected as a treatment modality for any disease stage; 
this response may reflect the very limited published evidence for their success (Breer, 
et al., 2013; Jureus, et al., 2012; Kraenzlin, et al., 2010). Additionally, bisphosphonate 
therapy may often be initiated and monitored by physicians, not surgeons, therefore by 
only including surgeons in this study, it may not fully relfect their overall usage in 
SONK.  
A further objective was to establish whether specialists regularly perform arthroscopic 
interventions, or high tibial osteotomy, and at what stage in the disease process were 
these techniques most appropriate. Arthroscopy with drilling and microfracture was 
uncommonly chosen by participants throughout the spectrum of disease. Although 
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there are various small case series documenting success with the various arthroscopic 
techniques, combined with drilling and grafting (Akgun, et al., 2005; Deie, et al., 2008; 
Forst, et al., 1998; Kotani, et al., 2003), the Delphi results have concluded that 
arthroscopic interventions are uncommonly used. Whether this is due to personal 
experience or lack of evidence to support use of such techniques is unclear and further 
studies may be needed to be able to appreciate the efficacy and role of different 
techniques.  
High tibial osteotomy (HTO) was also uncommonly selected, and its role was shown to 
be limited to late-stage disease with joint collapse and knee malalignment. This is not 
completely in keeping with the published evidence, which describes the use of HTO for 
intermediate as well as late-stage disease with mostly good results in moderately sized 
case series (Aglietti, et al., 1983; Koshino, 1982; Marti, et al., 2000; Takeuchi, et al., 
2009; Valentí Nín, et al., 1998). It appears from the Delphi results that HTO is less 
frequently employed that the published literature would suggest. This may reflect the 
limited guidance regarding when to use such techniques and whether it should be 
limited to certain stages of disease, for example, in the presence of malalignment. 
Currently the best available research describing the technique for SONK is limited to 
case series only.  
This study set out to achieve consensus on the treatment of patients with SONK and 
normal joint architecture. For patients with normal radiographic findings (Koshino stage 
1), a consensus has been reached on preferred first-line treatment, with rest, analgesia 
and a period of restricted weight-bearing being the management of choice. This result 
supports the findings of the systematic review to a certain degree; several authors 
stated their patients undergoing surgery had failed such interventions, suggesting that 
all patients (at least in the early stages) have had a trial of non-operative management 
(Duany, et al., 2010; Miller, et al., 1986; Takeuchi, et al., 2009). It is less clear from the 
results, which is the best treatment for early disease when initial measures fail and this 
is an area which would warrant further research.  
For intermediate-stage disease (Koshino stage 2/3), with normal joint architecture but 
radiographic evidence of SONK, by far the most popular first-line treatment was a 
period of rest and analgesia, without restriction in weight-bearing. For second-line 
treatment of this group of patients, knee arthroplasty was the most popular choice, but 
the percentage agreement of 50% was insufficient to establish consensus. This reflects 
the existing discussions in the literature emphasising that intermediate-stage disease is 
often the most difficult to deal with, particularly when patients have not improved from 
non-operative measures (Akgun, et al., 2005), but evidence from this Delphi shows that 
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arthroplasty may be an acceptable option in some of these patients, in whom first-line 
treatment measures have failed.  
A consensus for treatment of patients with joint-collapse and knee malalignment 
following failure of initial measures has been reached, with more than three quarters of 
participants in agreement that knee arthroplasty would be the preferred method of 
treatment. For first-line treatment of this group of patients however, a consensus was 
not reached, with 50% of the group selecting knee arthroplasty, and the remainder 
selecting a period of rest, analgesia and partial weight-bearing (21.4%), high tibial 
osteotomy (14.3%), arthroscopy with drilling or microfracture (7.1%), or a period of rest, 
analgesia and non-weight bearing (7.1%). These findings are in keeping with the 
general agreement in the literature that knee arthroplasty is commonly the only option 
for patients with late-stage SONK (Karim, et al., 2015; Bruni, et al., 2012; Mont, et al., 
2000).  
Strengths and Limitations 
At the time of writing, this is the first of any type of consensus study evaluating 
treatment of SONK, involving an international group of surgeons and has provided new 
evidence to support the use of different treatment modalities depending on disease 
stage, an area which is significantly lacking in currently available literature.  
The response rate to both rounds of the study, particularly round 2 was lower than 
anticipated. Round 1 achieved an overall response rate of 35% compared to 26% in 
round 2. However, it is recognised than online-based Delphi studies often have lower 
response rates to traditional paper-based methods, particularly with subsequent rounds 
(Kwak & Radler, 2002). Although this is a challenge with the Delphi method, other 
consensus options were considered prior to the onset of the study and decided not to 
be logistically feasible given the international nature of the participants.  
Although a lower number of participants were involved than planned, there are no clear 
guidelines on the ideal or minimum number for consensus studies; one study has 
suggested that Delphi studies with less than 6 participants have limited reliability, 
whereas any more than 12 results in an insignificant increase in reliability and have 
recommended an ideal panel size of 6-11 (Nair, et al., 2011).  
A third round to the study may have resulted in consensus being achieved for all 
scenarios but given the reducing participant numbers between rounds 1 and 2, a third 
round would likely have had even fewer respondents with limited value of the results. 
The lower than expected responses from the author group in round 1 led to an 
unexpected delay between the first and second rounds, while a second group of 
authors were contacted to take part; this is likely to have contributed to an additional 
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reduction in numbers between the two rounds. It is recognised that a lower than 
expected response rate can have an impact on the validity and overall quality of 
evidence and can risk introducing non-response bias (Hsu & Sandford, 2007). In 
hindsight, it may have been beneficial to ask potential participants to reply to the initial 
invitation, to gauge level of interest and identify a larger group of potential participants 
prior to the start of round 1.  
Although an international group of participants were recruited from 6 different countries, 
this did not fully represent the author group. A large proportion of the publications were 
from Asia; 29.4% of authors contacted were based in Japan, China and South Korea, 
but no responses were received from any of these countries. This may have 
represented a language barrier, or, along with other non-respondents, may be due to a 
failure of receipt of the email requests; it is possible that unknown emails are 
automatically put into a junk mail folder. Involving participants from the UK, USA and 
Europe only may not fully reflect current practice as treatments may have varying 
popularity and differ according to country or continent.  
A further limitation involves the definition of ‘expert’; the annual case load of SONK was 
widely variable, ranging from 2 to 30 cases per year. The lower end of the spectrum 
may represent similar numbers to most orthopaedic knee surgeons. For future studies, 
it would be helpful to know each surgeon’s overall experience (how many cases of 
SONK they have treated in total) as well as their annual case load as an initial 
information finding exercise, with only those treating a higher than average number of 
cases per year being selected for involvement in the final study. This would require 
many potential participants to be contacted in the initial stages and could lead to a 
limited population being eligible for inclusion.  
In terms of limitations of the scenarios presented, there were some comments given in 
the free text area about lesion size. It was felt that this was beyond the scope of this 
study but would be an area for future research to determine whether lesion size, in 
addition to disease stage influences treatment. For the later scenarios, weight-bearing 
status was grouped into partial or non-weight-bearing as a single answer. The intention 
was to limit the number of answer options, but this may influence outcomes and would 
have been better kept as separate answers.  
Implications for Clinical Practice  
The results of the Delphi study have established that a period of non-operative 
treatment with analgesia, physiotherapy with or without restriction in weight-bearing is 
an acceptable first-line treatment, often regardless of the stage of disease, for a period 
of up to 3 months. This information can be used to guide future decision making for 
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clinicians, and highlights that surgical intervention is not always necessary as a first-
line measure.  
Although knee arthroplasty for SONK was beyond the scope of the systematic review, 
the Delphi study has confirmed that this is often the treatment of choice for patients 
with advanced disease, but more specifically in such patients where other treatment 
has failed, with 78.6% of participants selecting this as their preferred option.   
Implications for future research  
Although the Delphi has determined that a 3-month period of analgesia and 
physiotherapy is often used as a first-line treatment, it is less clear when it is 
appropriate to restrict weight-bearing; participants were most likely to enforce 
restriction in earlier disease.  A comparative study evaluating whether weight-bearing 
status has any influence on disease progression and/or joint collapse would provide 
useful guidance for clinicians. There are numerous other areas where further research 
would be beneficial, particularly in providing further evidence on which treatments to 
use when initial measures fail, as this is where most of the uncertainty remains. 
Despite most research in the systematic review describing various arthroscopic 
interventions with drilling and grafting, the Delphi responses have not reflected the 
described techniques, with interventions being uncommonly selected. Further work is 
needed to determine whether such treatments have any role in management of SONK.  
Conclusion and recommendations  
Despite the limitations and smaller than anticipated numbers, this Delphi study has 
involved an international group of surgeons, who, when combined have a significant 
case load and years of experience in treating SONK. It has provided new evidence, 
which, following dissemination, may help to influence decision making for patients with 
different stages of disease and either support or change current practice, depending on 
clinicians’ usual treatment methods. The recommendations from the results of this 
Delphi study are as follows:  
1. A period of rest, analgesia with or without a period of restricted weight-bearing 
has an established role in the first-line treatment of early and intermediate 
stage disease in patients with SONK and normal joint architecture.  
2. The use of knee arthroplasty for patients with SONK and joint collapse is an 
appropriate modality following failure of other measures.  
3. The benefits of using bisphosphonate therapy at any disease stage is unclear.  
4. Arthroscopic techniques, including microfracture, debridement and open 
grafting techniques are uncommonly used.  
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5. High tibial osteotomy appears to be reserved for cases of late-disease with 
malalignment.  
This is the first study of its kind and will hopefully provide a basis for further work and 
potentially larger studies to clarify the best practice for stage-specific treatment of 
SONK. The overall combined implications of this study along with the systematic 
review will be discussed further in the following chapter. 
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4. CHAPTER FOUR: THESIS CONCLUSIONS 
 
This chapter will summarise the overall major findings of the systematic review and 
Delphi study, a discussion of the implications for current practice will then follow, along 
with the need and priorities for future research. Finally, the conclusions to the thesis will 
be presented. The objectives of the thesis were divided into specific areas to evaluate 
effectiveness of non-operative measures, joint-preserving surgical treatment and 
review the various treatment modalities according to stage of disease; the findings 
related to these areas are discussed below.  
 
Non-Operative Measures  
The combined results of the systematic review and Delphi study have highlighted that a 
period of non-operative management with analgesia and physiotherapy is an 
appropriate first-line treatment for patients with early and intermediate-stage disease 
and can be trialled for a period of approximately 3 months before deciding whether 
additional intervention is required.  Although only 3 included studies in the systematic 
review specifically evaluated a period of rest, analgesia and physiotherapy with 
improvement in overall clinical outcomes (Aglietti, et al., 1983; Valentí Nín, et al., 1998; 
Yates, et al., 2007), several additional studies have also implied that their entire 
population were treated with such measures, and it is only those who continued to 
have symptoms proceeded to alternative treatments (Akgun, et al., 2005; Duany, et al., 
2010; (Forst, et al., 1998) Miller, et al., 1986; Takeuchi, et al., 2009). Whether to restrict 
weight-bearing during this time remains debated, as does the most appropriate 
second-line treatment for patients with persisting significant symptoms. The limited 
amount of published research regarding non-operative treatment does not seem to 
reflect specialists’ willingness to trial a period of conservative treatment, with this being 
a popular choice throughout the spectrum of disease, but further research evaluating 
outcomes following these non-operative measures, and an assessment of whether 
weight-bearing status adversely effects outcomes would aid in clarifying the most 
appropriate treatment protocol for these patients.  
Whether bisphosphonate therapy has a role for any disease stage in SONK is unclear. 
Although the small included case series demonstrated improvements in clinical and 
radiological outcomes (Breer, et al., 2013;  Jureus, et al., 2012; Kraenzlin, et al., 2010), 
these were non-comparative . A recent systematic review specifically assessing the 
role of bisphosphonates in SONK has come to similar conclusions; more research is 
needed to ascertain whether they should have a continued role in management 
(Jordan, et al., 2016). This limited evidence has been reflected in the responses to the 
delphi study; bisphosphonate therapy was rarely selected by participants as a 
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treatment modality for early and intermediate-stage disease. This may either reflect the 
perceived lack of ineffectiveness or the fact that orthopaedic surgeons would only be 
involved in consideration and onward referral for treatment to another specialist, but not 
directly involved in administration and monitoring. This highlights the potential need to 
involve a more multi-disciplinary group of participants in any future consensus studies 
or workshops to guage a true overview of the frequency of bisphosphonate use in 
SONK.  
Joint-Preserving Surgical Measures  
Numerous joint-preserving surgical interventions have been described in the 
systematic review, both arthroscopic and open techniques; a similar range of 
modalities were identified as potential treatments in the Delphi study during collection 
of demographic information. They range from simple arthroscopic debridement to 
various drilling and grafting techniques and more invasive realignment surgery in the 
form of high tibial osteotomy. Although this is the area that had by far the most included 
research in terms of study numbers, it is limited to low level evidence only, with variable 
patient numbers, ranging from 6 to 36. This, along with hugely differing techniques and 
the numerous outcome measures used to quantify results makes it difficult to support 
the benefits of one type of joint-preserving surgical intervention over another. This lack 
of clarity is reflected in the Delphi study results; only drilling/microfracture and high 
tibial osteotomy were selected and carried forward to be possible answers in round 2, 
but even then they were rarely chosen by participants as preferred treatment options. 
Some joint-preserving surgical methods not described in the included research were 
also identified as preferred treatment modalities for patients in the initial rounds of the 
Delphi study; fine wire retrograde drilling was a technique identified by one participant 
as a preferred second-line treatment for early and intermediate disease. Another 
participant stated that they would consider BioPoly® resurfacing for small lesions, this 
is a resurfacing device made of up ultra-high molecular weight polyethylene and 
hyaluronic acid and has limited evidence to describe its use for various cartilage 
defects in the knee (Jeuken, et al., 2016; Nathwani, et al., 2017). Neither additional 
technique identified in the Delphi study has published evidence specific to treatment of 
SONK.  Overall, this category of joint-preserving surgical treatments is vast, with 
numerous existing and emerging techniques. The roles of such treatment remain 
unclear from both the systematic review and Delphi study; this reflects the need for 
further up-to-date research to clarify which of the treatments are effective, and at what 
stage of disease is their use most beneficial.  
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Implications for Clinical Practice 
The results of both the systematic review and Delphi study have established that a 
period of non-operative management with analgesia, physiotherapy with or without 
weight-bearing restriction for up to 3 months is an acceptable first-line treatment, often 
regardless of the stage of disease. A quarter of included studies employed this 
management for patients prior to proceeding with any surgery (Akgun, et al., 2005; 
Duany, et al., 2010; Forst, et al., 1998; Miller, et al., 1986; Takeuchi, et al., 2009). 
Consensus was reached that this was the preferred treatment option for patients with 
early and intermediate SONK, but some participants still selected this as a first-line 
treatment for all disease stages. This information can be used to guide future decision 
making for clinicians, and highlights that surgical intervention is not always necessary 
as a first-line measure.  
Although knee arthroplasty for SONK was beyond the scope of the systematic review, 
it has been established that this is often the preferred intervention for patients with late-
stage disease and associated joint collapse (Radke, et al., 2005). The Delphi study has 
confirmed that this remains the case and is often the treatment of choice for patients 
with advanced disease, but more specifically in such patients where other treatment 
has failed, with 78.6% of participants selecting this as their preferred option, confirming 
the general opinion in the literature (Karim, et al., 2015; Mont, et al., 2000).  
 
Implications for future research  
The findings of both the systematic review and Delphi study suggest that further 
research would be worthwhile, to reduce the level of uncertainty still present and work 
towards eliminating the knowledge gap regarding stage-specific treatment for SONK. A 
significant proportion of the included studies in the systematic review are over ten 
years old; this further highlights the need for more up to date, good quality research to 
reflect advances in techniques and current trends of practice.  
Although this thesis has determined that a 3-month period of analgesia and 
physiotherapy is often used as a first-line treatment, it has failed to clearly define during 
which stages of disease it is most appropriate to restrict weight-bearing. At the very 
least, a comparative study evaluating whether full weight-bearing versus partial or non-
weight bearing has any influence on disease progression would provide useful 
guidance for clinicians.  There are numerous other areas where further research would 
be beneficial, particularly in evaluating in more detail the efficacy of bisphosphonates, 
the various arthroscopic techniques, grafting and high tibial osteotomy. Despite 
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randomised controlled trials often being the gold-standard to determine true efficacy of 
treatments, they are not always feasible for less common conditions (Gagne, et al., 
2014; Kesselheim, et al., 2011). For all treatments, well designed comparative studies 
may provide further information regarding effectiveness, especially with more of a focus 
on outcomes related to disease stage. It is however, difficult to fully appreciate whether 
such studies would be possible given the infrequent presentation of SONK and would 
likely need to be at the very least multi-centre trials over a significant time period, either 
on a national or international basis.  
There is also a need to standardise outcome reporting, as the wide variety of measures 
used, which are often based on country of practice makes it difficult to compare clinical 
results. At present, most outcome measures used were developed for knee 
osteoarthritis and it is unclear if any have been validated specifically to assess SONK, 
this is an area which would also warrant further work to improve overall interpretation of 
results.  
The uncommon nature of SONK also makes working towards further consensus 
studies difficult; most knee surgeons will see very few cases of SONK throughout their 
career, so finding alternative approaches to identify experts with more experience than 
the average orthopaedic knee surgeon, other than using the methods employed in this 
Delphi study would prove challenging.   
Conclusion  
The results of the systematic review and Delphi study have provided a foundation of 
evidence regarding the effectiveness of joint-preserving treatments for SONK but have 
also identified large gaps in current research and the need for larger, well-designed 
and up-to-date studies to be able to work towards developing treatment guidelines for 
different stages of disease. At present, although this study has concluded that certain 
treatments are commonly used and effective, there is insufficient evidence to 
definitively state which treatment to use during each stage of disease.  
At the time of writing, this thesis is the first to describe the outcomes of both surgical 
and non-surgical joint-preserving treatment modalities for the management of SONK 
and is the first of any type of consensus study evaluating current practice and 
treatment according to disease stage. The results of the systematic review and Delphi 
study together are not fully conclusive; however, they do suggest that a period of non-
operative measures with analgesia and physiotherapy are often appropriate and
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effective for patients with early and intermediate-stage disease, with knee arthroplasty 
being warranted for patients with late-stage disease and joint collapse. The efficacy of 
other joint-preserving treatments remains debated, with only limited evidence to 
support their use. Further research is therefore needed before being able to state 
whether treatments such as bisphosphonate therapy, various arthroscopic techniques 
with lesion drilling and grafting or high tibial osteotomy should have a continued role in 
the routine management of patients.  
Spontaneous osteonecrosis of the knee is a relatively uncommon disease, and this is 
likely to be one of the major limiting factors in the currently available research and 
reasons behind the small studies and lack of established treatment guidelines, with 
high-level evidence almost non-existent. Future research in this area would 
undoubtedly be beneficial; clinical trials and larger consensus studies would be 
justifiable and worthwhile. This thesis has contributed new knowledge to the treatment 
of SONK, but more work is needed prior to being able to formulate formal guidelines for 
treatment according stage of disease.  
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Appendix 1: Results of AMED and Cochrane search 
 
AMED Search  
Search ID Search Terms  Number of Results  
3 1 AND 2 18  
2 TX osteonecrosis OR TX avascular necrosis OR 
TX bone necrosis OR TX aseptic necrosis 
295 
1 TX knee OR TX knee joint  9929 
Cochrane Search  
3 1 and 2  26 
2 Osteonecrosis  6 
1 Knee 136 
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Appendix 2: Systematic Review Data Collection Form  
 
Paper Details  
Title   
Study ID  
(surname, year) 
 
Name of review author  
Date Completed  
Notes (eg references to check)   
Database identified  MEDLINE (OVID); MEDLINE-in-Process (OVID); EMBASE (OVID); 
AMED (OVID); Cochrane (including CENTRAL, DARE and HTA) 
Translated to English  Yes/No 
Duplicate publication Yes/No 
 
Methodology  
Aim of study?  
 
Study design  
Level of evidence 
 
 
Recruitment method for 
participants  
 
 
Inclusion criteria  
 
Exclusion  
 
Informed consent Yes/No/Unclear 
Ethical approval? Yes/No/Unclear 
Funding Yes/No 
If yes, source/amount: 
Statistical methods 
Appropriateness 
 
 
Power Calculation? 
 
Yes/No 
 
Setting (eg specialist centre) 
 
 
 
Participants  
Number eligible and included  
 
 
Number excluded 
 
 
Number refused to take part 
 
 
Number randomised to intervention  
(if applicable) 
 
Number randomised to control  
(if applicable) 
 
Excluded post-randomisation 
(if applicable)  
 
Number withdrawn  
 
Number lost to follow-up  
 
Included in analysis  
(Included for each outcome if 
relevant) 
 
Age:    Mean- 
 
            Range- 
 
Gender distribution 
 
 
Ethnicity (if included) 
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Spontaneous or secondary ON 
(if secondary- cause eg steroids) 
 
Stage of disease  
--& method of staging (eg MR/XR) 
 
 
Time from diagnosis to treatment 
 
 
 
Patient co-morbidities  
 
 
 
 
Intervention  
Details of intervention(s) 
 
 
 
 
Details of control (if applicable) 
 
 
 
 
Co-interventions (if relevant) 
 
 
 
Delivery of intervention 
Timing 
Frequency 
Duration  
 
Providers (consultant/level of 
experience) 
 
Integrity of intervention  
(delivered as intended/any 
assessment in article?) 
 
 
Outcomes  
Primary outcome measure 
 
 
Secondary outcome measures (if 
included) 
 
Methods of assessing outcomes  
(clinical/radiological and scoring 
system used) 
 
Validity/reliability of outcome 
measures 
 
Methods of f/u for non-respondents 
(if any) 
 
Timing of f/u:  
Frequency  
Length of overall f/u 
 
Adverse events & frequency   
 
 
Additional treatment needed/given? 
 
 
 
 
Results  
Outcome Timing of 
outcome 
assessment  
Intervention group Control group (if 
applicable)  
Observed (n) Total (N) Observed (n) Total (N) 
4 
 
 
 
     
 
Notes on results/outcomes (and details if descriptive terms used only): 
 
Quality Assessment: 
MINORS  
 Score (0=not reported, 1=reported 
inadequately, 2=reported adequately) 
Clearly stated aim?  
Inclusion of consecutive patients?  
Prospective data collection?  
Endpoints appropriate to study aim?  
Unbiased assessment of the study endpoint?  
F/u period appropriate?  
Loss to f/u >5%  
Prospective calculation of study size?  
For comparative studies:  
An adequate control group?  
Contemporary groups?   
Baseline equivalence of groups   
Adequate statistical analysis   
TOTAL SCORE=   
Global ideal score=16 for non-comparative and 24 for comparative studies 
 
 
Cochrane risk of bias (for RCTs)  
Domain Review authors’ 
judgement 
Support for judgement 
Random sequence generation* 
 
High risk 
Unclear 
Low risk 
 
Describe the method used to generate the allocation 
sequence in sufficient detail to allow an assessment 
of whether it should produce comparable groups. 
Quasi-RCTs and Controlled Before and After (CBA) 
studies must be rated as ‘High Risk’ for random sequence 
generation as the methods were not, by definition, truly 
random.  
  
Allocation concealment 
 
High risk  
Unclear 
Low risk 
 
Describe the method used to conceal the allocation 
sequence in sufficient detail to determine whether 
intervention allocations could have been foreseen in 
advance of, or during, enrolment. 
CBA Studies should be rated ‘High Risk.  Quasi-RCTs 
are likely to be rated ‘High Risk but there may be some 
exceptions.   
 
Blinding of participants and 
personnel 
Assessments should be made for each 
main outcome (or class of outcomes). 
High risk  
Unclear 
Low risk  
Describe all measures used, if any, to blind study 
participants and personnel from knowledge of which 
intervention a participant received. Provide any 
information relating to whether the intended blinding 
was effective.  
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Blinding of outcome assessment  
Assessments should be made for each 
main outcome (or class of outcomes). 
High risk  
Unclear 
Low risk 
Describe all measures used, if any, to blind outcome 
assessors from knowledge of which intervention a 
participant received. Provide any information relating 
to whether the intended blinding was effective. If the 
outcome is objective (eg. length of hospital stay) the 
rating should be ‘Low risk.   
 
 
 
 
 
Incomplete outcome data  
Assessments should be made for each 
main outcome (or class of outcomes).  
 
High risk  
Unclear 
Low risk  
Describe the completeness of outcome data for each 
main outcome, including attrition and exclusions 
from the analysis. State whether attrition and 
exclusions were reported, the numbers in each 
intervention group (compared with total randomized 
participants), reasons for attrition/exclusions where 
reported, and any re-inclusions in analyses 
performed by the review authors. 
 
 
 
 
Selective reporting 
High risk  
Unclear 
Low risk  
State how the possibility of selective outcome 
reporting was examined by the review authors, and 
what was found. 
 
 
 
Other sources of bias  
 
Note: all answers 
should follow the 
format: 
High risk 
Unclear  
Low risk 
 
 
 
State any important concerns about bias not 
addressed in the other domains in the tool.  
If particular questions/entries were pre-specified in 
the review’s protocol, responses should be provided 
for each question/entry. 
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Appendix 3: List of Excluded Studies  
 
1st Author Year Title  Reason for Exclusion  
Beckmann  2012 
Intravenously applied prostacycline and bisphosphonates in osteonecrosis and 
bone-marrow oedema Full text not in English  
Carpintero-Benitez  1998 Osteonecrosis of the tibial plateau  No clinical or radiological outcome measures 
Convery  1991 Fresh osteochondral allografting of the femoral condyle Steroid associated cases only  
Feldkamp 1986 Arthroscopy of the spontaneous osteonecrosis of the knee joint. Full text not in English 
Flynn 1994 Osteoarticular Allografts to Treat distal femoral osteonecrosis  Mostly secondary ON (one patient with SONK) 
Fukui 2002 Iliac bone graft for steroid-associated osteonecrosis of the femoral condyle  Steroid associated cases only 
Gortz 2010 
Fresh Osteochondral Allografting for Steroid-Associated Osteonecrosis of the 
Femoral Condyles  Steroid associated cases only  
Gross 1983 
Reconstruction of skeletal deficits at the knee: a comprehensive Osteochondral 
Transplant programme  
No differentiation between SONK/secondary ON in 
results  
Hsu  1989 The Study of Maquet Dome High Tibial Osteotomy No differentiation between OA & SONK in results 
Jacobs  1989 Core decompression of the distal femur for avascular necrosis of the knee No differentiation between spontaneous/secondary ON  
Jureus 2013 The natural course of Spontaneous Osteonecrosis of the Knee Mostly arthroplasty (2 cases HTO) 
Karataglis 2006 
Autologous osteochondral transplantation for the treatment of chondral defects of 
the knee Only 2 cases SONK 
Koshino 2004 
Fifteen to twenty-eight years’ follow-up results of high tibial valgus osteotomy for 
osteoarthritic knee  No differentiation between OA & SONK in results 
Lotke 1982 The treatment of osteonecrosis of the medial femoral condyle  No clinical or radiological outcome measures   
Marulanda  2006 Percutaneous drilling for the treatment of secondary osteonecrosis of the knee  Secondary osteonecrosis only  
Maynou 1998 
Long-term results of autogenic osteochondral grafts in large articular defects of the 
knee Full text not in English  
Meier 
2014 Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomised, 
double blind, placebo controlled trial No separation of patient populations 
Meyers 1989 Resurfacing of the knee with fresh osteochondral allograft  Steroid associated cases only  
Mont  2000 Atraumatic osteonecrosis of the knee Secondary osteonecrosis only 
Mont  1997 Core decompression for avascular necrosis of the distal femur Steroid associated cases only 
Motohashi  1989 
Clinical course and roentographic changes of osteonecrosis in the femoral condyle 
under conservative treatment   
No differentiation between SONK/secondary ON in 
results 
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1st Author Year Title  Reason for Exclusion  
Ripoll 2009 Osteonecrosis of the knee. Iliac crest mesenchymal cell perfusion  Full text not in English  
Saito  2014 Five- to ten-year outcome following medial opening-wedge high tibial osteotomy No differentiation between OA & SONK in results 
Shasha  2002 
Long-term clinical experience with fresh osteochondral allografts for articular knee 
defects in high demand patients  No separation of patient populations  
Soucacos 1997 Idiopathic osteonecrosis of the medial femoral condyle: classification & treatment No clinical or radiological outcome measures  
Valenti  2005 Idiopathic osteonecrosis of the medial tibial plateau  No clinical or radiological outcome measures  
Wang 2002 Treatment of focal articular cartilage lesions of the knee No separation of patient populations  
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Appendix 4: MINORS assessment for relevant included studies  
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Clearly stated aim? 2 2 2 2 2 1 1 1 2 2 2 2 2 2 2 2 2 2 2 
Inclusion of consecutive patients? 0 2 0 0 1 2 0 0 0 2 0 0 2 2 0 0 0 0 2 
Prospective data collection? 2 2 0 0 0 0 0 0 2 2 0 2 2 2 2 0 0 0 0 
Endpoints appropriate to study aim? 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 2 1 1 
Unbiased assessment of the study endpoint? 0 0 0 2 2 0 1 1 0 0 0 1 2 0 0 0 1 0 0 
F/u period appropriate? 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 0 
Loss to f/u >5% 1 2 2 2 2 2 2 2 0 2 2 2 2 1 2 2 2 2 2 
Prospective calculation of study size? 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 
An adequate control group? 0 1 0 
Contemporary groups?  0 2 0 
Baseline equivalence of groups  0 1 0 
Adequate statistical analysis  0 2 2 
TOTAL SCORE=  9 18 10 10 9 9 7 7 8 12 8 11 16 11 10 8 9 7 7 
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Appendix 5: Description of Functional Scoring Tools  
 
Score name, abbreviation 
 
Domains assessed Max 
score  
Score breakdown  Developed for 
specific 
conditions? 
Clinical Scoring Tools  
Activity level of Cincinnati  
(Mandelbaum, et al., 2000) 
Pain, swelling, giving way, overall activity 
level, walking, stairs, running, jumping 
100 <30 poor; 30-54 fair;  
55-79 good; >80 excellent 
Originally for ACL 
injuries 
Euro-Qol (EQ-5D)  
(The EuroQol Group, 1990) 
Mobility, self-care, usual activities, 
pain/discomfort, anxiety/depression & EQ-
VAS 
Each domain scored: 1=no problems, 2=some 
problems, 3=extreme problems, EQ-VAS scored 
from 0-100 
Generic measure 
of health 
Fresh small fragment 
osteochondral allograft score  
(McDermott, et al., 1985) 
Pain, instability, walking aids, walking 
distance, knee range of motion, knee effusion  
100 Higher scores indicate better 
outcomes; 100= normal knee, ≥75= 
successful outcome 
Osteochondral 
allografts 
Hospital for special surgery knee 
score (HSS)/Ranawat knee score 
(Ranawat, et al., 1976) 
Pain, function, range of motion, muscle 
strength, flexion deformity, instability 
100 Excellent 85-100; good 75-84; fair: 
60-69; poor <60 
Developed for 
knee arthroplasty 
Japanese Orthopaedic Association 
score (JOA) (Japanese Orthopedic 
Association, 1988) 
Pain on walking, pain on ascending or 
descending, range of motion, joint effusion 
100 Higher scores indicate better 
outcomes  
Validated for knee 
osteoarthritis  
American Knee Society Score 
(KSS) (Insall, et al., 1989) 
Pain, stability, range of motion; function: 
walking distance, stair climbing  
100 Excellent 85-100; good 75-84; fair: 
60-69; poor <60 
Developed for 
knee osteoarthritis  
Lysholme Score (Lysholm & 
Gillquist, 1982) 
Pain, swelling, limp, squatting, instability, 
support, stair climbing, locking  
100 Higher scores indicate better 
outcomes 
Developed for 
ligamentous 
instability 
Ordoñez (Ordóñez, et al., 1987) 
 
Excellent: close to normal function, no pain & active life; Good: 90⁰ flexion, and mild occasional 
pain; Fair: <90⁰ flexion, mild pain, and limited gait; Poor: constant pain, limping, very limited 
function 
Initial description 
for osteonecrosis 
Summary of common complaints 
(Johnson, et al., 2014) 
Reported status (same/improved/worse); persistent symptoms; activity limitations; walking; 
physical examination  
Not stated 
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Score name, abbreviation 
 
Domains assessed Max 
score  
Score breakdown  Developed for 
specific 
conditions? 
Tegner score (Tegner & Lysholm, 
1985) 
Limp, support, locking, instability, pain, 
swelling, stair-climbing, squatting 
100 Higher scores indicate better 
outcome 
Introduced for 
knee ligament 
injuries 
Visual analogue scale (VAS) 
(Huskisson, 1974) 
Scale ranging from ‘no pain’ to ‘worst pain imaginable’, 
usually a numerical scale from 0-10 or 0-100 
Lower numerical value indicates less 
pain  
Generic pain 
scoring tool  
Radiological Indices and Scoring 
Tools  
Femorotibial angle (FTA)  
(Moreland, et al., 1987) 
The angle formed by the femur & the tibia, 
measured by drawing lines through the centre 
of tibial and femoral shafts 
Normal alignment considered to be between 182-
184 degrees 
N/A 
Whole Organ Magnetic Resonance 
Imaging Score (WORMS)  
(Peterfy, et al., 2004) 
Articular cartilage integrity, subarticular bone 
marrow abnormality/cysts/bone attrition, 
meniscal integrity, cruciate and collateral 
ligament integrity, synovitis/effusion, intra-
articular loose bodies, peri-articular 
cysts/abscesses 
332 Lower scores correlate with 
improved radiological findings  
Developed for 
osteoarthritis  
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Appendix 6: Delphi Invitation Email Templates 
 
Initial Invitation:  
Dear Doctor ________________,  
I am emailing to invite you to participate in an international Delphi study to support research into 
joint-preserving management of spontaneous osteonecrosis of the knee (SONK).  
 
As an established knee expert who has recently published on the topic (or is a member of the 
20/20 knee group) I am keen to gain your views and trends of practice to work towards a 
consensus for managing patients with SONK.  
 
Each round of the survey is anticipated to take 15 minutes to complete and a total of three 
rounds are planned.   
 
At present, there is no well-established evidence base for the treatment of SONK or 
recommendations for treatment depending on disease stage 
Your expertise would be extremely beneficial in understanding current treatment trends and 
working towards the development of higher level evidence for the management of SONK.  
 
Please find attached a participant information leaflet containing further information. 
The first round of the survey will be distributed in the next 2 weeks via email and I would be 
grateful if you would consider participating.  
Please find attached a participant information leaflet containing further information.  
 
Yours Sincerely,  
  
Maire-Clare Killen 
Research Student, University of Central Lancashire 
Orthopaedic Registrar, Northern Deanery, UK  
 
Round 1 Invitation:  
Further to my initial email, I am attaching the link for the first round of the Delphi study to 
support research into joint-preserving management of Spontaneous Osteonecrosis of the Knee. 
 
This first round will remain open for two weeks; your timely response would be appreciated. 
 
Here is a link to the survey: 
 
http://www.smartsurvey.co.uk/s/T3LXJ/ 
  
 
Thank you in advance for your participation.  
 
Yours Sincerely,  
 
Maire-Clare Killen  
 
Research Student, University of Central Lancashire 
Orthopaedic Registrar, Northern Deanery, UK 
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Round 2 email:  
I am emailing with regard to the second round of a Delphi study aiming to reach consensus in 
the management of spontaneous osteonecrosis of the knee. In the first round, we presented 
several clinical scenarios and asked participants to state their preferred treatment from a variety 
of options. 
  
Following analysis of the responses from the first round, we are now presenting the clinical 
scenarios again, alongside the most commonly chosen treatment strategies obtained from 
round 1. We aim to work towards reaching a further treatment consensus using the limited 
treatment options presented. 
  
We are asking you to participate in this second round by following the link below, regardless of 
whether or not you took part in the first round. 
  
http://www.smartsurvey.co.uk/s/1K7BL/ 
  
This link will remain open for 2 weeks and a reminder will be sent at the one week stage.  
Thank you in advance for your continued participation. 
  
Yours Sincerely,  
 
Maire-Clare Killen  
 
Research Student, University of Central Lancashire 
Orthopaedic Registrar, Northern Deanery, UK 
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Appendix 7: Participant Information Leaflet  
Spontaneous Osteonecrosis of the Knee 
We would like to invite you to take part in a Delphi consensus study investigating 
treatment of spontaneous osteonecrosis of the knee.   
This is being undertaken as part of an MSc in research alongside a systematic review of the 
condition at the University of Central Lancashire.  
Before you decide whether or not you would like to take part, please take time to read this 
information sheet, detailing why this research is being done and what it will involve. 
What is the purpose of the study? 
At present, there is no well-established evidence base for the treatment of Spontaneous 
Osteonecrosis of the Knee (SONK) or recommendations for treatment depending on disease 
stage. The multitude of treatments available can make it difficult to decide which treatment 
options to use and when.  
There is a clear indication for non-operative management in patients with mild symptoms who 
are in the early stage of osteonecrosis. In addition, there is some consensus in the literature on 
the indications and outcomes for patients with severe SONK requiring total knee arthroplasty. 
However, the difficulty lies with the group of patients with osteonecrosis without features of 
arthritis.  
Overall, the Delphi study will hopefully provide information on whether there is consensus on 
primary, secondary, and, where necessary, tertiary treatment for patients with intermediate-
stage SONK.  
This will hopefully allow for clinicians, who often only see a few cases of SONK per year to 
make a more informed, evidence-based decision on which treatment is best for their patient.  
Why have I been invited to take part? 
As an established knee expert, who has recently published on the topic we are keen to gain 
your views and trends of practice to work towards a consensus of opinion for managing patients 
with SONK.  
What will I be asked to do if I take part? 
We are inviting you to participate as a Delphi panel member. This would involve completing a 
brief online questionnaire, regarding your current area of practice and the approximate number 
of cases of SONK you see and treat each year.  
Following this, you will be asked to complete a short questionnaire regarding your most likely 
course of treatment for several patient scenarios.  
Following your response to each round, you will receive feedback regarding the groups’ 
response prior to the beginning of the next round.  
Each round of the survey is anticipated to take 15 minutes to complete and a total of three 
rounds are planned.   
In order to allow timely conclusion of the study we would respectfully request a response time of 
2 weeks for completion of each round.  
Reminder emails will be sent (via the survey website) to participants at weekly intervals.  
 
You have the right to withdraw from the study at any time. However, we will be unable to 
withdraw data already submitted by you as this will have been anonymised.  
Withdrawal will be assumed on non-response to the survey.  If you would prefer to stop 
receiving any further emails, please email MKillen1@uclan.ac.uk.  
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Who is organising the research? 
The Delphi study will be conducted by Maire-Clare Killen, as part of a research MSc under the 
supervision of the College of Clinical and Biomedical Sciences at the University of Central 
Lancashire.  
Confidentiality 
Your contact details will be held in a password-protected file on the UCLAN server and 
destroyed immediately following completion of the study; all submitted data will be anonymised 
upon receipt prior to analysis. 
All responses received in the study will remain confidential, and your identity will not be 
divulged. Direct quotes to free-text answers may be used as part of the study report, but these 
will be anonymised so as not be traceable back to you. 
Data protection 
Survey responses will be collected online using a survey company, utilising an encrypted 
internet server, based in the United Kingdom.  
Anonymised data will be downloaded to a password protected folder on the UCLAN server to 
allow analysis; data will be stored for the duration of the research project and for a maximum of 
12 months following completion to allow write-up and publication then deleted.  
Research ethics 
The proposed Delphi study abides by the ethical requirements of the University of Central 
Lancashire and has been approved by the STEMH Ethics Committee at the University of 
Central Lancashire. Consent to take part will be assumed on completion and submission of the 
on-line questionnaires. 
What will the data be used for?  
Primarily, the data will be used in combination with the results of a systematic review and 
presented as part of an MSc thesis. Following this, the aim is to disseminate the results in either 
a conference presentation or a peer-reviewed journal.  
What if I have any complaints?  
If you have any complaints, concerns or issues about this study, please contact the University 
Officer for Ethics at OfficerForEthics@uclan.ac.uk. To help identify the study please include the 
study name or description and the researcher. Please also include information about the 
substance of the complaint.  
What do I do now? 
Thank you for reading this information sheet and for considering taking part in this research. 
Your expertise would be extremely beneficial in understanding current treatment trends and 
working towards the development of higher level evidence for the management of SONK.  
 
The first round of the survey will be distributed in the next 2 weeks via email and I would be 
grateful if you would consider participating. 
If you do not wish to be included from the onset, please inform me by email: 
MKillen1@uclan.ac.uk  
 
If you have any further questions or concerns, please do not hesitate to contact me on the email 
address below. 
Maire-Clare Killen  
MKillen1@uclan.ac.uk  
Research Student, University of Central Lancashire  
Orthopaedic Registrar, Northern Deanery, UK  
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Appendix 8: Round 1 Questionnaire as presented to participants 
 
1. Where is your country of practice? * 
 
2. Approximately how many years have you been practicing as a knee specialist? * 
 
3. On average, how many cases of Spontaneous Osteonecrosis of the Knee do you treat per 
year? * 
 
4. Please indicate which of the following treatments for Spontaneous Osteonecrosis of the Knee 
you have personally performed (select as appropriate): * 
Arthroscopic debridement, 
Arthroscopic drilling/microfracture: transchondral 
Arthroscopic drilling/microfracture: extra-articular 
Osteochondral transplantation: allograft 
Osteochondral transplantation: autograft 
High tibial osteotomy (to offload the affected compartment) 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
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5. Scenario 1a. 
A 60 year old, active patient, with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee are normal, but MRI changes are in 
keeping with isolated spontaneous osteonecrosis of the weight bearing portion of the medial 
femoral condyle (no other degenerative changes or pathology). 
 
What would be your first line treatment (preferably state one, but if you use a combination of 
treatments please tick more than one)? * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above. 
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6. Scenario 1b. 
A 60 year old, active patient, with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee are normal, but MRI changes are in 
keeping with isolated spontaneous osteonecrosis of the weight bearing portion of the medial 
femoral condyle (no other degenerative changes or pathology). 
 
Following failure of your first line treatment, with ongoing pain but no radiological progression, 
what would be your usual second line management? (Preferably state one, but if you use a 
combination of treatments please tick more than one)? * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above. 
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7. Scenario 2a. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion in the weight-
bearing portion of the medial femoral condyle. MRI scan demonstrates a lesion with 
appearances consistent of spontaneous osteonecrosis, isolated to the medial femoral condyle 
(no other degenerative changes or pathology). 
 
What would be your first line treatment (Preferably state one, but if you use a combination of 
treatments please tick more than one)? * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above. 
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8. Scenario 2b. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion in the weight-
bearing portion of the medial femoral condyle. MRI scan demonstrates a lesion with 
appearances consistent of spontaneous osteonecrosis, isolated to the medial femoral condyle 
(no other degenerative changes or pathology). 
 
Following failure of your first line treatment, with ongoing pain but no radiological progression, 
what would be your usual second line management? (Preferably state one, but if you use a 
combination of treatments please tick more than one)? * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above. 
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9. Scenario 3a. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion with associated 
collapse of the weight-bearing portion of the medial femoral condyle. MRI confirms appearances 
in keeping with spontaneous osteonecrosis, isolated to the medial femoral condyle (no other 
degenerative changes or pathology) with associated collapse of the weight bearing portion. 
 
What would be your first line treatment (Preferably state one, but if you use a combination of 
treatments please tick more than one)? 
  * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above. 
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10. Scenario 3b. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion with associated 
collapse of the weight-bearing portion of the medial femoral condyle. MRI confirms appearances 
in keeping with SONK, isolated to the medial femoral condyle (no other degenerative changes 
or pathology) with associated collapse of the weight bearing portion. 
 
Following failure of your first line treatment, with ongoing pain but no radiological progression, 
what would be your usual second line management? (Preferably state one, but if you use a 
combination of treatments please tick more than one)? * 
A period of rest, analgesia and full-weight bearing (please state duration of this in comment 
box below) 
A period of rest, analgesia and partial-weight bearing (please state duration of this in 
comment box below) 
A period of rest, analgesia and non-weight bearing (please state duration of this in 
comment box below) 
Arthroscopy with debridement of the lesion 
Arthroscopy with transchondral drilling/microfracture of the lesion 
Arthroscopy with extra-articular drilling/microfracture of the lesion 
Arthroscopy with grafting of the affected area (osteochondral autograft) 
Arthroscopy with grafting of the affected area (osteochondral allograft) 
High tibial osteotomy 
Bisphosphonate treatment 
Metal button resurfacing of lesion 
Uni-compartmental knee replacement 
Total knee replacement 
Other (please specify): 
 
Comments: Please state duration of period of observation if selected above 
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Appendix 9: Round 2 Questionnaire as presented to participants  
 
1. Where is your country of practice? * 
UK 
USA 
Germany 
Spain 
Luxembourg 
Other (please specify): 
 
2. Approximately how many years have you been practicing as a knee specialist? * 
1-5 
5-10 
10-20 
20-30 
30-40 
>50 
3. On average, how many cases of Spontaneous Osteonecrosis of the Knee do you treat per 
year? * 
1-5 
5-10 
10-20 
20-30 
30-40 
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>40 
 
Scenario 1a. 
A 60 year old, active patient, with no other medical problems presents with significant knee pain 
despite regular analgesia. 
Plain radiographs of the knee are normal, but MRI changes are in keeping with isolated 
spontaneous osteonecrosis of the weight bearing portion of the medial femoral condyle (no 
other degenerative changes or pathology). 
 
What would be your most likely first line treatment using the options listed below? * 
A period of rest, analgesia and full weight bearing/weight bearing as tolerated 
A period of rest, analgesia and partial weight bearing 
A period of rest, analgesia and non-weight bearing 
Bisphosphonate treatment ± correction of calcium haemostasis 
None of the above 
 
5. If you have selected a period of rest and observation for your preferred choice, what would be 
your recommended treatment duration? * 
Up to 6 weeks 
Up to 3 months 
> 3 months 
N/A (other treatment modality chosen) 
 
6. If you have selected a period of rest and observation for your preferred choice, would you 
routinely use adjuvant offloading knee bracing during this time? * 
Yes 
No 
Not applicable 
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7. Scenario 1b. 
A 60 year old, active patient, with no other medical problems presents with significant knee pain 
despite regular analgesia. 
Plain radiographs of the knee are normal, but MRI changes are in keeping with isolated 
spontaneous osteonecrosis, limited to the weight bearing portion of the medial femoral condyle. 
There are no other degenerative changes or pathology, and normal joint alignment. 
 
Following failure of your first line treatment, defined by ongoing significant pain but no 
radiological progression, what would be your most likely second line management from the 
options below? * 
A period of rest, analgesia and full-weight bearing/weight bearing as tolerated 
A period of rest, analgesia and partial or non-weight bearing 
Arthroscopy with drilling/microfracture of the lesion 
Bisphosphonate treatment ± correction of calcium haemostasis 
Knee arthroplasty (either uni-compartmental or total knee replacement) 
None of the above 
 
8. Scenario 2a. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion in the weight-
bearing portion of the medial femoral condyle. 
MRI scan demonstrates a lesion with appearances consistent of spontaneous osteonecrosis, 
isolated to the medial femoral condyle (no other degenerative changes or pathology, and 
normal joint alignment). 
 
What would be your most likely first line treatment using the options listed below? 
  * 
A period of rest, analgesia and full weight bearing/weight bearing as tolerated 
A period of rest, analgesia and partial or non-weight bearing 
Arthroscopy with drilling/microfracture 
Bisphosphonate treatment ± correction of calcium haemostasis 
Knee arthroplasty (uni-compartmental or total knee replacement) 
None of the above 
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9. If you have selected a period of rest and observation for your preferred management, what 
would be your recommended treatment duration? * 
Up to 6 weeks 
Up to 3 months 
>3 months 
N/A (other treatment modality chosen) 
 
10. Scenario 2b. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. Plain radiographs of the knee show a sclerotic lesion in the weight-
bearing portion of the medial femoral condyle. 
MRI scan demonstrates a lesion with appearances consistent of spontaneous osteonecrosis, 
isolated to the medial femoral condyle (no other degenerative changes or pathology and normal 
joint alignment). 
 
Following failure of your first line treatment, defined by  ongoing pain but no radiological 
progression, what would be your most likely second line management using the options listed 
below? * 
A period of rest, analgesia and partial or non-weight bearing 
Arthroscopy with drilling/microfracture 
Grafting of the lesion 
High tibial osteotomy 
Knee arthroplasty (either uni-compartmental or total knee replacement) 
None of the above 
 
11. Scenario 3a. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. 
Plain radiographs of the knee show a sclerotic lesion with associated collapse of the weight-
bearing portion of the medial femoral condyle and varus malalignment of the knee. 
MRI confirms appearances in keeping with spontaneous osteonecrosis, isolated to the medial 
femoral condyle (no other degenerative changes or pathology). 
 
What would be your most likely first line treatment using the options listed below? * 
A period of rest, analgesia and partial weight bearing 
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A period of rest, analgesia and non-weight bearing 
Arthroscopy with drilling/microfracture 
High tibial osteotomy 
Knee arthroplasty (uni-compartmental or total knee replacement) 
None of the above 
12. Scenario 3b. 
A 60 year old, active patient with no other medical problems presents with significant knee pain 
despite regular analgesia. 
Plain radiographs of the knee show a sclerotic lesion with associated collapse of the weight-
bearing portion of the medial femoral condyle and varus malalignment of the knee. 
MRI confirms appearances in keeping with spontaneous osteonecrosis, isolated to the medial 
femoral condyle (no other degenerative changes or pathology). 
 
Following failure of your first line treatment, defined by ongoing pain but no radiological 
progression, what would be your most likely second line management using the options listed 
below? * 
Arthroscopy with drilling/microfracture 
Grafting of the lesion 
High tibial osteotomy 
Knee arthroplasty (uni-compartmental or total knee replacement) 
N/A (selected arthroplasty in scenario 3a) 
 
13. Thank you for your participation in round 2 of this Delphi Study. We will be in touch soon 
with the results. Please leave any additional comments below. 
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suitable 
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